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Chapter 1 
Introduction 
Genomic Stability: 
 Maintenance of genomic stability is an essential feature in preventing development of cancer. 
Prevention of DNA damage accumulation is also very vital in delaying the aging phenotype. When 
damages occur in the genome through replicative processes and /or through transcription associated 
mutagenesis, this damage becomes permanent, in the form of mutations which could potentially lead to 
chromosomal breakage and genomic instability. This increased genomic instability negatively alters both 
the carcinogenic and aging processes. There are many types of DNA repair mechanisms that have evolved 
to help maintain genomic integrity. Different types of damages encountered by DNA are repaired via 
specialized repair mechanism evolved to repair that specific damage. Most of the repair pathways and the 
enzymes functioning in these pathways are stress inducible genes and can be upregulated during stress.  
DNA damages and mechanism of DNA repair: 
           Genomic integrity depends on the speed and fidelity with which the damages to DNA are repaired. 
As mentioned above, there are specific repair pathways for the different types of damages encountered by 
the DNA. The different kinds of damages to DNA and the types of repair mechanisms are briefly 
discussed below (1,2).  The various insults the genomic DNA are exposed to can be classified as 
endogenous and exogenous damages. The endogenous damages include mainly replication errors, 
alkylating damages, Oxidative and hydrolytic damages arising from the surrounding water and cellular 
metabolism. Some of the hydrolytic damages encountered by the DNA are,  
               (i) Depurination/Depyrimidination of the nucleotides 
               (ii) Deamination of nitrogenous bases (e.g. Cytosine Deamination to Uracil). 
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The oxidative damages to the DNA include,   
             (i) Ring-saturated pyrimidines like thymine glycols and cytosine hydrates        
            (ii)Ring-opened purines forming FaPy products (formamidopyrimidine),  
          (iii)8-oxoguanine,        
          (iv)Damages arising from lipid peroxidation products like M1G and etheno adduct 
The various exogenous insults to the DNA are introduced by Physical and Chemical agents. Some of 
them are, 
                             (1) Physical agents like ionizing radiations (e.g. oxidative damages), Ultraviolet rays       
(e.g. Cyclobutane dimers and DNA double strand breaks) and Heat 
                              (2) Chemical agents: (i) direct acting – Alkylating agents, (ii) Indirect acting requiring 
activation like Benzopyrene. 
 Despite the large exposure of the DNA to these damages, only a few accumulate as stable heritable 
mutations. This lower frequency for mutations shows the existence of Extensive repair mechanisms which 
very efficiently removes the damages to the DNA. Different caretaker/repair pathway has evolved to deal 
with all types of insult suffered by the DNA. The biological response pathway to DNA damage can be 
classified as, 
       (1) Reversal of damage 
       (2) Excision of damage 
       (3) Tolerance of damage 
Reversal of Damage: Simplest repair mechanism requiring no knowledge of genetic information. 
Repairs both single and double stranded DNA. This mechanism involves single enzyme that catalyzes 
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direct reversal of damage. This is a highly specific, error free energetically expensive repair mechanism. 
Few examples are as follows, 
             A) Reversal of cyclobutane pyrimidine dimers and (6-4) photoproduct by photolyases utilizing 
light of a specific wavelength. Hence the reaction called as Photoreactivation. This process is absent in 
eukaryotes. 
           B) Reversal of O
6
alkyl guanine and other related alkylated products (e.g. MGMT) 
           C) Reversal of N
1
 alkyl A and N
3
 alkyl C (ABH2 & ABH3) 
Excision of Damage/ Excision repair: The pathway for most type of damages incurred by the DNA. 
Excision repair deals with double stranded DNA. In this pathway, the damaged/incorrect nucleotides will 
be excised out and replaced with appropriate nucleotides using the genetic information from the 
complementary DNA strand. There are three kinds of excision repair pathway,  
(i) Base Excision repair 
(ii) Nucleotide excision repair and 
 (iii) Mismatch excision repair   
All three excision pathways involve five steps to execute the repair. They are: 1) Damage recognition, 2) 
Incision of the DNA strand on either side of the damage, 3) Excision of the damaged 
nucleotide/oligonucleotide, 4) Replacement synthesis of new DNA, 5) Ligation 
Base excision repair pathway (BER): BER pathway is involved in the repair of endogenous damages 
that arise spontaneously in the living cell. This pathway repairs nucleotides with small base adducts like 
oxidized bases (e.g. 8-oxoG), hydrolytically deaminated bases (e.g. Cytosine to Uracil) and alkylated 
bases (e.g. 3-methyl adenine). BER usually replaces a single damaged nucleotide and sometimes can 
replace up to 6 nucleotides hence classified as short patch and long patch BER. 
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     The initial step in BER involves highly specific DNA glycosylases which recognizes and removes 
altered bases creating an abasic site (AP site). AP site can also arise due to spontaneous hydrolysis of the 
N-glycosidic bonds linking the purine/pyrimidine base to the deoxyribose residue. The second step occurs 
with the help of apurinic/apyrimidinic endonucleases which creates an incision 5’ to the abasic site. The 
resulting sugar phosphate is removed by a deoxyribophosphodiesterase and the gap created is filled with a 
new appropriate nucleotide by DNA polymerase. Many studies with cells/tissues show that DNA 
polymerase  is responsible for the gap filling reaction. After the repair synthesis of the DNA the nick is 
sealed enzymatically by ligase which marks the completion of the repair pathway. 
Mismatch Repair pathway (MMR): This pathway predominantly repairs replication errors and also 
when there is insertion or deletion of nucleotides in DNA. The mismatch repair system is efficient enough 
to discriminate the incorrect base from the correct base in a mispair as both the bases would be a normal 
base of the DNA. Mismatch repair involves five main events in its pathway. They are: i) Recognition of 
the mismatch (e.g. Mut S or Msh), ii) Strand discrimination to identify the incorrect base in the daughter 
strand. Unmethylated daughter strand in prokaryotes and daughter strands with nicks arising during 
replication in eukaryotes act as markers for strand discrimination, iii) Incision on either 5’ or 3’ side of 
the mismatch (Eukaryotic Mlh and prokaryotic Mut L and Mut H help in this process), iv) Unwinding of 
DNA by helicase and Excision of the damage by Exonuclease (e.g. Exo1) and v) Resynthesis of the DNA 
by Polymerase (e.g. pol δ) and Ligation by Ligase leading to completion of repair. 
Nucleotide Excision repair (NER): NER repairs large and bulky helix distorting adducts to DNA like 
the ones created by carcinogens (e.g. Benzopyrene, Cis-platin), UV (e.g. cyclobutane pyrimidines dimers) 
and some oxidative adducts. The enzymes involved in BER and MMR have strict substrate specificity 
whereas the enzymes in NER have a very broad specificity accommodating a large number of substrates. 
NER also involves five distinct steps ,they being : i) Recognition of damage by DNA binding protein 
which also unwinds the DNA , ii) Incision of the damaged DNA strand on either side of the bulky adduct 
by endonucleases. One incision is made at 22
nd
 or 24
th
 phosphodiester bond 5’ to the damage and the 
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second incision made at the 5
th
 phosphodiester bond 3’ to the damage, iii) Excision of a 27-29 oligomer 
containing the damage creating a gap, iv) Repair synthesis to fill the gap by Polymerase (e.g. pol δ and ε) 
and v) DNA ligation by Ligase. Prokaryotic NER requires 3 proteins (UvrABC endonuclease) for 
recognition and incision steps whereas Eukaryotic NER requires 16 proteins. NER in human cells 
requires 25 proteins including seven associated with the genetic disease Xeroderma Pigmentosum (XP). 
Damage Tolerance: Certain biological responses to DNA damage, does not remove the damaging 
lesion and replace it with normal DNA constituents like the repair mechanism. These biological responses 
postpones repair to alleviate the then condition like arrested replication fork. Such mechanisms are called 
as DNA damage tolerance mechanism and they are different from the classic Repair pathways. There are 
three kinds of damage tolerance mechanism, they are: i) Recombinational repair, ii) Replication fork 
regression and iii) Tranlesion DNA synthesis. 
Recombinational repair: Recombinational repair helps in the repair of arrested replication forks 
created by various DNA damages like bulky adducts, single and double strand DNA breaks. This process 
helps in reinitiating DNA synthesis after a replication fork arrest, a little downstream of the arrested fork 
creating a gap. This gap will be filled by strand exchanges between the altered DNA and unaltered newly 
synthesized DNA. The original damage is not removed but will be tolerated to be repaired later. This is an 
error- free mechanism as the damaged strand will not be used as template. 
Replication fork Regression: The arrested replication fork folds back allowing the newly synthesized 
strand to be used as template instead of the damaged DNA strand. This again is a error-free mechanism. 
Tranlesion DNA Synthesis: Specialized polymerases like polymerase η catalyze the replication bypass 
past the DNA damaged sites in the template. These polymerases have poor fidelity making them error-
prone and are associated to mutagenesis. 
             Having understood the mechanism of different DNA repair processes, many laboratories are 
conducting research to understand the integrity of these pathways in a cancer model and also researching 
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on how different environmental factors inclusive of dietary manipulations such as caloric restriction and 
folate deficiency affect these repair pathways. 
Folate deficiency and Genomic instability:  
Folate plays an important role in DNA metabolism (3). Folate and its intermediates forming the folate 
cycle are very important for the maintenance of genomic stability. Folate is involved in one carbon 
transfer mainly in the form of methyl group. As illustrated in the figure, folic acid intermediate 5-
methyltetrahydrofolate helps in the regeneration of methionine from homocysteine. 
Methionine in turn helps in the formation of S-adenosylmethionine (SAM), the primary intracellular 
methyl donor which plays a key role in epigenetic regulation of gene expression. SAM methylates 
cytosine residues in the CpG sites of DNA. This cytosine methylation regulates gene transcription. 
During FD, SAM levels are reduced affecting DNA methylation, altering gene expression potentially 
leading to proto-oncogene expression (4-7). Unmethylated cytosines arising due to low levels of SAM 
can undergo spontaneous deamination to thymine (8). Folate also helps in the formation of thymine from 
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Uracil with 5, 10-methylenetetrahydrofolate acting as a methyl donor to Uracil which is crucial for DNA 
synthesis and repair (9). Oxidized form of 5, 10 methylene tetrahydrofolate, 10-formyltetrahydrofolate is 
required for the denovo synthesis of purines (10,11). When folate is depleted the nucleotide pool is 
affected impacting on DNA stability, synthesis and repair. Reduced synthesis of thymidylate during 
Folate deficiency (FD)  leads to increased Uracil misincorporation into the DNA. Misincorporated Uracil 
in DNA and Uracil arising from deamination of cytosine would lead to U:G mispairing and finally C:G to 
T:A transitions if not repaired before replication (12,13). This misincorporation can cause DNA strand 
breaks (14), deletions, chromosomal breaks, micronucleus formation (15,16) and loss of heterozygosity, 
which can activate proto-oncogenes and inactivate tumor suppressor genes (17-19) all contributing to the 
increased risk of cancer (18,20) 
Folate deficiency and cancer 
 The prevalence of folate deficiency remains in the US population in spite of efforts to eliminate 
folate deficiency through fortification of grain products (21). Folate deficiency is an important public 
concern because of the role folate plays in the development of many different health problems, including 
neural tube defects, cardiovascular disease, Alzheimer’s disease and cancer. A putative role for folate in 
protecting from cancer is suggested by the substantial amount of epidemiologic data suggesting that a diet 
high in fruits and vegetables protects against the development of cancer (22,23). As these foods are rich in 
sources of folate, this suggests a role for dietary folate in this protective effect of fruits and vegetables. 
Other nutrients and phytochemicals present in fruits and vegetables may also exert this protective role.   
 In support of a role for folate is the growing body of data linking folate deficiency to specific 
types of cancer. The strongest such link exists in the connection between folate status and colon cancer. 
Additionally, folate deficiency is related to cancers of the lung, cervix, brain, esophagus, pancreas and 
breast (22,24). Also low folate diets have been found to increase premalignant cervical dysplasia (25) and 
to increase breast cancer risk when combined with excessive alcohol consumption (26). On the other hand 
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when folate intake is increased it has been found to decrease squamous metaplasia of bronchial 
epithelium (27). Additionally a decline in gastric cancers has been found to parallel the decline in neural 
tube defects (28), which is known to occur with folate supplementation. In an animal model of colon 
carcinogenesis, folate deficiency enhances the carcinogenic effect of dimethylhydrazine (29) while excess 
folate significantly reduced the number of macroscopic neoplasms in this same model of 
dimethylhydrazine-induced tumorigenesis (30).In the apcMin mouse, increasing dietary folate 
significantly reduces the number of ileal polyps and aberrant crypt foci (ACF) found at 3 months (31). 
Human cultured colonocytes exposed to a folate deficient medium showed accumulation of strand breaks 
and Uracil misincorporation, in response to oxidative and alkylation damage (61). In addition, folate 
supplementation in patients with recurrent adenomatous polyps of the colon showed a decrease in colonic 
mucosal cell proliferation (32).However, folate has also been found to increase neoplastic transformation 
in preneoplastic cells and a deficiency in folate has been found to be protective in preventing progression 
of tumors (33). Studies have shown that high levels of folate in a procarcinogenic environment promote 
the progression of colon cancer (30,34,35). This paradox may be explained by differences in animal 
models studies, differences in the severity of folate deficiencies instituted, and/or differences in the stage 
of cancer being assessed. In fact folate deficiency in preneoplastic cells may act in much the same way 
that methotrexate act, by causing genetic damage (i.e. Uracil incorporation) in rapidly dividing cells. 
Nonetheless, these last data provide an absolute indication that recommendations about folate 
supplementation and requirements must take into consideration the population under investigation. 
Folate Deficiency and Oxidative stress:  
 Oxidative stress and Reactive oxygen species (ROS) are established factors in the genesis of 
cancer. Free radicals and oxidative stress induced redox imbalance have been implicated in many types of 
cancer (36). Oxidative stress leads to damages to the genome which acts as an initiating point in 
tumorigenesis. Also folate deficiency plays an important role in the pathogenesis of cancer. Uracil 
misincorporation, imbalance in DNA synthesis by alterations in the denovo synthesis of purines and 
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pyrimidines, alterations in the SAM: SAH ratio and modifications of DNA repair pathways are some of 
the consequences of folate deficiency implicated in development of cancer. Apart from these effects, 
folate deficiency can potentially lead to carcinogenesis by creating oxidative stress. Folate deficiency 
leads to increase in homocysteine levels, which is a pro-oxidant and has been implicated in neurological 
disorders, cardiovascular diseases and carcinomas (37-40). Increased homocysteine levels leads to 
increased hydrogen peroxide formation (41,42). Therefore folate deficiency by way of elevated 
homocysteine concentrations creates oxidative stress in rodents (43). Moreover, folate and its 
intermediates are involved directly in free radical scavenging (44). Hence depletion of the same could 
lead to increased ROS and oxidative stress. It would be interesting to elucidate the role of oxidative stress 
in folate deficiency induced cancer and the same will be addressed in this study.  
Folate Deficiency and Base Excision repair Folate has several specific functions that make it inviting 
to hypothesize about the mechanisms of its role in carcinogenesis. It has been proposed that the 
carcinogenic properties of folate deficiency may be related to a 
decrease in DNA methylation, perhaps as a function of reduced S-
adenosylmethionine (SAM) levels, and/or to an increase in the 
uracil content of DNA. Both hypomethylation (45) and uracil 
incorporation (14,18,31,46,47) are solidly established effects of 
folate deficiency. While Uracil is not a normal constituent of 
DNA it can arise in DNA during replication when dUMP:dTMP 
ratios are imbalanced. It may also arise as a result of the 
deaminations of cytosine. Based on a genetic reversion assay (48) it 
can be conservatively estimated that this occurs approximately 50 
times per cell per day in the human genome. But, in the presence of 
low SAM levels (as occurs in folate deficiency) the rate of cytosine 
deaminations increases as much as 10,000-fold (8). This is 
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supported by data showing that SAM inhibitors have a similar effect on deaminations rates (49). The 
deamination of cytosine yields uracil, and even a fraction of this amount of DNA damage would likely 
stress or overwhelm the repair pathway for uracil in DNA. 
 The DNA repair pathway for removal of uracil is the base excision repair (BER) pathway as 
depicted in the figure.  The BER pathway is believed to repair small, non-helix-distorting lesions in the 
DNA. It has been estimated to be responsible for the repair of as many as one million nucleotides per cell 
per day (50), stressing its importance in the maintenance of genomic stability. It has been suggested that 
BER has evolved in response to in vivo exposure of DNA to ROS and endogenous alkylation, and that 
this pathway suppresses spontaneous mutagenesis (51). 
 BER is also the main repair pathway for the repair of oxidative damages like 8-OHdG, which 
mispairs with Adenine. 8-OHdG is repaired by 8-oxoguanine DNA glycosylase (OGGI), a bifunctional 
enzyme involved in the initial step of BER. 
 Several lines of evidence suggest a reduced ability to process DNA damage when folate 
deficiency is present. Duthie and Hawdon (14) have shown that folate depletion in human lymphocytes 
makes the cells more sensitive to oxidative damage induced by hydrogen peroxide. Duthie et al. (31) have 
further shown that human colon epithelial cells grown in the absence of folate are poorly able to repair 
damages induced by MMS (an alkylating agent) and hydrogen peroxide (an oxidizing agent). Data from 
our lab show that folate deficiency reduces the efficiency of BER by inhibiting the DNA damage 
inducibility of DNA polymerase beta, the rate limiting enzyme of the pathway (52). With the major 
pathway, designated to repair oxidative damages like 8-OHdG, being compromised during folate 
deficiency, the oxidative stress impact of folate deficiency should be further enhanced. This effect of 
folate deficiency and its role in the pathogenesis of cancer will be addressed in this study. 
METHIONINE RESTICTION 
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Methionine, an essential amino acid, is involved in the folate cycle where 5-methyl 
Tetrahydrofolate helps in the regeneration of methionine from homocysteine. Methionine and folate are 
part of the same folate metabolic cycle, alterations in which are implicated in many pathological 
conditions.  
Folate deficiency causes uracil misincorporation, imbalance in dNTP pools, SAM: SAH ratio and 
potentially oxidative stress via alterations in redox balance and increase in homocysteine, a pro-oxidant. 
All these effects of folate deficiency could lead to tumorigenesis.  
Another component of the folate metabolic cycle, methionine has been shown to have beneficial effects 
when restricted. Methionine restriction (MR) has been reported to reduce mitochondrial ROS production 
and increase life span in laboratory rodents (53,54). And methionine restriction has also been shown to 
inhibit colon carcinogenesis in rats when exposed to Azoxymethane (55). Tumor cells have been shown 
to be more sensitive than normal cells to methionine restriction. Studies have reported the induction of 
apoptosis by MR in cancer cell lines (56,57).However, there have been studies that show the role of free 
and protein bound methionine as antioxidants, required for the stability of proteins (58,59). The only 
protein repair system identified so far is the methionine sulfoxide repair system involved in repairing 
oxidative damages to methionine (Methionine sulfoxide) in a protein molecule. Two major enzymes in 
this pathway are Methionine sulfoxide Reductase A (MSRA) and Methionine sulfoxide Reductase B 
(MSRB) each for the S and R stereoisomers of methionine sulfoxide respectively. Many studies have 
shown the importance of the optimum activity of this repair system. Knockout mouse models (MsrA
-/-
) 
show increased sensitivity to oxidative stress and decreased life span (60).With these accumulating 
evidences for the role played by Methionine in regulating the redox status and providing protection 
against cancer, it would be interesting to elucidate the effect of folate deficiency on Methionine pool. 
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Chapter 2 
Background, Significance and Specific Aims 
Folate deficiency has been implicated in the genesis of many types of cancer especially colon cancer. 
While the mechanism by which folate deficiency increases cancer risk is not well understood, it has been 
demonstrated to alter both DNA damage accumulation and DNA methylation.  Some of the well 
established consequences of folate deficiency are modifications in DNA methylation, increase in DNA 
damages such as single strand breaks, micronucleus formation, and mutation frequency. Recent studies 
from our laboratory indicate that FD results in: (i) uracil misincorporation into DNA, a damage repaired 
by DNA polymerase beta dependent Base excision repair (BER); (ii) inability to induce repair  activity; 
(iii) increased accumulation of repair intermediates; (iv) increased sensitivity to exogenous ROS and 
alkylation damage; (v) chromosomal instability; and (vi) inhibition of DNA damage inducibility of DNA 
polymerase beta creating a functional BER deficiency.  
Base excision repair pathway is the pathway responsible for repairing non helix distorting 
damages such as oxidative damages, alkylation damages and misincorporated uracil, which occurs more 
frequently during folate deficiency. Base excision repair pathway is initiated by a glycosylase which 
removes the damaged base. Subsequently an endonuclease removes and the abasic site and the DNA 
polymerase add the new nucleotide. Ligase further seals the nick completing the repair. In this co-
ordinated repair process different enzymes act as rate determining factors while repairing different types 
of damage. The endonuclease, APE1/Ref-1 has been suggested to be the rate limiting enzyme during the 
repair of oxidative damages in cell cultures, whereas DNA polymerase  has been shown to be rate 
limiting while repairing misincorporated uracil. Previous data from our lab shows, incapacitation of the 
base excision repair pathway during folate deficiency. We have previously demonstrated the 
accumulation of toxic repair intermediates such as abasic sites and single strand breaks during folate 
deficiency. Furthermore, apart from uracil misincorporation, folate deficiency also can potentially lead to 
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oxidative damages. Folate deficiency leads to the accumulation of homocysteine, a pro-oxidant and 
inhibits the regeneration of methionine, an antioxidant. Studies have shown that increased homocysteine 
leads to increased production of hydrogen peroxide, a potent oxidative stress inducing factor. These 
effects of folate deficiency taken together with the fact that BER is the major pathway involved in the 
repair of all damages associated to folate deficiency, impairment of base excision repair during FD could 
potentially lead to tumorigenesis. Therefore, it is important to understand the exact mechanism behind 
folate deficiency induced inhibition of base excision repair pathway. 
Methionine, another important component of the folate cycle, interestingly, on its restriction has 
been shown to reduce production of mitochondrial reactive oxygen species and extend life-span in 
laboratory rodents. In addition methionine restriction has been shown to provide protection against colon 
cancer. In other words, folate and methionine, components of the same folate metabolic cycle show 
differential effect when depleted individually. Therefore, in this study we determined the impact of folate 
deficiency and methionine restriction on base excision repair pathway in response to a carcinogen. We 
also evaluated the development of preneoplastic lesions during folate deficiency and methionine 
restriction. Further, we directly tested the impact of APE1/Ref-1 haploinsufficiency during oxidative 
stress using an APE1/Ref-1 haploinsufficient mouse model. These studies have important health 
implications, as polymorphisms in genes involved in the folate cycle and base excision repair pathway 
within human population may render individuals functionally deficient in these nutrients and repair 
increase their risk for cancer development.  
Study 1: To determine whether oxidative stress alters base excision repair pathway and increases 
apoptotic response in apurinic/apyrimidinic endonuclease 1/refox factor-1 haploinsufficient mice. 
Utilizing mice containing a heterozygous gene targeted deletion of APE1/Ref-1 we determined the impact 
of this haploinsufficiency on the processing of oxidative DNA damages induced by 2-nitropropane in the 
liver tissue of mice. Using this model we directly tested the hypothesis that APE1/Ref-1is rate limiting in 
an oxidative stress mediated base excision repair process. We also tested the impact of this APE1/Ref-1 
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haploinsufficiency on NF-kB DNA binding activity and the apoptotic capacity in response to oxidative 
stress created by 2-nitropropane.  
Study 2:  To determine whether folate deficiency regulates the expression of DNA polymerase b in 
response to oxidative stress.  That is to test whether folate deficiency inhibits the upregulation of b-pol 
during oxidative stress. We in this study show the inhibition in the upregulation of b-pol during folate 
deficiency in response to a carcinogen. We further determined the mechanism behind this inhibition in b-
pol expression. We evaluated the alterations in DNA methylation in b-pol promoter during folate 
deficiency to check whether folate deficiency mediated inhibition of b-pol is via epigenetic alterations. 
Furthermore, using techniques such as DNA footprinting and gel shift assays, we determined the hot spot 
regions in the b-pol promoter which makes the gene more susceptible during folate deficiency and 
oxidative stress. Through this study we hoped to dissect out the mechanism of deregulation of b-pol by 
folate deficiency. 
Study 3: To determine the impact of folate and methionine dietary interventions on base excision 
repair pathway and preneoplastic lesion development in colon in response to a carcinogen.  As 
stated previously, folate and methionine are components of the same folate cycle but show differential 
impact on cancer development. Here, we determined the development of preneoplastic lesions, i.e., 
aberrant crypt foci, during folate deficiency and methionine restriction in the colon of mice in response to 
1,2-dimethylhydrazaine , a potent colon and liver carcinogen. We also studied the impact of these dietary 
interventions on the base excision repair pathway in the liver tissue of mice in response to 1,2-
dimethylhydrazaine treatment. For this purpose we evaluated the effect of these diets on the individual 
enzymes in this pathway. We also determined the impact of folate deficiency and methionine restriction 
on the apoptotic capacity of mice in response to a carcinogen. 
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Abstract 
 Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is the redox regulator of 
multiple stress-inducible transcription factors, such as NF-B, and the major 5'-endonuclease in base 
excision repair (BER).  We utilized mice containing heterozygous gene-targeted deletion of APE1/Ref-1 
(Apex
+/-
) to determine the impact of APE1/Ref-1 haploinsufficiency on the processing of oxidative DNA 
damage induced by 2-nitropropane (2-NP) in the liver tissue of mice.  APE1/Ref-1 haploinsufficiency 
results in a significant decline in NF-kB DNA binding activity in response to oxidative stress in liver.  In 
addition, loss of APE1/Ref-1 increases the apoptotic response to oxidative stress where a significant 
increase in GADD45g expression, p53 protein stability and caspase activity are observed.  Oxidative 
stress displays a differential impact on monofunctional (UDG) and bifunctional (OGG1) DNA 
glycosylase initiated BER in liver of Apex
+/- 
mice.  APE1/Ref-1
 
haploinsufficiency results in a significant 
decline in the repair of oxidized bases (e.g., 8-OHdG), while removal of uracil is increased in liver 
nuclear extracts of mice using an in vitro BER assay.  Apex
+/- 
mice exposed to 2-NP displayed a 
significant decline in 3'-OH-containing single-strand breaks and an increase in aldehydic lesions in their 
liver DNA suggesting an accumulation of repair intermediates of failed bifunctional DNA glycosylase 
initiated BER. 
 
Key Words:  Apurinic/apyrimidinic endonuclease 1/redox factor-1; Redox activity; Base Excision 
Repair; oxidative DNA damage; NF-kB; apoptosis; Liver 
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Introduction 
An imbalance between pro-oxidants and anti-oxidants within the cellular milieu promotes a chronic 
state of
 
oxidative stress which can damage DNA and other macromolecules
 
within the cell [62]. The 
steady-state accumulation of oxidative damage is thought to be an important mechanism underlying aging
 
and age-related diseases such as cancer [63,64]. In order to maintain DNA integrity, cells employ 
elaborate DNA repair mechanisms of which base excision repair (BER) is the most versatile and the 
pathway of choice for repairing oxidative damage, single-strand breaks, and other small, non helix-
distorting DNA damage [65-67]. 
Apurinic/apyrimidinic (AP) endonuclease 1 (APE1) was originally characterized as an 
endonuclease that cleaves the backbone of double-stranded DNA containing AP sites [68,69]. 
Subsequently, APE1 was shown to possess 3'-phosphodiesterase, 3'-phosphatase, and 3'5' exonuclease 
activities [70]. APE1 was also independently characterized as redox factor-1 (Ref-1), a redox activator of 
cellular transcription factors [71,72]. APE1/Ref-1 participates in cellular signaling via activation of 
multiple transcription factors involved in the cellular stress response, such as NF-B [73].  Studies of NF-
B DNA binding indicate a mechanism that is redox regulated by and dependent upon APE1/Ref-1. For 
example, APE1/Ref-1 was shown to enhance the DNA binding activity of NF-B in vitro as well as NF-
B-dependent transcriptional activation in vivo [74]. Furthermore, deletion of the redox-sensitive domain 
of APE1/Ref-1 significantly inhibited TNF-induced NF-B activation [75]. Loss of APE1/Ref-1 also 
resulted in decreased NF-B DNA binding and transcriptional activation, in addition to increased 
susceptibility to TNF-induced apoptosis [76,77]. These findings establish APE1/Ref-1 as an essential 
upstream signaling molecule regulating NF-κB. 
Research focused on understanding the role of APE1/Ref-1 in the BER response to oxidative 
stress provides insight into its multifunctional activity. Initially, BER was believed to be a simplistic 
linear pathway involving damage recognition and removal, followed by base insertion and nick-sealing 
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activity, requiring only four enzymatic reactions [78]. However, recent studies have indicated that BER is 
a dynamic and environmentally responsive DNA repair pathway [79, 80], with individual BER enzymes 
being induced by oxidizing agents [81, 82]. Our laboratory has demonstrated that both BER activity and 
DNA polymerase  (-pol) levels increase in response to the oxidative stress [83]. Research has also 
shown that APE1/Ref-1 expression is inducible by oxidative stress [84,85], while its down regulation 
increased sensitivity to DNA damaging agents [86,87] and its overexpression protected against oxidative 
stress-induced genotoxicity [88]. Recently, Fung and Demple [89] showed that APE1/Ref-1 repair 
activity is essential for cellular viability and indicate that APE1/Ref-1 redox activity may be dispensable. 
However, Izumi et al. [90] and Vasko et al. [91] present data supporting the notion that both functions of 
APE1/Ref-1, repair and redox, are essential for cell survival. 
The objective of this study is to determine the functional importance of APE1/Ref-1 in the repair 
of oxidative damage in vivo. We provide evidence that in response to in vivo exposure to oxidative stress, 
an increase in BER activity, -pol, and APE1/Ref-1 protein levels are observed. We also present data 
demonstrating increased activation of NF-kB in response to oxidative stress in vivo. To determine 
whether BER activity in response to oxidative stress is affected by reduced APE1/Ref-1, we utilized a 
mouse model of APE1/Ref-1 haploinsufficiency [Apex
+/-
] previously characterized by our lab [92].  We 
find that oxidative stress displays a differential impact on monofunctional (UDG) and bifunctional 
(OGG1) DNA glycosylase initiated BER in Apex
+/- 
mice.  Oxidative stress results in a significant increase 
in UDG initiated BER activity, but a significant decline in the repair of oxidized bases (8-OHdG).  We 
also observed reduced DNA binding activity of NF-kB in Apex
+/-
 mice exposed to oxidative stress 
establishing a significant role for APE1/Ref-1 redox function in the activation of NF-B in response to 
oxidative stress in vivo.  Our data has relevant translational implications since APE1/Ref-1 variants have 
been identified in the human population [932], and variants in BER have been associated with increased 
cancer risk [94,954]. 
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MATERIALS AND METHODS 
Animals 
    The experiments were performed in young (3-6 month), wild-type and APE1/Ref-1 heterozygous 
heterozygous (Apex
+/-
) male C57BL/6 specific pathogen-free mice in accordance with NIH guidelines for 
the use and care of laboratory animals. Mice were backcrossed to C57BL/6 background. The Wayne State 
University Animal Investigation Committee approved the animal protocol. Mice were maintained on a 
12-hr light/dark cycle and fed standard mouse chow and water ad libitum. Mice were anesthetized in a 
CO2 chamber and sacrificed by cervical dislocation. Harvested liver was flash frozen in liquid nitrogen 
and stored at -70C for further analysis. 
DNA damage induction 
     Experimental mice were i.p. injected with 100 mg/kg body weight 2-nitropropane (2-NP; Aldrich 
Chemical Company, Chem. Abstr. Serv. Reg. No. [79-46-9]) dissolved in olive oil. Control mice were 
injected with olive oil vehicle. Mice were sacrificed after 24-hr. The dose and exposure time were based 
on previous studies characterizing the effect of 2-NP on DNA damage and repair induction [83]. 
Gene expression profiling 
      The mRNA expression level of APE1/Ref-1 was quantified using a real-time PCR-based pathway 
focused on gene expression profiling of mouse DNA damage. Total RNA was extracted from liver tissue 
of control and 2-NP-treated mice using TRIzol

 Reagent [GibcoBRL, Rockville, MD]. First strand cDNA 
was synthesized from 1 g RNA using random primers and purified using QIAquick PCR purification kit 
(Qiagen, Valencia, California). Gene-profiling was analyzed using Realtime PCR array (SuperArray, 
Frederick, MD) according to manufacturer’s instructions. Briefly, a cocktail of cDNA samples was 
prepared using a supplied master mix and aliquoted into each well of a 96-well plate containing primer 
pairs specific for 84 genes involved in the DNA damage pathway, including 5 housekeeping genes. 
Among the 84 genes analyzed, changes in the expression of genes related to BER pathway were   
confirmed using real time PCR and reported herein. Expression of -pol, UNG, OGG1 and GADD45g 
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were also quantified using real time PCR with RNA extracted from liver tissue of control and 2-NP 
treated mice. UNG primers were designed to detect both UNG1 and UNG2 message.  Primer 
sequences used for β-pol, GADD45g, APE-1/Ref-1, UNG, OGGI, GAPDH and β-actin transcripts are 
detailed in Table 1.    External standards for all the genes were prepared by subcloning the amplicons, 
synthesized using the primers listed in Table 1, into PGEM-T easy vector. The vectors were linearized 
using Ecor1 to make the standard curves. All gene transcripts were normalized to both GAPDH and β-
actin.  
Nuclear protein isolation  
      Nuclear proteins were isolated as previously described [92]. Briefly, nuclear extracts were isolated 
using transfactor extraction kit (Clontech, Mountain View, CA). The kit uses a hypotonic buffer to lyse 
the cell allowing the removal of cytosolic fractions and is followed by the extraction of nuclear proteins 
by a high salt buffer. All samples and tubes were handled and chilled on ice, and all solutions were made 
fresh according to manufacturer’s protocol. Low molecular weight contaminants were removed from 
extracts by dialysis in 1L dialysis buffer (20 mM Tris-HCl, pH 8.0; 100 mM KCl; 10 mM NaS2O5; 0.1 
mM DTT; 0.1 mM PMSF; 1 g/ml Pepstatin A) for 4-hr at 4C using Slide-A-Lyzer mini-dialysis units 
(Pierce Biotechnology, Rockford, IL) with a molecular weight cut off of 3.5kDa. Dialyzed extracts were 
aliquoted and flash frozen in liquid nitrogen and stored at -70C for subsequent analyses. Protein 
concentrations were determined according to Bradford using Protein Assay Kit I (Bio-Rad, Hercules, 
CA). 
Protein expression analysis 
        Western blot analysis was performed using 200 g nuclear protein as previously described [92]. 
Upon completion of SDS-PAGE, the region containing the protein(s) of interest was excised and prepared 
for western blot analysis while the remaining portion of the gel was stained with GelCodeBlue Stain 
Reagent (Pierce Biotechnology, Rockford, IL) to ensure equal protein loading. Manufacturer 
recommended dilutions of anti-sera developed against APE1/Ref-1 (Clone 13B8E5C2, Novus 
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Biologicals, Littleton, CO), -pol (Ab-1 Clone 18S, NeoMarkers, Fremont, CA) and p53( Pab 240, Santa 
Cruz Biotechnology, Delaware, CA) were used to detect proteins of interest followed by incubation with 
HRP-conjugated secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA). As an internal control 
to ensure equal protein transfer, membranes
 
were reprobed with anti-Lamin B antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA)  The bands were visualized and quantified using a ChemiImager 
System (AlphaInnotech, San Leandro, CA) after incubation in SuperSignal West Pico 
Chemiluminescent Substrate (Pierce Biotechnology, Rockford, IL). Data are expressed as the integrated 
density value (I.D.V.) of the band per g of protein loaded. 
Electrophoretic mobility shift assay (EMSA) 
        A non-radioisotopic EMSA was used to determine the NF-B and CREB DNA binding activity of 
nuclear extracts isolated from liver tissue of control and 2-NP-treated Apex
+/+
 and Apex
+/-
 mice according 
to the manufacturer's protocol (LightShift Chemiluminescent EMSA kit, Pierce Biotechnology, 
Rockford, IL). Briefly, 40 fmol biotin-end-labeled DNA containing an NF-B consensus sequence ( 5’ 
AGTTGAGGGGACTTTCCCAGG 3’BTN from Panomics, Redwood City, CA) and CRE sequence with 
-pol flanking region (-36..AGCCTGGCGCGTGACGTCAC CGCGCTGCGC..-7)  was incubated with 
10 µg nuclear extract in a 20 µl reaction mixture containing 1X binding buffer (100 mM Tris, 500 mM 
KCl, 10 mM DTT; pH 7.5), 2.5% glycerol, 5 mM MgCl2, 50 ng/µl poly (dI-dC), and 0.05% NP-40. 
Negative controls (all components except nuclear extract) were included in all experiments. In 
competitive assays, 100X molar excess of unlabeled oligonucleotide was added to the reaction mixture. 
Samples were incubated for 20 min at room temperature then resolved on a 6% non-denaturing 
polyacrylamide gel in 0.5X TBE buffer. After electrophoresis, samples were transferred from the gel to a 
positively charged nylon membrane and cross-linked. Biotin-labeled protein/DNA complexes were 
detected by chemiluminescence and quantified using a ChemiImager System (AlphaInnotech, San 
Leandro, CA). Data are expressed as the integrated density value (I.D.V.) of the band per g of protein 
loaded. 
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DNA base excision repair activity assay 
       The G:U mismatch repair assay is developed to measure monofunctional glycosylase-initiated base 
excision repair (BER) activity.  Purified radio-end-labeled 30-bp oligonucleotides (upper strand: 5'-
ATATACCGCGGUCGGCCGATCAAGCTTATTdd-3'; lower strand: 3' ddTATATGGCGCCG 
GCCGGCTAGTTCGAATAA-5') containing a G:U mismatch and a Hpa II restriction site (CCGG) were 
incubated in a BER reaction mixture containing 50 g nuclear protein as previously described [90]. This 
repair assay uses a 30bp long oligonucleotide with G:U mismatch as no significant difference was seen in 
the catalytic efficiency of the in vitro assay when a plasmid or oligonucleotide was used as a substrate 
[96].  Repair of the G:U mismatch to a correct G:C base pair was determined via treatment of the duplex 
oligonucleotide with 20U of HpaII (Promega, Madison, WI) for 1-hr at 37C and analysis by 
electrophoresis on a 20% denaturing 19:1 acrylamide/bis-acrylamide gel (SequaGel Sequencing 
System, National Diagnostics, Atlanta, GA). Repair activity (presence of a 16-mer band) was visualized 
and quantified using a Molecular Imager System (Bio-Rad, Hercules, CA) by calculating the ratio of the 
16-mer product with the 30-mer substrate (product/substrate). Data are expressed as machine counts per 
g of protein.   
The 8-OH G:C repair assay is utilized to measure bifunctional glycosylase- initiated BER 
activity. Fluorescein-end-labeled 30-bp oligonucleotides (upper strand: 5'-ATATACCGC 
GGGCG*GCCGATCAAGCTTATTdd-3'; lower strand:3' ddTATATGGCGCCGGCCGGCTAGTT 
CGAATAA-5',* G=8-hydroxydeoxyguanine) containing a Hpa II restriction site (CCGG) were incubated 
in a BER reaction mixture containing 50 g nuclear protein as described previously [92]. The repair 
activity was determined as described above.  
DNA damage analysis: Random oligonucleotide primed synthesis [ROPS] Assay 
        The relative number of single-strand breaks containing a 3'-OH group was quantified using a 
Klenow (exo
- 
) incorporation ROPS assay as previously described [92,97]. This assay is based on the 
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ability of Klenow to initiate DNA synthesis from 3'-OH ends of single-strand DNA. Incorporation of     
( 
32
P) dCTP was quantified using a Packard scintillation counter. DNA for the ROPS assay was isolated 
using Qiagen (Valencia, CA) gravity tip columns as described in the manufacturer's protocol. This 
method generates large fragments of DNA (up to 150-kb) while minimizing shearing. 
ASB Assay 
        Detection of aldehydic DNA lesions (ADLs) was carried out by ASB as described previously [98] 
with slight modifications. DNA [8ug] from liver tissue was incubated in 30ul of phosphate-buffered 
saline with 2 mM aldehyde reactive probe (Dojindo Laboratories, Kumamoto, Japan) at 37 °C for 10 min. 
DNA was precipitated by the cold ethanol method and resuspended in 1X TE buffer overnight at 4 °C. 
DNA was heat-denatured at 100 °C for 10 min, quickly chilled on ice, and mixed with an equal volume of 
2 M ammonium acetate. The nitrocellulose membrane (Schleicher & Schuell) was prewet in deionized 
water and washed for 10 min in 1 mM ammonium acetate. DNA was immobilized on the pretreated 
nitrocellulose membrane using an Invitrogen filtration manifold system. The membrane was washed in 
5X SSC for 15 min at 37 °C and then baked under vacuum at 80 °C for 30 min. The dried membrane was 
incubated in a hybridization buffer (20 mM Tris, pH 7.5, 0.1 M NaCl, 1 mM EDTA, 0.5% (w/v) casein, 
0.25% (w/v) bovine serum albumin, 0.1% (v/v) Tween 20) for 30 min at room temperature. The 
membrane was then incubated in fresh hybridization buffer containing 100 ul of streptavidin-conjugated 
horseradish peroxidase (BioGenex, San Ramon, CA) at room temperature for 45 min. Following 
incubation in horseradish peroxidase, the membrane was washed three times for 5 min each at 37 °C in 
TBS, pH 7.5 (0.26 M NaCl, 1 mM EDTA, 20 mM Tris, pH 7.5, 0.1% Tween 20). Membrane was 
incubated in ECL (Pierce) for 5 min at room temperature and visualized using a ChemiImager™ system 
(AlphaInnotech, San Leandro, CA). 
Caspase Activity 
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          Caspase-3 activity was measured using Enzchek Caspase-3 Assay kit No.1 (Molecular probes 
Eugene, OR). Briefly, Liver tissues were homogenized, and cytosolic extracts were isolated using 
transfactor extraction kit (Clonetech, Mountain View, CA). The extract
for 2hr at room temperature in the working solution (25mM PIPES, pH 7.4, 5mM EDTA and 0.25% 
CHAPS) containing synthetic Caspase-3 substrate, Z-DEVD-AMC.  Caspase mediated proteolytic 
cleavage of the substrate yields a bright blue-fluorescent product. An additional control assay was 
performed using reversible aldehyde inhibitor Ac-DEVD-CHO to confirm that the fluorescence observed 
in the sample assay was due to caspase activity. The fluorescence was measured using a fluorescence 
microplate reader (Genios plus, Tecan) at excitation:342nm, emission:441nm.  The caspase activity was 
determined using an AMC (7-amino-4-methylcoumarin) standard curve (0-100uM), and reported as 
fluorescence per microgram of protein. 
Statistical analysis 
       Statistical significance between means was determined using ANOVA followed by the Fisher’s least 
significant difference test where appropriate [99]. P-values less than 0.05 were considered statistically 
significant. 
RESULTS 
Analysis of the liver tissue for APE1/Ref-1 expression and redox activity in response to 2-Nitropropane 
       Using the hepatocarcinogen 2-nitropropane (2-NP), we analyzed the impact of oxidative stress on the 
expression and redox activity of APE1/Ref-1 in vivo. Metabolism of 2-NP in liver generates reactive 
oxygen species (ROS) and promotes oxidative DNA damage, e.g., 8-oxo-7,8-dihydro-2'-deoxyguanosine 
(8-OHdG), both of which are believed to be one of the causative factors behind 2-NP-induced 
carcinogenesis [100].  2-NP has also been shown to be genotoxic in vitro, inducing mutations in bacteria 
and unscheduled DNA synthesis in hepatocytes [101].  Our laboratory has demonstrated that 2-NP 
(100mg/kg body weight) induces levels of 8-OHdG [by 4-5 fold, p< 0.01], followed by a concomitant 
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increase in BER activity and -pol protein levels [50%, p< 0.01] in liver tissues of mice and rats [83].  In 
addition, 2-NP is also shown to increase mutation frequency in liver tissues of these animals [83].  Using 
RT-PCR and Western blot analyses, we analyzed the expression of APE1/Ref-1 in response to 2-NP 
treatment. Our data show that 2-NP induces APE1/Ref-1 mRNA (Fig. 3.1A) and protein levels 
significantly (Fig. 3.1B) in the liver.  Thus, we confirmed previous reports from cultured cells e.g. HeLa 
S3 tumor cells and WI 38 primary fibroblast [85] where expression of APE1/Ref-1 was shown to be 
inducible by oxidative stress and extended this observation to in vivo study establishing APE1 as a stress 
response gene,.  Consequently, we examined the impact of 2-NP on DNA binding activity of NF-B 
(Fig.3.1C).  As expected, NF-kB DNA binding activity was significantly increased in response to 
oxidative stress in liver nuclear extracts.  Furthermore, increase in NF-kB DNA binding activity was 
correlated with an increase in expression/activity of APE1/Ref-1, the redox activator of NF-kB.  To 
determine the role of APE1/Ref-1 and its redox function in this process, we evaluated the activation of 
NF-kB DNA binding activity in response to 2-NP in mice heterozygous for the APE1/Ref-1 gene, i.e., 
Apex
+/-
 mice.  
Analysis of APE1/Ref-1 expression and redox activity in response to oxidative DNA damage in liver 
nuclear extracts of Apex
+/-
 mice.  
         We determined whether reduced level of the APE1/Ref-1 gene in Apex
+/-
 mice would impact the 
activation of NF-kB in response to oxidative damage generated by 2-NP treatment.  APE1/Ref-1 protein 
level was significantly reduced in Apex
+/- 
mice (Fig. 3.2), in addition, NF-B DNA binding activity was 
reduced in Apex
+/- 
mice suggesting that the redox activation of NF-B and its consequent DNA binding 
activity is significantly reduced when the expression of APE1/Ref-1 is compromised (Fig. 3.3). The 
specificity of the NF-kB DNA binding activity in our assay is established as the shifted band is 
completely abolished using an oligonucleotide containing the NF-B unlabeled consensus sequence (Fig. 
3.3, Lane A).  In agreement with our previous data [92], we confirmed that APE1/Ref-1 heterozygosity 
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promoted haploinsufficiency with respect to APE1/Ref-1 gene expression.   In this study we established 
that wild-type mice exposed to 2-NP showed a significant increase in APE1/Ref-1 protein and redox 
activation of NF-kB in vivo, while mice haploinsufficient for APE1/Ref-1 showed similar response to 
oxidative stress via their intact allele, the ultimate level of induction was significantly lower in 
heterozygous mice reducing its redox capacity (Figs. 3.2 and 3.3). This suggests that the induction in 
APE1/Ref-1 expression and increased NF-kB activation in response to oxidative stress are dependent on 
APE1/Ref-1 genotype. Based on these data, it appears that the level of APE1/Ref-1 protein is 
instrumental in redox activation of NF-kB and its DNA binding activity in vivo. 
Analysis of DNA damage intermediates in the liver tissue of Apex
+/-
 mice 
        Data from our laboratory and other labs indicate that down regulation of APE1/Ref-1 promotes a 
damage hypersensitive phenotype [87, 92]. Thus, it was essential to determine the impact of APE1/Ref-1 
haploinsufficiency on the level of DNA damage. We have previously reported the levels of AP sites, 
single-strand breaks and Aldehydic lesions in DNA isolated from liver of young Apex
+/-
 mice under 
normal condition.  Interestingly, no significant difference in DNA damage in Apex
+/-
 mice as compared to 
wildtype counterparts was observed [97].  In this study, wild-type mice exposed to oxidative stress 
displayed a 2-fold induction in the level of 3'-OH-containing single-strand breaks (Fig. 3.4A) and no 
significant increase in the level of Aldehydic lesions (Fig. 3.4B).  Interestingly, the level of 3'-OH-
containing single-strand breaks was significantly lower in Apex
+/-
 mice exposed to similar treatment as 
compared to their wildtype counterparts (Fig. 3.4A).  However, the level of aldehydic lesions was 
significantly higher in Apex
+/-
 mice exposed to oxidative stress as compared to wildtype animals (Fig 
3.4B).  We suggest that the processing of oxidized bases by a bi-functional DNA glycosylase such as 
OGG1 (8-oxoguanine DNA glycosylase) could result in generation of aldehydic blocking lesions at 3’ 
end.  Inability to process these 3’ blocking groups in the absence of the 3’-phophoesterase activity of 
Apex in Apex
+/-
 mice [102], could result in lower detection of endonuclease-mediated single-strand breaks 
in the heterozygous animal.   
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Nevertheless, the decrease in the detection of 3'-OH-containing single-strand breaks in Apex
+/-
 
mice could also arise from an increase in -pol-dependent BER capacity and rapid removal of oxidized 
bases and their repair-intermediates.  Based on the findings that APE1 is not the rate limiting enzyme in 
Uracil initiated BER pathway [92,102] and emergence of AP endonuclease-independent BER pathway for 
repair of oxidized bases [103], upregulation in BER pathway could be the plausible mechanism for 
decline in 3’-OH-containing single strand breaks in Apex+/- mice exposed to oxidative stress.  
Accordingly, it has become important to evaluate BER capacity using a BER assay and determine the 
expression of its rate limiting enzyme, -pol, in Apex+/- mice in response to oxidative stress.  
Understanding this mechanism is important as these data potentially sheds light on the means by which 
APE1/Ref-1 haploinsufficiency alters the DNA damage signal in Apex
+/- 
mice.   
Analysis of the BER response to oxidative DNA damage in the liver nuclear extracts of Apex
+/-
 mice 
           We examined whether loss of APE1/Ref-1 affects the BER activity in liver in response to 2-NP-
induced oxidative DNA damage in vivo.  Using a G:U mismatch repair assay where APE1 endonuclease 
activity is essential, we analyzed the in vitro BER activity in Apex
+/-
 mice and their wild-type counterparts 
in response to 2-NP treatment. For this assay we utilized a 30bp long oligonucleotide as no significant 
difference has been observed in the catalytic efficiency of the G:U mismatch assay when a plasmid or 
small oligonucleotide were used as substrate [96].  As expected, BER activity was significantly increased 
in response to oxidative stress in wildtype mice (Fig. 3.5A) with a concomitant increase in -pol protein 
(Fig. 3.5B).  We confirmed previous reports that mice haploinsufficient for APE1/Ref-1 display reduced 
in vitro BER activity (Fig. 3.5A) and -pol expression (Fig. 3.5B).  However, while the BER activity 
significantly declined in Apex
+/-
 mice, much to our surprise this activity was significantly higher in 
Apex
+/-
 mice treated with 2-NP as compared to its wildtype littermates.  In other words, APE1/Ref-1 
haploinsufficiency resulted in a significant increase in BER activity in response to oxidative stress.   In 
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addition, we provide evidence that 2-NP treatment resulted in a significantly higher induction in -pol 
expression/protein stability as compared to wildtype animals (Fig. 3.5B).   
Regulation of eukaryotic gene expression is controlled, in part, though interaction of cis-elements 
within promoters of the genes with their associated DNA-binding factors.  One of the candidates 
responsible for triggering induction of a specific gene by oxidative stress is the cAMP responsive element 
(CRE). The CRE sequence is present within the promoter of both the APE1/Ref-1 as well as the -pol 
genes.  Interestingly, mutational inactivation of CRE sequence in the APE1/Ref-1 promoter completely 
eliminates APE promoter activity in response to oxidative stress in cells [104]. In addition, the CRE 
sequence in human-pol promoter has been shown to play a key role in the basal expression as well as 
induction of -pol in response to DNA-alkylating agents [105,106].  Based on these findings, we propose 
that attenuation in the redox function of APE1/Ref-1 in Apex
+/-
 mice impacts the handling of oxidative 
stress perhaps via alterations in activation of factors such as NF-kB and consequently results in increased 
CREB binding activity that impacts the expression of the -pol gene. In support of this notion, we 
determined whether APE1/Ref-1 haploinsufficiency alters ATF/CREB binding activity to CRE sequence 
within the -pol promoter.  In gel retardation experiments, the protein binding capacity of the CRE 
element was significantly increased in Apex
+/-
 mice in response to oxidative stress as compared to their 
wildtype littermates (Fig. 3.5C).  The shifted band is completely abolished using an oligonucleotide 
containing the consensus CRE sequence as competitor (Fig 3.5C, Lane B) while using an oligonucleotide 
with mutational inactivation of the CRE site does not compete with the shifted band (Fig 3.5C, Lane A).   
Interestingly, the increase in CREB/CRE binding activity within the -pol promoter in Apex+/- mice 
corresponds to an increase in -pol mRNA levels in heterozygous animals (Fig 3.5C).  Based on these 
results, it appears that alteration in the redox function of APE1/Ref-1 enzyme impacts the handling of 
oxidative stress and consequently results in an oxidative DNA damage repair response, e.g., increased 
expression of -pol gene. 
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Further, to directly determine the role of APE1/Ref-1 in the repair of oxidized bases, we used a 8-
OHdG:C repair assay where APE1 3’-phosphoesterase activity are reported to be rate limiting [102].  As 
expected, the wildtype animals displayed an increase in 8-OHdG:C repair activity when exposed to 2-NP 
(Fig. 3.6A).  However, while the Apex
+/-
 mice showed similar response to 2-NP, the overall repair activity 
remained considerably lower for Apex
+/-
 mice when compared to their wildtype counterparts (Fig. 3.6A). 
Additionally, to confirm the role of APE1/Ref-1 in repairing the oxidized base, the 8-OHdG:C BER assay 
was performed in the presence of  APE1/Ref-1 purified protein. When purified APE1/Ref-1 (Novus 
biologicals, Littleton, CO) was added to the reaction mixture, the reduced BER activity was restored in 
control and 2-NP treated Apex
+/-
 mice, while the wildtype mice displayed no noticeable differences (Fig. 
3.6B). Taken together, these results confirm that APE1/Ref-1 plays an important role in the repair of 
oxidized bases (e.g., 8-OHdG) and that APE1/Ref-1 haploinsufficiency results in a significant decline in 
this repair activity, while monofunctional DNA glycosylase dependent BER activity is increased in these 
mice. 
Analysis of Glycosylases in the liver of Apex
+/- 
mice in response to oxidative DNA damage 
           To further confirm the impact of APE1/Ref-1 heterozygosity on the BER pathway, we determined 
the expression of two glycosylases responsible for initiating the repair of oxidative damage. Using Real 
time PCR we determined the expression of OGGI, a bi-functional glycosylase and UNG (Uracil DNA 
glycosylase), a monofunctional glycosylase. Both these glycosylases are involved in the removal of 
oxidized bases from DNA. There are two types of 8-Oxoguanine DNA glycosylase; OGG1 and OGG2 
[107].  Hazra et al, [107] have demonstrated that both these enzymes are involved in processing oxidized 
bases, with OGG1 being involved in the removal of 8-OHdG paired with cytosine, thymine and guanine 
and OGG2 in responsible for the removal of 8-OHdG paired with Adenine. UNG has two isoforms 
arising from alternative splicing; UNG1 and UNG2 [108,109]. UNG 1 is a mitochondrial enzyme whereas 
UNG2 is found in the nucleus [108,109]. In addition to initiating uracil removal from DNA, UNG is also 
involved in the repair of Uracil derivatives like isodialuric acid, 5-hydroxyuracil and alloxan, derived 
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from oxidative damage to cytosine residues in the DNA [110], thus playing an important role in repair of 
oxidative damage. Interestingly, UNG expression follows the profile of -pol and the G:U mismatch BER 
activity.  In other words, mice treated with 2-NP showed significant increase in UNG expression with 
maximum induction seen in Apex
+/-
 mice (Fig. 3.7A).  Using a UDG activity assay as described by our 
laboratory [97], we determined the impact of oxidative stress on UNG activity in liver tissue of mice 
treated with 2-NP.  Interestingly, oxidative stress resulted in a significant increase in UNG activity 
following the expression of UNG gene and BER activity (data not shown).  However, OGG1 mRNA 
levels did not change significantly among the control and experimental groups (Fig. 3.7B). Interestingly, 
addition of purified human OGG1 (Novus biologicals, Littleton, CO) protein to BER reaction mixture did 
not increase OGG1 initiated BER activity in 2-NP treated Apex
+/-
 mice (data not shown) suggesting that 
APE1/Ref-1 activity is essential for bifunctional DNA glycosylase initiated BER.  Thus, upregulation in 
UNG expression and simultaneous increase in -pol protein explain the increase in G:U mismatch BER 
activity in 2-NP treated Apex
+/-
 mice (Fig. 3.5A).  Conversely, lack of induction of OGG1 initiated BER 
in the liver tissue of Apex
+/-
 mice exposed to 2-NP (Fig. 3.6A) are expected to increase oxidative DNA 
damage that drives apoptosis.   
Analysis of Apoptosis in the liver of   Apex
+/- 
mice in response to oxidative stress 
           To characterize the effect of Ape1/Ref-1 heterozygosity on cell cycle arrest and apoptosis during 
oxidative stress, we analyzed three factors associated with apoptosis; GADD45g (Growth Arrest and 
DNA-damage-inducible, gamma), p53 and Caspase-3. GADD45g, a genotoxic stress inducible gene 
associated with cell cycle arrest and apoptosis was analyzed by real time PCR. The mRNA level of 
GADD45g was significantly increased in Apex
+/+
 mice in response to 2-NP (Fig. 3.8A). Under control 
conditions, there was no effect of genotype on GADD45g expression (Fig. 3.8A), while in response to 
oxidative stress, expression of GADD45g was significantly greater in Apex
+/-
 mice as compared to their 
wildtype counterparts.  As a p53 responsive gene, we wanted to evaluate the role of p53 in GADD45g 
gene response. Using western blot assay, we determined the effect of Ape1/Ref-1 heterozygosity on p53 
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stability in response to oxidative stress in the liver nuclear extracts. p53, a tumor suppressor protein is a 
well established determinant of cell cycle arrest and apoptosis.  p53 protein stability followed the same 
trend as GADD45g expression, with 2-NP treated Apex
+/-
 mice displaying the highest level of p53 protein 
stability (Fig. 3.8B). We further analyzed the activity of caspase-3, one of the final effectors in the 
apoptotic pathway under the same conditions using liver cytosolic extracts. Caspase-3 activity was 
significantly induced in the 2-NP treated Apex
+/-
 mice compared to its untreated counterpart (Fig. 3.8C).  
Thus, loss of APE1/Ref-1 increases the apoptotic response to oxidative stress.  
DISCUSSION 
APE1/Ref-1 is a multifunctional protein involved in the maintenance of genomic integrity and in 
the regulation of gene expression. In addition to its role in BER as the major 5'-endonuclease and 
3’phosphoesterase, APE1/Ref-1 was independently characterized as a redox activator of cellular 
transcription factors. Although research has demonstrated that APE1/Ref-1 is involved in the cellular 
response to oxidative DNA damage, it is currently unclear whether this response is strictly due to 
APE1/Ref-1 repair activity, APE1/Ref-1 redox regulatory activity, or both. A study by Fritz et al. [111] 
suggests that APE1/Ref-1 repair activity is constitutively expressed, while APE1/Ref-1 redox activity is 
subject to regulation under various stimuli. Furthermore, Hsieh et al. [112] present data indicating that 
APE1/Ref-1 redox activity is mediated by phosphorylation in response to oxidative stress.  
Reports to date have shown that APE1/Ref-1 expression is inducible by various forms of 
oxidative stress in vitro [84-91].  For example, HeLa cells exposed to damaging agents like hypochlorite 
or methyl methane sulfonate show an increase in both the APE1/Ref-1 expression and activity [112].  
Additionally, Ramana et al. [85] have shown induction of APE1/Ref-1 mRNA and protein levels with 
increased translocation of the protein into the nucleus when HeLa S3 tumor cells and WI 38 primary 
fibroblasts were exposed to ROS generators. Ape1/Ref-1 protein has also been shown to be translocated 
from the cytoplasm to the nucleus during H2O2 and ATP stimulation [113]. In order to determine the 
effect of oxidative stress on APE1/Ref-1 in vivo, we used mice containing a heterozygous gene-targeted 
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deletion of APE (Apex
+/-
).  Homozygous deletion of the APE1/Ref-1 gene (Apex
-/-
) is embryonic lethal, 
but heterozygous mice survive and are fertile [87, 114,115]. These APE1/Ref-1 haploinsufficient (Apex
+/-
) 
mice show tissue specific differences in BER capacity characterized using an in vitro G:U mismatch 
repair assay. In addition Huamani et al. [116] have demonstrated that Apex
+/- 
mice show a significant 
increase in spontaneous mutagenesis in lacI transgenes in liver and spleen. Furthermore, MEF’s and brain 
cells obtained from Apex
+/- 
mice have been shown to be more susceptible to oxidizing agents [87,117]. In 
this study we used 2-nitropropane (2-NP), a well known hepatocarcinogen [100,118] to induce oxidative 
stress in vivo.  2-NP, an industrial solvent, is found in paints, varnishes and cigarette smoke [100,118].  2-
NP promotes formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-OHdG) and 8-aminoguanine through 
its metabolites N-isopropylhydroxylamine and hydroxylamine-O-sulfonic acid, which are believed to be 
the causative factors behind 2-NP-induced carcinogenesis [100].   In addition, 2-NP occurs as Propane 2-
nitronate (P2N) at physiological pH and promotes genotoxicity through production of NO species [118].  
NO is shown to induce genotoxicity by deaminating DNA and increasing uracil to cytosine ratio [109, 
119].  2-NP has also been shown to be genotoxic in vitro, inducing mutations in bacteria and increasing 
unscheduled DNA synthesis in cultured hepatocytes [101]. Additionally, our laboratory has previously 
demonstrated that 2-NP-treatment results in an increase in the levels of 8-OHdG in vivo in the liver of 
mice and rats, followed by a concomitant increase in -pol expression and BER activity [83]. Here we 
verify that APE1/Ref-1 is indeed an inducible protein (Fig. 3.1B).  While fold increase is the same in 
response to oxidative stress across the genotypes, the total accumulative level of APE1/Ref-1 protein is 
lower in the liver of Apex
+/-
 mice, i.e., even though the intact allele is induced in response to 2-NP, it does 
not compensate for the lost allele.  
APE1/Ref-1 has been shown to be an essential component of transcription complexes by directly 
interacting with other transcription factors such as HIF-1 and p300 [120,121]. Research has shown that 
APE1/Ref-1 enhances the DNA binding activity of NF-κB in vitro as well as NF-κB-dependent 
transcriptional activation in vivo [74,75]. Deletion of the redox-sensitive domain of APE1/Ref-1 has been 
shown to inhibit TNF-induced NF-κB activation, while loss of APE1/Ref-1 is shown to result in a 
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significant decline in NF-κB activity and increased susceptibility to TNF-induced apoptosis [76,77]. 
Furthermore, down-regulation of APE1/Ref-1 by soy isoflavones in vitro and in vivo resulted in 
concomitant reduction of NF-κB activity, while a 2-fold increase in APE1/Ref-1 expression, obtained by 
cDNA transfection, resulted in a concomitant 2-fold increase in NF-κB activity, confirming the cross-talk 
between these molecules [122]. In line with these findings the Apex
+/+ 
mice showed a significant increase 
in APE1/Ref-1 redox activation of NF-B when exposed to 2-NP, while increase in NF-kb activation is 
the same in response to oxidative stress across the genotypes, the total NF-kb DNA binding activity is 
lower in the liver of Apex
+/-
 mice, i.e., the ultimate level of NF-kB activation was significantly attenuated 
in the heterozygous animals.  It is well established that NF-B is a mediator of inflammatory responses 
promoting cell proliferation and survival by inhibiting cell cycle arrest & apoptosis [123,124], thus 
reduced activation of NF-B and other redox-regulated transcription factors in response to oxidative 
stress in Apex
+/- 
mice may prove detrimental due to alterations in the signaling mechanisms necessary to 
differentiate between repair and apoptosis.  
We have previously reported tissue-specific differences in BER capacity in APE1/Ref-1 
haploinsufficient mice [92].  Moreover, previous studies have indicated that down-regulation of 
APE1/Ref-1 may promote a damage hypersensitive phenotype [87-89]. Therefore, it was essential to 
analyze the effect of reduced APE1/Ref-1 on the level of DNA damage production and BER.  In this 
study, we demonstrate that the liver tissue of Apex
+/-
 mice expresses a BER phenotype that is more 
susceptible to accumulation of DNA damage in response to oxidative stress as a result of reduced 
APE1/Ref-1 3’-phoshoesterase activity in vivo. Here we show the differential impact of APE1/ref-1 
heterozygosity on monofunctional and bifunctional glycosylase initiated BER. The traditional BER 
response to certain DNA base damages like uracil and alkylated bases, involves a monofunctional 
glycosylase-mediated removal of the damaged base resulting in the generation of an abasic site (AP site) 
that serves as a substrate for APE1/Ref-1 endonuclease activity. APE1/Ref-1 subsequently promotes 
formation of a transient single-strand break that serves as a substrate for -pol-mediated nucleotide 
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insertion and is followed by DNA ligase-mediated BER completion. -pol, dRP lyase activity serves as 
the rate limiting step in this pathway [125]. On the other hand, other damages like oxidized bases (e.g. 8-
hydroxyguanosine and thymine glycol) requires a bi-functional glycosylase mediated removal of the 
damage. These glycosylases have associated AP lyase activity resulting in 3’blocking ends. DNA 
polymerase requires a 3’OH group as its substrate for repair synthesis. Therefore 3’-blocking end 
trimming requires the 3’-phosphoesterase activity of APE1/Ref-1. -pol and DNA ligase subsequently 
complete the repair process. The 3’-phoshoesterase activity of APE1/Ref-1 is a crucial step in this bi-
functional glycosylase mediated BER [102].   In this study, we show the difference in the requirement of 
Ape1/Ref-1 in BER pathway in vivo. Our Apex
+/-
 mice exposed to 2-NP show significant upregulation in 
the UNG message with concomittant increase in the -pol protein and G:U mismatch BER capacity in the 
liver tissue.  We suggest that 2-NP, via its NO generation leads to increased uracil levels in the DNA 
resulting in the upregulation of UNG, a monofunctional glycosylase which is also associated in the 
processing of oxidized cytosine derivatives [110]. Since -pol is the rate limiting enzyme in this pathway, 
the liver extracts of Apex
+/-
 mice treated with 2-NP show significant induction in the G:U mismatch 
repair.  Apex
+/-
 mice treated with 2-NP showed increased CREB binding activity, a stress response 
transcriptional activator of -pol promoter, potentially explaining the induction of -pol expression [105]. 
It is widely accepted that -pol protein expression and activity strongly correlate with BER activity in 
response to a variety of stressors [83, 126-128].  Moreover, the endonuclease activity of APE1/Ref-1 is 
100 fold more efficient than the 3’ phosphoesterase activity [129], thus we suggest that the available 
APE1/Ref-1 protein in apex
+/-
 mice is adequate to sustain the monofunctional glycosylase initiated BER.  
In addition, increased p53 level can stabilize the APE1/Ref-1 and -pol protein complex on the DNA 
abasic site which would enhance BER activity [130,131].  
Alternatively, the liver tissues of the 2-NP treated Apex
+/-
 mice displayed significantly lower 8-
OH G:C BER activity compared to the wildtype animals.  OGG1 is a bifunctional glycosylase known to 
be involved in the removal of 8-OHdG.  While, OGG1 mRNA and protein levels are shown to be 
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unaffected during oxidative stress, the activity of this enzyme is enhanced by the increased APE1/Ref-1 
protein [132].  In line with these findings, our 2-NP treated Apex
+/-
 mice did not show any significant 
difference in the OGG1 mRNA levels.  Furthermore, addition of purified human OGG1 protein to BER 
reaction mixture did not increase OGG1 initiated BER activity in 2-NP treated Apex
+/-
 mice.  However, 
addition of purified APE1/Ref-1 protein to BER reaction mix resulted in a significant increase in the 8-
OH G: C BER activity in these mice confirming the significant role played by APE1/Ref-1 in the removal 
of 3’blocking groups.  These data indicate that APE1/Ref-1 3’ phosphoesterase activity is critical in 
removing the 3’blocking lesion created by a bifunctional glycosylase, e.g., OGG1. Therefore, APE1/Ref-
1 heterozygosity compromises this function resulting in reduced detectable single strand break, increased 
aldehydic lesions and reduced bifunctional DNA glycosylase initiated BER activity.   
Previously, we have measured the presence of AP sites, single-strand breaks and aldehydic 
lesions in isolated liver DNA from APE1/Ref-1 haploinsufficient mice and observed no significant 
difference in DNA damage accumulation as a result of reduced APE1/Ref-1 [92]. The lack of damage 
accumulation in untreated Apex
+/-
 mice suggested that APE1/Ref-1 haploinsufficiency in liver does not 
cause an accumulation of genotoxic DNA repair intermediate products under baseline conditions. In line 
with previous studies from our laboratory [83] and others [133], we have demonstrated a significant 
increase in 3'-OH-containing single-strand breaks in response to oxidative stress. However the level of 
detectable single strand breaks (SSB’s) in the liver tissue of 2-NP treated Apex+/- mice was found to be 
significantly lower than its wildtype counterpart while the level of aldehydic lesion was significantly 
higher. We suggest that the processing of oxidized bases by a bi-functional DNA glycosylase such as 
OGG1 (8-oxoguanine DNA glycosylase) could result in generation of aldehydic blocking lesions at 3’ 
end.  Inability to process these 3’ blocking groups in the absence of the 3’-phophoesterase activity of 
Apex in Apex
+/-
 mice [102], could result in lower detection of endonuclease-mediated single-strand breaks 
in the heterozygous animal.  
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Herein, we demonstrate that Ape1/Ref-1 haploinsufficiency does not promote a concomitant 
decline in G:U mismatch BER activity in the liver in response to oxidative stress, it rather displays a 
significant increase in this activity.  While, the high efficiency of APE1/Ref-1 endonuclease activity, 
upregulation in UNG and -pol expression appear to be the reason behind the significant increase in G:U 
mismatch repair activity, alternatively, recent studies report an APE1/Ref-1-independent BER pathway in 
human cells [103].  While mono-functional DNA glycosylases such as SMUG1 and TDG and bi-
functional DNA glycosylases/lyases such as OGG1 and NTH require APE1/Ref-1 to process AP sites and 
the 3’-OH aldehydic groups, respectively, APE1/Ref-1 backup enzymes have been identified for the 
repair of oxidative damage in vivo [134]. The recently discovered mammalian DNA glycosylase/AP 
lyases NEIL1 and NEIL2 recognize oxidative damage and generate DNA strand breaks with 3'-phosphate 
termini. Removal of the 3'-phosphate termini was shown to be dependent upon polynucleotide kinase 
(PNK) activity, not APE1/Ref-1, with NEIL1 serving as a backup enzyme. Additionally, a study by Das 
et al. [135] has demonstrated that NEIL1 is induced by oxidative stress. Therefore, it is likely that the 
observed increase in BER may be due to increased processing of DNA damage by an APE-independent 
-pol regulated BER pathway, however, this alternative pathway does not rescue the observed decline in 
8OHdG:C BER capacity in APE1/REF-1 haploinsufficient mice.  
In conclusion, we suggest that the optimal balance between the stress response transcription 
factors, notably NF-B, and the DNA repair pathway required for cell survival is attenuated in APE1/Ref-
1 haploinsufficient mice exposed to oxidative stress. Reduced redox activity of APE1/Ref-1 leads to 
reduced activation of NF-B potentially leading to cell cycle arrest and apoptosis. This notion is 
supported by the augmentation of GADD45g expression, a cell cycle arrest gene, observed in the liver of 
2-NP treated Apex
+/- 
mice. GADD45g has also been implicated in the promotion of apoptosis under 
environmental stress via the p38K-Jun NH2-terminal Kinase pathway [136,137]. Furthermore, Apex
+/- 
mice exposed to 2-NP show significant induction in the p53 protein levels and Caspase-3 activity in the 
liver, both being markers of apoptosis. Therefore, when APE1/Ref-1 is compromised the cells are more 
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susceptible to oxidative stress mainly due to reduced redox and 3’phosphodiestrase activity impacting cell 
survival, pushing it towards apoptosis. This finding has therapeutic importance as increased APE1/Ref-1 
levels in tumor cells have been shown to confer resistance to chemotherapeutic drugs perhaps via 
decrease in apoptosis [138].  In line with previous findings, inhibition of DNA repair or redox or both 
activities of APE1/Ref-1 using inhibitors could potentially sensitize the tumor cells to the therapeutic 
agents [138] making APE1/Ref-1 an attractive molecular target in the treatment of cancer.  
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FIGURE LEGENDS 
Fig. 3.1.  Expression and activity of APE1/Ref-1 in response to 2-NP in vivo. (A) APE1/Ref-1 mRNA 
expression was quantified using a real-time PCR and the data were normalized using GAPDH. Values 
represent an average ( S.E.M.) for data obtained from 5 mice in each group (B) The level of the 37-kDa 
APE1/Ref-1 protein in 200 g of liver nuclear extract as determined by western blot analysis. Values 
represent an average ( S.E.M.) for data obtained from 5 mice in each group (C) The level of APE1/Ref-1 
redox-activation of NF-B in 10 g of live nuclear extract as determined using EMSA. Values represent 
an average ( S.E.M. ) for data obtained from 5 mice in each group and are representative of separate 
independent experiments. (I.D.V.): integrated density value corresponding to the level of APE1/Ref-1 
protein as quantified by an AlphaInnotech ChemiImager; Lane A: nuclear extracts incubated in the 
presence of 100X molar excess of unlabeled NF-kB consensus DNA to confirm binding specificity; (*): 
value significantly different from control, wild-type mice at P < 0.05; (**): value significantly different 
from control, Apex
+/-
 mice at P < 0.05. Lamin B protein level served as nuclear protein loading control. 
The picture depicts the representative sample from each group. 
 
 
 
 
 
 
 
 
39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L
e
v
e
l 
o
f 
A
P
E
1
/R
e
f-
1
 m
R
N
A
(C
t 
V
a
lu
e
)
*
0
1
2
3
4
5
6
Control 2-NP Treated
L
e
v
e
l 
o
f 
A
P
E
1
/R
e
f-
1
 P
ro
te
in
(I
.D
.V
 p
e
r 

g
 p
ro
te
in
)
0
100
200
300
400
500
600
*
Control 2-NP Treated
TreatedControl
APE1/Ref-1
Lamin b
A
B
L
e
v
e
l 
o
f 
A
P
E
1
/R
e
f-
1
 m
R
N
A
(C
t 
V
a
lu
e
)
L
e
v
e
l 
o
f 
A
P
E
1
/R
e
f-
1
 P
ro
te
in
(I
.D
.V
 p
e
r 

g
 p
ro
te
in
)
40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NF-B
Control 2-NP A
free probe
*
L
e
v
e
l 
o
f 
N
F
-
B
D
N
A
 B
in
d
in
g
(I
.D
.V
. 
 p
e
r 

g
 p
ro
te
in
)
0
20
40
60
80
100
120
140
160
180
Control 2-NP Treated
C
L
e
v
e
l 
o
f 
N
F
-
B
D
N
A
 B
in
d
in
g
(I
.D
.V
. 
 p
e
r 

g
 p
ro
te
in
)
41 
 
 
Fig. 3.2.  Effect of 2-NP on APE1/Ref-1 expression levels in Apex
+/-
 mice. The level of the 37-kDa 
APE1/Ref-1 protein in 200 g of liver nuclear extract was determined by western blot analysis. Values 
represent an average ( S.E.M.) for data obtained from 5 mice in each group and are representative of 
separate independent experiments. (SDS-PAGE]: the level of APE1/Ref-1 protein was normalized based 
on the amount of protein loaded on each gel. (I.D.V.): integrated density value corresponding to the level 
of APE1/Ref-1 protein as quantified by an AlphaInnotech ChemiImager; Values with different letter 
superscripts indicate significant differences at P < 0.05. Lamin B protein level served as nuclear protein 
loading control. The picture depicts the representative sample from each group. 
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Fig. 3.3.  Effect of 2-NP on APE1/Ref-1 redox activation of NF-B in Apex+/- mice. The level of NF-B 
DNA binding in 10 g of liver nuclear extract was determined using EMSA. Values represent an average 
( S.E.M.) for data obtained from 5 mice in each group and are representative of separate independent 
experiments. (I.D.V.): integrated density value corresponding to the level of NF-B DNA binding as 
quantified by an AlphaInnotech ChemiImager;  Lane A: nuclear extracts incubated in the presence of 
100X molar excess of unlabeled NF-B consensus DNA to confirm binding specificity; Values with 
different letter superscripts indicate significant differences at P < 0.05. The picture depicts the 
representative sample from each group. 
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Fig. 3.4.  DNA Damage analysis in liver DNA of Apex
+/-
 mice injected with 2-NP.  (A) The level of 3'-
OH single-strand breaks as determined by the ROPS assay in liver of wild-type (Apex
+/+
) and Apex
+/-
 mice 
treated with 100 mg/kg body weight 2-NP.  (B) The level of Aldehydic lesions as determined by the ASB 
assay in liver of wild-type (Apex
+/+
) and Apex
+/-
 mice treated with 100 mg/kg body weight 2-NP.Values 
represent an average ( S.E.M.) for data obtained from 5 mice in each group and are representative of 
separate identical experiments. (C.P.M.): machine counts per minute corresponding to the level of -
[
32
P]dCTP incorporation as quantified by a Packard scintillation counter; (I.D.V.): integrated density 
value corresponding to the level of DNA as quantified by an AlphaInnotech ChemiImager; Values with 
different letter superscripts indicate significant differences at P < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
100
200
300
400
500
L
e
v
e
l 
o
f 
s
s
D
N
A
b
re
a
k
s
(d
C
T
P
In
c
o
rp
o
ra
ti
o
n
, 
C
P
M
)
Control 2-NP Treated
Apex+/+ Apex+/-
Control 2-NP Treated
0
20
40
60
80
100
N
u
m
b
e
r 
o
f 
A
D
L
s
p
e
r 
1
0
6
N
u
c
le
o
ti
d
e
s
(I
.D
.V
. 
p
e
r 

g
 D
N
A
)
Control 2-NP Treated
Apex+/+ Apex+/-
Control 2-NP Treated
120
a a
b
c
a
a
b
a
A
B
L
e
v
e
l 
o
f 
s
s
D
N
A
b
re
a
k
s
(d
C
T
P
In
c
o
rp
o
ra
ti
o
n
, 
C
P
M
)
N
u
m
b
e
r 
o
f 
A
D
L
s
p
e
r 
1
0
6
N
u
c
le
o
ti
d
e
s
(I
.D
.V
. 
p
e
r 

g
 D
N
A
)
47 
 
 
Fig. 3.5.  Effect of APE1/Ref-1 haploinsufficiency and 2-NP on G:U mismatch BER, DNA polymerase  
expression and CREB DNA binding activity. (A) The in vitro G:U mismatch BER was conducted using 
nuclear extracts from liver of control and 2-NP treated Apex
+/+
 and Apex
+/-
 mice. Base excision repair 
(BER) reaction products were resolved on a sequencing gel and visualized by autoradiography. Repair 
activity is visualized by the appearance of a 16b fragment. The relative level of BER was quantified using 
a Bio-Rad Molecular Imager
 
System. The data were normalized based on the amount of protein used in 
each reaction and expressed as machine counts per g of protein. (B) The level of the 39-kDa -pol 
protein in 200 g of liver nuclear extract was determined by western blot analysis. (SDS-PAGE): the 
level of -pol protein was normalized based on the amount of protein loaded on each gel. (C) The level of 
CREB DNA binding in 10 g of liver nuclear extract was determined using EMSA and -pol mRNA 
expression level as quantified using a real-time PCR and normalized with GAPDH Values represent an 
average ( S.E.M.) for data obtained from 5 mice in each group and are representative of separate 
identical experiments. (M): molecular weight standard; (-): negative control, G:U mismatch 
oligonucleotide incubated in the absence of nuclear extract and treated with HpaII restriction 
endonuclease; (+): positive control, G:U mismatch oligonucleotide incubated with recombinant -pol and 
treated with HpaII restriction endonuclease; (G:C): positive control, G:C oligonucleotide incubated with 
nuclear extract and treated with HpaII restriction endonuclease; (I.D.V.): integrated density value 
corresponding to the level of -pol protein and the level of CREB DNA binding as quantified by an 
AlphaInnotech ChemiImager; Lane A & B: nuclear extracts incubated in the presence of 100X molar 
excess of mutated and unlabeled CRE sequence with β-pol flanking region respectively to confirm 
binding specificity; Lamin B protein level served as nuclear protein loading control. Values with different 
letter superscripts indicate significant differences at P < 0.05. (*): value significantly different from wild-
type (Apex
+/+
) mice treated with 2-NP at P < 0.05. The picture depicts the representative sample from 
each group. 
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Fig. 3.6.  Effect of APE1/Ref-1 haploinsufficiency and 2-NP on 8 OH G:C BER and the consequence of  
hApe1 enrichment on the repair capacity. (A) The in vitro 8-OH G:C BER was conducted using nuclear 
extracts from liver of control and 2-NP treated Apex
+/+
 and Apex
+/-
 mice in the presence of 1.6 U of ogg1 
enzyme (New England Biolab, MA).  Base excision repair (BER) reaction products were resolved on a 
sequencing gel. Repair activity is visualized by the appearance of a 16b fragment. The relative level of 
BER was quantified using an Bio-rad ChemiImager.  The data were normalized based on the amount of 
protein used in each reaction and expressed as machine counts per g of protein. (B) The in vitro 8-OH 
G:C BER was conducted with human Ape1/Ref-1 (hApe1) enrichment. Values represent an average ( 
S.E.M.) for data obtained from 5 mice in each group and are representative of separate identical 
experiments. (M): molecular weight standard; (-): negative control, G:U mismatch oligonucleotide 
incubated in the absence of nuclear extract and treated with HpaII restriction endonuclease; Values with 
different letter superscripts indicate significant differences at P < 0.05. The picture depicts the 
representative sample from each group. 
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Fig. 3.7. Effect of 2-NP on UNG and OGG1 expression in Apex
+/-
 mice. (A) UNG mRNA expression 
level in control and 2-NP treated Apex
+/+
 and Apex
+/-
 mice as quantified using real-time PCR and 
normalized against GAPDH. (B) OGG1 mRNA expression level in control and 2-NP treated Apex
+/+
 and 
Apex
+/-
 mice as quantified using real-time PCR and normalized against GAPDH. Values represent an 
average ( S.E.M.) for data obtained from 5 mice in each group and are representative of separate 
identical experiments; Values with different letter superscripts indicate significant differences at P < 0.05. 
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Fig. 3.8. Effect of 2-NP on apoptosis in Apex
+/-
 mice. (A) GADD45g mRNA expression level was 
quantified using real-time PCR and normalized with GAPDH. (B) The level of the p53 protein in 200 g 
of liver nuclear extract was determined by western blot analysis. (SDS-PAGE): the level of p53 protein 
was normalized based on the amount of protein loaded on each gel. (C) The level of Caspase-3 activity in 
liver cytosolic extract as determined by Caspase-3 enzyme assay. Values represent an average ( S.E.M.) 
for data obtained from 5 mice in each group and are representative of separate identical experiments; 
Values with different letter superscripts indicate significant differences at P < 0.05. Lamin B protein level 
served as nuclear protein loading control. The picture depicts the representative sample from each group. 
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Table 1: Primer Sequences for Real-Time PCR 
5’- ATAAGAGCCCCAGAGGAGGAA-3’ 5’-AAGAGCTGTCTACAGACATCGA- 3’   UNG 
5’-AACAGGCTTGGTTGGCGAAGG-3’ 5’- CGGCTGGCATCCTAAGACATC-3’ OGG1 
5’-TACGACCAGAGGCATACAGGGACT-3’ 5’-GCACAGTCAAGGCCGAGA-3’ GAPDH 
5’-GCCAGCACGCAAAAGGTCACATTGT-3’ 5’-AGTTCCGGAAAGCACAGCCAGGATG-3’ GADD45g 
5’-GCGCCACTGGATGTAATCAAAAATG-3’ 5’-CTGGAAAAGGGCTTCACAATCAATG-3’ -pol 
5’-TACGACCAGAGGCATACAGGGACT-3’ 5’-ACCAACTGGGACGACATGGAGAAG-3’ -actin 
5’-GTGTAAGCGTAAGCAGTGTTG-3’ 5’-ATGAAGAAATTGACCTCCGTAACC-3’ Ape1/Ref-1 
Antisense Primer Sequence Sense Primer Sequence Gene 
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ABSTRACT 
Folate deficiency has been shown to influence carcinogenesis by creating an imbalance in the 
base excision repair (BER) pathway impacting BER homeostasis.  The inability to mount a BER response 
to oxidative stress in a folate deficient environment results in the accumulation of DNA repair 
intermediates, i.e., DNA strand breaks.  Our data indicate that upregulation in -pol expression in 
response to oxidative stress is inhibited by folate deficiency at the level of gene expression. Alteration in 
expression of -pol in a folate deficient environment is not due to epigenetic changes in the core promoter 
of the -pol gene, i.e., the CpG islands within the -pol promoter remain unmethylated in the presence 
and/or absence of folate.  However, the promoter analysis studies show a differential binding of 
regulatory factor(s) to the -36 to -7 region (the folic acid response region, FARR) within the core 
promoter of β-pol.  Moreover, we observe a tight correlation between the level of binding of regulatory 
factor(s) with the FARR and inhibition of -pol expression.  Based on these findings, we propose that 
folate deficiency results in an upregulation/stability of negative regulatory factor(s) interacting with 
FARR, repressing the upregulation of the -pol gene in response to oxidative stress. 
 
KEYWORDS: Oxidative stress; DNA polymerase-; Base excision repair; cAMP response element; 
DNA methylation; transcriptional regulation; folate deficiency  
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INTRODUCTION 
Bioactive food components found in normal diets have been determined to confer protection 
against many diseases by impacting the onset, progression and severity of the disease [139]. Studies on 
nutritional genomics, nutritional transcriptomics, nutritional epigenomics and proteomics provide 
evidence of the effect of these bioactive food components on individual biomolecules and their overall 
effect on health and disease.  Through their effect on biomolecules, bioactive food components can 
regulate many different pathways such as cell growth, differentiation, DNA repair, apoptosis and 
carcinogenesis [140]. These essential and/or non-essential factors of the diet have been shown to be 
capable of regulating gene expression [139]. Folic acid, an essential water soluble vitamin and a cofactor 
in one-carbon metabolism, has been associated with the etiology of many chronic diseases such as 
cardiovascular disease, neurological degeneration and cancer. Folate deficiency has been shown to 
enhance the potency of carcinogenic agents [141] and increase the accumulation of preneoplastic changes 
in the colon and liver of animal models [141,142]. Although the underlying mechanism of folate 
deficiency induced tumorigenesis is largely unknown, many different factors have been suggested as 
being responsible for its carcinogenic effect. Among those are epigenetic alterations, e.g., DNA 
methylation possibly via the reduction of S-adenosylmethionine [143,144], uracil misincorporation into 
the DNA [144,145] and deoxynucleotide imbalance [145,146].  However, data from human and animal 
studies reject the possibility of global DNA methylation as a potential mechanism behind folate 
deficiency induced tumorigenesis [147].  
Data from our laboratory and others suggest that apoptotic and DNA repair pathways might be 
potential targets of folate deficiency [146,148]. In other words, increased accumulation of DNA damages 
such as DNA strand breaks, increased somatic mutations and chromosomal aberrations observed during 
folate deficiency can be attributed to defective DNA repair. Moreover, folate deficiency has been shown 
to act synergistically with DNA damaging agents to increase mutation frequency and DNA strand breaks, 
suggesting potential compromises in DNA repair capacity as has been discussed previously[144,146,149].  
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Base Excision Repair [BER] is a sequential pathway involved in the repair of endogenous DNA 
damage and damages that arise from alkylation and oxidative stress, along with misincorporated uracil 
[150].  Data from our laboratory and others have provided strong evidence to indicate that BER is a stress 
response pathway [151,152].  In addition, we have previously demonstrated deregulation of BER in 
response to folate deficiency [149].  We have shown that folate deficiency impacts initiation of the BER 
pathway, i.e., uracil DNA glycosylase activity is upregulated, while no upregulation in the DNA 
polymerase  -pol) protein level and/or activity is observed. The inability to mount a BER response to 
stress in a folate deficient environment resulted in accumulation of DNA repair intermediates, i.e., DNA 
strand breaks which could potentially result in double strand breaks and chromosomal aberrations.  The 
objective of this study was to elucidate the molecular mechanism by which folate status impacts the 
regulation of DNA polymerase- expression.   
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EXPERIMENTAL PROCEDURES 
Animals -The experiments were performed in young (3-4 month), wild-type male C57BL/6 
specific pathogen-free mice in accordance with NIH guidelines for the use and care of laboratory animals. 
The Wayne State University Animal Investigation Committee approved the animal protocol. The mice 
were maintained on a 12-hr light/dark cycle and fed standard mouse chow and water ad libitum. At 3-4 
months of age, the mice were randomly assigned to two dietary groups and were fed
 
AIN93G-purified 
isoenergetic diets (Dyets, Inc., Lehigh Valley,
 
PA). Diets were stored at –20°C. 1% succinyl sulfathiazole 
was added to all diets. The control group received a folate adequate diet containing
 
2 mg/kg folic acid. 
The experimental group received a folate-deficient
 
diet containing 0 mg/kg folic acid. The
 
animals' food 
intake and body weights were monitored twice weekly
 
to monitor for signs of toxicity (e.g., weight loss), 
and the
 
experimental diets were continued for 8 weeks.  Mice were anesthetized in a CO2 chamber and 
sacrificed by cervical dislocation. Harvested liver was flash frozen and stored in liquid nitrogen. 
DNA damage induction- Experimental mice were intraperitonealy injected with 100 mg/kg body 
weight 2-nitropropane [2-NP; Aldrich Chemical Company, Chem. Abstr. Serv. Reg. No. (79-46-9)] 
dissolved in olive oil. Control mice were injected with olive oil vehicle intraperitonealy. Mice were 
sacrificed after 12hrs, 24hrs and 48hrs. The dose and exposure time were based on previous studies 
characterizing the effect of 2-NP on DNA damage and repair induction [153]. 
Analysis of 8-OHdG levels- Genomic DNA isolation was done using the NaI DNA extractor kit 
(Wako chemicals, Inc.,Richmond, VA) as described previously [154]. DNA oxidation that occurs during 
DNA isolation was minimized by the usage of NaI instead of phenol.  Nuclease P1 and calf alkaline 
phosphatase were used to hydrolyze 30ug of DNA. The levels of both 8-OHdG and 2dG in the DNA 
hydrolysates were quantified using a HPLC-EC detection system with a polar mobile phase. The level of 
DNA oxidation is expressed as the ratio of 8-OHdG to 2dG. 
64 
 
 
Gene expression profiling-The mRNA expression level of -pol was quantified using real-time 
PCR as described previously [155]. Briefly, total RNA was extracted from liver tissue of folate adequate 
and folate deficient control and 2-NP treated mice using the RNeasy Kit (Qiagen, Valencia, CA). First 
strand cDNA was synthesized from 1 g RNA using random primers (Promega, Madison, Wisconsin) 
and purified using the QIAquick PCR purification kit (Qiagen, Valencia, California). Expression of -pol 
was quantified using real time PCR with specific primers for the gene. The gene transcript was 
normalized to both Gapdh and β-actin [155]. External standards for all the genes were prepared by 
subcloning the amplicons, synthesized using the specific primers into PGEM-T easy vector.  
Nuclear protein isolation- Nuclear extracts were isolated using a transfactor extraction kit 
(Clontech, Mountain View, CA) as described previously [155]. The kit uses a hypotonic buffer to lyse the 
cell allowing the removal of cytosolic fractions and is followed by the extraction of nuclear proteins by a 
high salt buffer. All samples and tubes were handled and chilled on ice, and all solutions were made fresh 
according to the manufacturer’s protocol. Low molecular weight contaminants were removed from 
extracts by dialysis in 1L of dialysis buffer (20mM Tris-HCl, pH 8.0; 100mM KCl; 10mM NaS2O5; 
0.1mM DTT; 0.1mM PMSF; 1mg/ml PepstatinA) for 3 hours at 4C using Slide-A-Lyzer mini-dialysis 
units (Pierce Biotechnology, Rockford, IL) with a molecular weight cut off of 3.5kDa. Dialyzed extracts 
were aliquoted and flash frozen in liquid nitrogen and stored at -70C for subsequent analyses. Protein 
concentrations were determined according to Bradford using Protein Assay Kit I (Bio-Rad, Hercules, 
CA). 
Protein expression analysis- Western blot analysis was performed using 200 g of nuclear 
protein as described previously [155]. Upon completion of SDS-PAGE, the region containing the 
protein[s] of interest was excised and prepared for western blot analysis while the remaining portion of 
the gel was stained with GelCodeBlue Stain Reagent (Pierce Biotechnology, Rockford, IL) to ensure 
equal protein loading. Anti-sera developed against pol were used to detect the proteins of interest 
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followed by incubation with HRP-conjugated secondary antibody (Santa Cruz Biotechnology, Santa 
Cruz, CA). As an internal control to ensure equal protein transfer, membranes
 
were reprobed with PCNA 
antibody.  The bands were visualized and quantified using a ChemiImager System (Bio-Rad, Hercules, 
CA) after incubation in SuperSignal West Pico Chemiluminescent Substrate (Pierce Biotechnology, 
Rockford, IL). Data are expressed as the integrated density value (I.D.V.) of the band per mg of protein 
loaded. 
DNA Base Excision Repair Assay- The G:U mismatch repair assay is developed to measure 
monofunctional glycosylase-initiated base excision repair (BER) activity.  Radio-end labeled 30-bp 
oligonucleotides (upper strand: 5'-ATACCGCGGUCGGCCGATCAAGCTTATT dd-3'; lower strand: 3'-
ddTATATGGCGCCG GCCGGCTAGTTCGAATAA-5') containing a G:U mismatch and a Hpa II 
restriction site (CCGG) were incubated in a BER reaction mixture containing 50 g of the nuclear protein 
as previously described [156]. Repair of the G:U mismatch to a correct G:C base pair was determined via 
treatment of the duplex oligonucleotide with 20U of HpaII (Promega, Madison, WI) for 1hour at 37
◦
C and 
analysis by electrophoresis on a 20% denaturing 19:1 acrylamide/bis-acrylamide gel (SequaGel 
Sequencing System, National Diagnostics, Atlanta, GA). Repair activity (presence of a 16-mer band) was 
visualized and quantified using a Molecular Imager System (Bio-Rad, Hercules, CA) by calculating the 
ratio of the 16-mer product with the 30-mer substrate (product/substrate). Data are expressed as machine 
counts per microgram of protein.   
Methylation Assay- Methylation status of -pol promoter region: -643 to +44 was determined 
using the bisulfite genomic sequencing method to generate a methylation map with single base resolution. 
In brief, genomic DNA was isolated (Qiagen, Valencia, CA) from liver tissue obtained from folate 
adequate/deficient animals treated with/without 2-NP. DNA samples were treated with a bisulfite 
conversion reagent converting unmethylated cytosine residues to uracil according to the manufacturer’s 
protocol (Zymo Research, Orange, CA). Then, bisulfite treated DNA was PCR amplified using primers 
66 
 
 
designed around CpG islands: -105 to +44 and  -322 to -123 (Methprimers, San Francisco, CA) present in 
the  -pol promoter. The resulting amplicons were cloned into pGEM-T Easy Vector (Promega, Madison, 
Wisconsin). Plasmids from 7 colonies of each subclone were sequenced and the presence of preserved 
methylated cytosine residues representing methylation status was determined.    
Cell Culture and promoter Analysis- Mouse hepatoma (hepa 1-6) cells of epithelial origin were 
obtained from American Type Culture Collection (ATCC). The cells were cultured in monolayer 
condition in a standard DMEM medium (GIBCO BRL, Grand Island, NY) containing 4.5g/L glucose, 
4mg/L folic acid, or in a customized DMEM medium (GIBCO BRL, Grand Island, NY) free of folic acid 
and supplemented with 10% dialyzed fetal bovine serum (Thermo Scientific Hyclone, West Palm Beach, 
FL). Each of the growth mediums were supplemented with 1% penicillin streptomycin and maintained at 
37ºC in 10% CO2 and 95% relative humidity.  
For the promoter analysis a number of promoter-reporter constructs were created using fragments 
of the -pol promoter. The fragments    -924 to +38,  -602 to +38, -360 to + 38, -173 to +38, and -104 to 
+38 of the 5'-flanking region of the mouse β-pol gene encompassing the basal promoter and 5’ 
untranslated region were inserted into a pGL3 vector creating an array of promoter-reporter constructs: 
p924Luc, p602Luc, p360Luc, p173Luc and p104Luc, respectively. The hepa 1-6 cells maintained in a 
folate adequate medium were transfected with these promoter-reporter constructs using the effectene 
transfection reagent according to the manufacturer’s protocol [Qiagen, Valencia, CA].   After 24 hours of 
transfection, the cells were treated with 100µM of H2O2 for two hours.  24 hours later  the cell lysates 
were quantified for the luciferase activity using the Luciferase assay kit (Promega, Madison, WI) utilizing 
a 20/20 luminometer (Turner Biosystems).  β-galactosidase was used as an internal control for 
transfection.  For determining the β-pol promoter activity during folate deficiency,  hepa 1-6 cells 
maintained in folate adequate and folate deficient medium for 48hrs were transfected with p924Luc using 
the effectene transfection reagent following the manufacturer’s protocol (Qiagen, Valencia, CA).   After 
24 hours of transfection, the cells were treated with 100µM of H2O2 for two hours.  24 hours later, the cell 
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lysates from each of the conditions were quantified for the luciferase activity using the Luciferase assay 
kit (Promega, Madison, WI) utilizing a 20/20 luminometer (Turner Biosystems, Promega, Madison, 
Wisconsin). β-galactosidase was used as an internal control for transfection. 
DNA Foot printing- For DNA foot printing analysis fragments contained by the -924 to +311 
region of the -pol gene was amplified that included a 6-FAM labeled oligonucleotide for the forward 
primer. The 6-FAM labeled fragment consisted of a region of the -pol promoter, exon 1 and a portion of 
intron 1. We used this fragment for DNA footprinting. Each reaction required 8µg of nuclear extract, and 
50µg of template DNA. Nuclear extract, buffer and DNA template were added in this order to each tube 
while being kept on ice. Reactions were then transferred to a room temperature water bath and incubated 
for 20 minutes. Following the 20 min incubation at room temperature, 10 µl of a 1:50 dilution of DNase 1 
(10 U/µl) was added to each reaction and reaction mixtures were incubated at room temperature for 1 
minute. After 1 minute incubation with DNase 1, 50 µl of cold EDTA was added to each reaction, and the 
reactions were placed on ice. A control without nuclear extracts was also treated with DNase 1 along with 
the other samples. The completed reactions were then purified using the Qiaquick nucleotide removal kit 
(Qiagen, Valencia, CA). Fragments were separated on an ABI Prism 310 DNA genetic analyzer (Life 
Technologies, Carlsbad, CA) and processed by software using the Gene Scan application 
Electrophoretic mobility shift assay (EMSA)- A non-radioisotopic EMSA was used to determine 
the protein-DNA binding activity of nuclear extracts isolated from liver tissue of folate adequate and 
folate deficient mice treated with and without 2-NP, according to the manufacturer's protocol 
(LightShift Chemiluminescent EMSA kit, Pierce Biotechnology, Rockford, IL). Briefly, 40 fmol of 
biotin-end-labeled DNA -36 to -7  upstream β-pol promoter was incubated with 10 µg of nuclear extract 
in a 20 µl reaction mixture containing 1X binding buffer (100 mM Tris, 500 mM KCl, 10 mM DTT; pH 
7.5), 2.5% glycerol, 5 mM MgCl2, 50 ng/µl poly (dI-dC), and 0.05% NP-40. Negative controls (all 
components except nuclear extract) were included in all experiments. In competitive assays, 100X molar 
excess of unlabeled -36 to -7 oligonucleotide, mutant -36 to -7 oligonucleotide or consensus CRE/CREB 
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sequence were added to the reaction mixture. Samples were incubated for 20 min at room temperature 
and then resolved on a 6% non-denaturing polyacrylamide gel in 0.5X TBE buffer. After electrophoresis, 
samples were transferred from the gel to a positively charged nylon membrane and cross-linked. Biotin-
labeled protein/DNA complexes were detected by chemiluminescence and quantified using a 
ChemiImager System (AlphaInnotech, San Leandro, CA). Data are expressed as the integrated density 
value (I.D.V.) of the band/mg of protein loaded.  
Statistical analysis- Statistical significance between means was determined using ANOVA as 
described previously [155]. P-values less than 0.05 were considered statistically significant. 
RESULTS 
Analysis of formation of 8-OHdG, expression of DNA polymerase β and G:U mismatch BER during folate 
deficiency and 2-NP treatment in the liver of mice-  
Folate deficiency has been shown to influence carcinogenesis by creating an imbalance in the base 
excision repair pathway [149].  In this study we have characterized the effect of folate deficiency on BER 
in response to oxidative stress in vivo.  We used 2-Nitropropane (2-NP, a hepatocarcinogen) to induce 
oxidative stress in the liver of C57BL/6 mice.  2-NP has been shown to increase mutation frequency in 
rodents and has been suggested to induce cancer through the formation of DNA damages such as 8-OHdG 
and 8-aminoguanine in liver [153,155]. As reported previously by our laboratory [153,154], 2-NP 
treatment (i.p. injection of 100 mg/kg body weight) resulted in a significant increase in DNA oxidation, 8-
OHdG, and an upregulation in expression of pol in a time dependent manner.  We observed a six-fold 
increase (p < 0.001) in 8-OHdG levels 12 hr post treatment (Fig. 4.1A), while the -pol mRNA level 
reached its maximum at 12 hr and remained high at 24 hr post 2-NP treatment (Fig. 4.1B).  Moreover, we 
show a steady increase in the level of -pol protein in response to 2-NP (Fig. 4.1C).  Previously, it has 
been shown that -pol is a critical enzyme in BER [154,157]. As such, we observed a concurrent increase 
in BER activity (40%, p < 0.01) in response to 2-NP in liver tissues of the mice (Fig. 4.1D).   
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To further study the effect of folate deficiency on BER in response to oxidative stress, we 
analyzed BER activity in 2-NP treated animals fed a folate deficient diet.  We performed an eight-week 
feeding study where the C57BL/6 mice were fed a folate deprived diet.  As reported previously [148], this 
regimen resulted in a 90% decrease in plasma folate level and a 40% decrease in tissue folate levels with 
no significant change in the food intake and weight of these animals (data not shown).  As such, we 
expected to see an increase in BER activity in these animals. However, BER activity failed to be 
upregulated in response to folate deficiency. Moreover, we expected to see a further increase in BER 
activity in folate deficient mice in response to 2-NP.  Surprisingly, we observed no increase in BER 
activity in response to 2-NP in mice fed a folate deficient diet (Fig. 4.1D).  In agreement, we show that 
the lack of inducibility of BER in response to 2-NP in a folate deficient environment is preceded by a lack 
of induction in β-pol expression, i.e., β-pol mRNA and protein levels (Figs. 4.2A and 4.2B).  
Interestingly, 2-NP treatment of folate deficient mice resulted in a significant up-regulation in the 
expression of two key enzymes in the BER pathway, Ung and Ape1/Ref-1 (data not shown), while, 
upregulation of the β-pol gene was inhibited by folate deficiency. These findings signify that the effect of 
folate on gene expression is tightly regulated, i.e., the impact of folate deficiency is gene dependent.  
Thus, the inability to induce BER in response to oxidative stress in a folate deficient environment appears 
to be due to attenuation in the ability of the -pol gene to mount a response to oxidative stress.  Based on 
these findings, it is inviting to suggest that the mechanism by which folate deficiency induces 
carcinogenesis in response to DNA damaging agents is due in part to the inability to induce a BER 
response at the level of -pol expression, an important observation in the realm of nutrient gene 
interaction.  
Analysis of the promoter of DNA polymerase β for the methylation of CpG islands in the liver of mice-  
Folate deficiency has been shown to alter S-adenosylmethionine/S-adenosyl homocysteine ratio, 
thus impacting the levels of the universal methyl donor.  As such, folate deficiency has been suggested to 
impact gene expression through epigenetic modulation by modifying the methylation pattern of the 
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genome. DNA methylation generally occurs in the cytosine of CpG dinucleotides, converting the cytosine 
to 5-methyl cytosine. In order to dissect out the epigenetic effect of folate deficiency on β-pol expression, 
we analyzed the methylation status of the CpG islands found in the promoter of the β-pol gene, using the 
bisulfite genomic sequencing method. Using MethPrimer software [158], we identified two CpG islands 
within the first 687bp region of the β-pol promoter, and part of exon 1(Island 1: -105 to +44 and Island 2: 
-322 to -123).  Subsequently, primers were designed to amplify both islands, and the methylation status of 
the CpG sites within these regions was determined.  Herein, we demonstrate that folate deficiency does 
not alter the methylation pattern of the CpG islands in the promoter region of β-pol. Interestingly, no CpG 
sites were methylated in DNA samples obtained from liver of mice fed a folate deficient and/or adequate 
diet and treated with 2-NP (Fig.4.3).  We were concerned whether the lack of methylation at the CpG 
sites within these two islands is due to an artifact of the assay conditions.  Thus, we examined the 
methylation pattern of exon 8 of the p53 gene as control.  Exons 5-8 of p53 has been shown to be a ‘hot 
spot’ involved in neoplastic transformations, and this region has been shown to undergo alteration in its 
methylation patterns during folate deficiency [143,159]. Interestingly, all the CpG sites within exon 8 of 
the p53 gene were methylated.  Our findings with respect to the methylation patterns of the -pol 
promoter are consistent with the notion that promoter regions of housekeeping genes remain 
unmethylated. Therefore, our data illustrate that deregulation of β-pol expression by folate deficiency is 
not through epigenetic alteration of the core region of its promoter. It is inviting to suggest therefore that 
folate deficiency might be impacting β-pol expression transcriptionally by way of regulatory factors. 
Analysis of the DNA polymerase β promoter using DNA footprinting and gel retardation assays-  
           To further investigate the mechanism of altered transcription of DNA polymerase gene in 
response to oxidative stress in folate deficient mice, the cis acting region that is involved in this regulation 
was analyzed.  We initially determined the promoter region required for the upregulation of β-pol gene in 
response to oxidative stress in cultured liver cell lines, hepa 1-6.  First, the effect of H2O2 on β-pol mRNA 
in the mouse hepa 1-6 was examined.  In hepatoma cells, β-pol mRNA increased 2-fold by 100M H2O2 
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treatment for 2 hr, where no sign of cellular toxicity was observed (Fig.4.4A).  Consequently, we used a 
similar treatment to determine the promoter activity of the β-pol gene in cultured cells to identify the 
region of the promoter responsible for upregulation in response to oxidative stress.  Using a promoter 
analysis assay, we examined the regulation of -pol promoter activity in response to H2O2 and folate 
deprivation. The fragments -924 to +38,  -602 to +38, -360 to + 38, -173 to +38, and -104 to +38 of the 5'-
flanking region of the mouse β-pol gene were inserted into pGL3 vector creating an array of promoter-
reporter constructs: p924Luc, p602Luc, p360Luc, p173Luc and p104Luc, respectively.  After 
transfection, the luciferase activity for each construct was quantified and normalized against β-
galactosidase activity. The luciferase activity in the cells transfected with p924Luc, p602Luc, p360Luc, 
p173Luc and p104Luc were stimulated 2 to 3.5-fold following a 2 hr treatment with 100M H2O2.  This 
suggests that the core promoter encumbers the necessary elements required for response to oxidative 
stress (Fig.4.4B).  Interestingly, while folate deprivation resulted in a slight increase in β-pol promoter 
activity in cell culture, the robust upregulation in luciferase activity in response to oxidative stress was 
lost when the cells were cultured in the medium without folic acid (Fig. 4.4C).  These results suggest that 
the sequence -924 to +38 contains the cis-element which responds to oxidative stress as well as the 
elements harboring the regulatory factor(s) responding to folate deprivation.  This is the first report 
demonstrating that the folate responsive region of the β-pol gene promoter is located within the basal 
promoter encumbering the CRE region. 
To determine the differential protein-DNA binding pattern within the β-pol promoter, we 
performed a footprinting assay using DNA fragments contained by the -924 to +311 region of the β-pol 
promoter. To elucidate the protein/DNA interactions in a physiologically relevant model, liver nuclear 
extracts from mice were utilized for this assay. As depicted in Fig. 4.5, a significant difference in 
protection pattern in a region previously shown to hold the core promoter activity of human β-POL 
[160,161] was detected. In other words, the DNA footprinting profiles generated using this fragment 
showed differential protein-DNA binding patterns in the -36 to -7 upstream β-pol promoter region. 
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Interestingly extracts from 2-NP treated animals fed a folate adequate diet displayed maximum DNase I 
sensitivity suggesting the absence /reduced protein binding in this region (Fig. 4.5).   
The above findings provide evidence that region -36 to -7 upstream of the mouse -pol promoter 
shows a differential DNA protein binding pattern in response to folate deprivation and oxidative stress.  
This region which we refer to as the Folic Acid Response Region (FARR) contains a binding site for 
CRE.  CREB is a stress induced transcription factor shown to be responsible for activating gene 
expression when bound to the CRE region. The CRE site of the human β-POL promoter has been 
demonstrated to be involved in its expression both under basal conditions and when exposed to DNA 
alkylating agent [162-164]. Herein we attempted to identify transcription factor(s) that mediate the up-
regulation of the -pol in response to oxidative stress and potential factors that appear to have negative 
regulatory impact on the expression of -pol in response to folate deficiency.  We performed 
electrophoresis mobility shift assays (EMSA) to measure the ability of nuclear extracts isolated from the 
liver of mice to bind to the FARR (-36 to -7).   For these experiments, nuclear extracts from the liver of 
mice fed a folate adequate and a folate deficient diet, were subjected to gel shift assays using the FARR 
probe.   As shown in Fig. 4.6A, we observed a shifted band, complex 1. The intensity of this band was 
consistently stronger in extracts obtained from liver tissues of folate deficient mice as compared to mice 
fed a folate adequate diet and/or mice exposed to oxidative stress, 2-NP.  In other words, the protein 
composing this shifted band appeared to be the factor that responds to oxidative stress and folate 
deficiency by altering its binding capability to the FARR.  For example, the 2-NP treated folate adequate 
animals showed protein binding ~50% lower than the controls (Fig. 4.6A, lane 3), whereas the folate 
deficient animals exposed to oxidative stress showed ~50% increase in binding activity (Fig. 4.6A, lane 
3).  Interestingly, these data show an inverse correlation between the level of DNA binding activity to the 
β-pol promoter, FARR, and the β-pol mRNA expression (Fig. 4.1 D), i.e., the least binding activity in 
folate adequate 2-NP corresponds to maximal β-pol expression, and higher binding activity in folate 
deficient 2-NP corresponds to the lowest β-pol expression.   
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To address the specificity of the protein/DNA binding activity observed above, we performed 
competition assays, using cold, mutated FARR and CRE/CREB consensus oligonucleotides.  Fig. 4.6C 
shows the results of a competition assay using 100X molar excess of the unlabelled probe.  This 
competitor eradicated the shifted band indicating the binding activity to be specific.  Moreover, the 
shifted band was also eliminated with 100X molar excess of an unlabelled mutated -36 to -7 probe 
(FARR with mutation in the CRE site: 5’-TGACGTCA-3’ mutated to 5’-TGTGGTCA-3’) suggesting 
that the binding activities seen in these conditions are not specific to the consensus CRE site (Fig. 4.6C 
lane 3).   Furthermore, Fig. 4.6C also shows the result of a competition assay using a consensus 
CRE/CREB (5’-TGACGTCA-3’) probe as competitor. This competitor did not affect the formation of the 
shifted band, indicating that the factor involved is less likely to belong to the CREB/ATF family. We 
cannot, however, exclude the possibility that CREB/ATF is one of the components of this complex, given 
that the affinity of CREB/ATF to the CRE site of the mouse -pol promoter is not known. Additionally, a 
gel shift assay performed with the labeled CRE mutated FARR showed significant DNA binding activity, 
confirming that the binding is not specific to CRE, while the shifted band did not show any super shifts 
when antibodies to ATF and AP-1 complex were added to the nuclear extracts (Data not shown). These 
findings indicate that the factors which show differential binding activity to the FARR segment of the β-
pol promoter do not belong to the ATF or AP-1 families. Therefore, it is inviting to suggest that the 
proteins binding to the elements within the FARR region in nuclear extracts obtained from 2-NP treated 
mice fed a folate deficient diet are negative regulatory factors independent of CREB/ATF, and inhibit 
induction of -pol expression in response to oxidative stress. 
DISCUSSION 
Folate deficiency has been associated with many types of cancer, but the underlying molecular 
mechanism of its tumorigenic effect has not yet been elucidated. Inconsistencies observed in studies 
conducted on folate deficiency and supplementation suggest that association between cancer and folate 
status is dependent on the timing of dietary treatment and the exposure to stress inducing agents and 
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carcinogens [165-169]. Low plasma folate levels have been associated with increased risk of colorectal 
cancer development in individuals with single nucleotide polymorphism in the methylene tetrahydrofolate 
reductase gene [139,170]. Folate deficiency has also been shown to incapacitate the DNA repair 
pathways, a potential mechanism behind the accumulation of DNA damage during this deficiency 
[144,146,149,171]. Moreover, agents such as methotrexate, an inhibitor of dihydrofolate reductase, have 
been shown to reduce the efficiency of excision repair in CHO cells [172]. Furthermore, BER, a DNA 
damage inducible pathway [151-153,164,173,174] has been shown to lose its ability to respond to damage 
during folate deficiency, leading to the accumulation of toxic intermediates [149].  
Although folate deficiency has been implicated in inducing cellular stress and impacting DNA 
repair potential in cells and animal models, the exact mechanism is still not understood. Using microarray 
analysis and a proteomics approach, recent studies demonstrate the differential effect of folate deficiency 
on pathways associated with cancer development, DNA repair and apoptosis.  A study done on colon 
cancer cells  shows that folate deficiency alters the expression of vital genes involved in many pathways, 
such as DNA repair, apoptosis, angiogenesis and cell cycle control [175]. Data from our lab shows that 
folate deficiency in BER compromised mice suppresses DNA repair and promotes apoptosis by altering 
the expression of key genes involved in these pathways [148].  Furthermore, proteomic analyses, done on 
folate deficient rat livers, show differential expression of certain proteins involved in oxidative stress and 
cancer pathways [176]. Thus folate deficiency seems to affect these pathways by targeting specific genes 
involved in them. In line with these studies, earlier data from our lab demonstrate that folate deficiency 
negatively regulates BER by affecting the expression of its key enzyme DNA polymerase β, and that 
folate deficiency and β-pol haploinsufficiency interact to increase the accumulation of DNA damage 
[149]. In this study, we provide further data that sheds light on the mechanism by which folate deficiency 
impacts β-pol expression at the level of transcription and prevents its upregulation even under the 
influence of oxidative stress.   
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DNA polymerase β plays a very important role in embryogenesis, gap-filling repair synthesis and 
recombination repair [161-163]. β-pol is considered to be a housekeeping gene and is constitutively 
expressed in all cell cycle stages with differential expression based on the tissue type [161-163]. β-pol 
exhibits dual function in short patch BER, namely polymerase and dRP lyase activity, and has also been 
demonstrated to play a critical role in Long-Patch BER [157,177,178]. Homozygous deletion of β-pol is 
embryonic lethal, whereas the heterozygous knockouts survive and are fertile [179]. β-pol 
haploinsufficient mice display ~ 50% reduced β-pol protein levels and significant reduction in their β-pol 
dependant G:U mismatch BER efficiency [153,154]. This reduction in β-pol and BER efficiency is 
thought to be responsible for the increase in mutation frequency seen in these animals when exposed to 
alkylating agents [154]. In addition, studies conducted on β-pol null cells show the accumulation of DNA 
damage in response to stress inducing agents [180,181].   
DNA polymerase β has been demonstrated to be a DNA damage inducible gene i.e., β-pol 
expression has been shown to be upregulated in response to alkylating and oxidizing agents 
[153,155,164]. In this study, folate deficiency is shown to inhibit the upregulation of β-pol mRNA and 
protein levels in response to 2-NP, an oxidizing agent, whereas, upregulation of other key enzymes in the 
BER pathway, namely Ung and Ape1/Ref-1, are unaffected. Thus, the impact of folate deficiency on gene 
expression seems to be gene specific.  Folate deficiency is well known for its effect on DNA methylation 
via the reduction of the universal methyl donor, SAM. Alterations in DNA methylation in general have 
been strongly associated with cancer formation, and these alterations are believed to occur early in cancer 
development [182]. Due to the strong association between genomic hypomethylation and tumor formation 
especially in colon, stomach, thyroid, breast, uterine and prostate cancers [166,182-185], folate deficiency 
is suggested to cause cancer via this epigenetic effect. Here in this study, we observed no alterations in the 
methylation pattern of the CpG rich regions within β-pol promoter during folate adequacy and deficiency. 
No methylated CpG sites were found in the CpG islands identified within this region of β-pol promoter. 
This data suggests that epigenetic alterations, at least in the core promoter region of β-pol, are not the 
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mechanism behind the loss of induction of β-pol during folate deficiency. This observation is in line with 
the notion that the promoter regions of the housekeeping genes are usually not methylated to maintain 
basal expression [186].  
Expression of a gene can be tightly regulated at different points during its conversion from DNA 
to protein. Gene expression in part is controlled by the interaction of cis-elements within the promoter of 
the gene with their associated protein factors. Our study shows that the elements within the -104 to +38 
region of a β-pol promoter are sufficient for the induction of the β-pol gene in hepa 1-6 cells exposed to 
oxidative stress. This finding is in agreement with previous work from other labs which showed that the 
first 100 nucleotides 5’ of exon 1 of human β-POL had the core promoter activity [160,161].  Wilson et al 
further identified SP1 and CRE sites within this region [161]. Sp1 sites in the human core β-POL 
promoter have been shown to be involved in the transcriptional activation of the TATA less promoter 
[187]. The CRE site, the general binding site for ATF-1, CREB-1, CREM-1 and AP-1, has been shown to 
be involved in the expression of human β-POL during basal conditions and during stress [162-164,188]. 
Mouse β-pol has also been shown to have this consensus palindromic sequence for CREB, and was 
shown to be required for transcriptional activation of β-pol by adenovirus type 12 E1A proteins [189]. 
DNA alkylating agents like MNNG require the CRE region for inducing β-pol [162]. MNNG treatment 
increases CREB-1 levels by 10-fold in CHO cells which in turn is responsible for β-pol induction [162]. 
In addition, Lamph et al. have demonstrated that CREB, the CRE binding protein, can act as an activator 
when phosphorylated, and can also act as a repressor in the dephosphorylated state [190]. Further, the 
CRE consensus sequence has similarities to the AP-1 binding site (TGACTCA) [190,191] and the AP-1 
complex can act both as an activator and repressor [192-194]. It has also been shown that AP-1 can bind 
to the CRE site and act as a repressor in the expression of MyoD1 involved in muscle cell differentiation 
[195]. Additionally, Wilson et al, have identified a 60Kda novel ATF protein called ATF2d in human 
testis with incomplete N-terminus [163]. This ATF-2d protein has been demonstrated to have the capacity 
to bind to a β-pol promoter and negatively regulate it [163]. Our data from hepa1-6 cells show that the 
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promoter activity of β-pol is attenuated during folate deficiency even under oxidative stress. This 
correlates closely with the attenuation of β-pol expression observed in mouse liver during folate 
deficiency. Our footprinting analysis and gel shift assays done on mouse liver extracts show the 
involvement of the FARR site of β-pol promoter encompassing the CRE in the regulation of β-pol 
expression during folate deficiency and oxidative stress. The footprinting and gel shift assays provide 
evidence that the elements within the FARR site behaves as a negative regulatory site, and the factors 
binding to these elements act as potential repressors of β-pol expression, keeping the -pol expression at 
the basal level. Furthermore, our data show that the factors binding to the FARR are not specific to the 
consensus CRE sequence. This observation indicates that the negative regulatory factor binding to the 
FARR site during folate deficiency might be independent of the CREB/ATF family. 
In conclusion, folate deficiency impacts the BER capacity by regulating β-pol expression at the 
level of transcription. This regulation possibly goes beyond folate deficiency’s general impact on DNA 
methylation and controls the β-pol expression through the interplay of cis and trans acting regulatory 
factors. Our data provides evidence that folate deficiency potentially inhibits β-pol induction through 
negative regulatory factors and keeps its expression at the basal level. However, further characterization is 
required to identify the inhibitory factors as well as other potential regions of repression. 
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FIGURE LEGENDS 
Fig. 4.1. Effect of 2-NP on β-pol expression and level of 8-OHdG in liver of C57BL/6 mice.  [A] The 8-
OHdG levels in liver tissues of control and 2-NP treated mice were measured by HPLC and EC detector. 
The data are expressed as values relative to the amount of 2dG detected by UV absorbance at 290nm. [B] 
DNA polymerase β mRNA levels in the liver tissues of control and 2-NP treated mice were quantified 
using real-time PCR and normalized against Gapdh. [C] The levels of β-pol protein in 100 g of liver 
nuclear extract obtained from control and 2-NP treated mice were determined by western blot analysis. 
The level of β-pol protein was normalized based on the amount of protein loaded on each gel. PCNA 
served as the nuclear protein loading control. [I.D.V.]: integrated density value corresponding to the level 
of β-pol protein as quantified by a Bio-Rad ChemiImager System.  Effect of folate deficiency and 2-NP 
on Base Excision Repair activity. [D] The in vitro G:U mismatch BER assay was conducted using nuclear 
extracts obtained from liver of control and 2-NP treated mice fed a folate adequate and/or folate deficient 
diet. The reaction products were resolved on a sequencing gel. Repair activity was visualized by the 
appearance of a 16b fragment. The relative level of BER was quantified using a Bio-Rad Molecular 
Imager
 
System. The data were normalized based on the amount of protein used in each reaction and 
expressed as machine counts per g of protein. Values represent an average [ S.E.M.] for data obtained 
from 5 mice in each group and are representative of separate identical experiments. Values with different 
letter superscripts indicate significant differences at P < 0.05. FA: Folate adequate; FD: Folate deficient. 
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Fig. 4.2.  Effect of folate deficiency and 2-NP on the expression of β-pol. [A] DNA polymerase β mRNA 
expression level in the liver tissues of control and 2-NP treated mice fed a folate adequate and/or folate 
deficient diet were quantified using real-time PCR and normalized against Gapdh. [B] The levels of β-pol 
protein in 100 g of liver nuclear extract obtained from control and 2-NP treated mice fed a folate 
adequate and/or folate deficient diet were determined by western blot analysis. The levels of β-pol protein 
were normalized based on the amount of protein loaded on each gel. [I.D.V.]: integrated density value 
corresponding to the level of β-pol protein as quantified by a Bio-Rad ChemiImager System. Values 
represent an average [ S.E.M.] for data obtained from 5 mice in each group and are representative of 
separate identical experiments. Values with different letter superscripts indicate significant differences at 
P < 0.05. FA: Folate adequate; FD: Folate deficient. 
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Fig. 4.3.  Effect of folate deficiency and 2-NP on methylation of β-pol promoter.  Methylation of 
promoter/Exon1 of the β-pol gene was determined by bisulfite sequencing assay with single base 
resolution.  The bisulfite treated DNA was PCR amplified using primers designed around CpG islands. 
The resulting amplicons were cloned into pGEM-T Easy Vector. Plasmids from 7 colonies of each 
subclone were sequenced and the presence of preserved methylated cytosine residues representing 
methylation status was determined. [A] Sequence of the two CpG islands [Island 1: -105 to +44 and 
Island 2: -322 to -123] present in the β-pol promoter/Exon1 has been illustrated. [B] Methylation patterns 
of the CpG sites present within the CpG islands of the β-pol promoter/Exon1 has been depicted. Open 
circle: unmethylated CpG site; Solid circle: methylated CpG site.   FA: Folate adequate; FD: Folate 
deficient. 
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Fig.4.4. Effect folate deficiency and hydrogen peroxide on β-pol expression and promoter activity in hepa 
1-6 cell line. [A] DNA polymerase β mRNA levels in hepa 1-6 cells treated with H2O2 [0, 100, 200, 300, 
500µM] were determined.  Hepa 1-6 cells were treated for 2 and 4 hrs with H2O2 and the levels of -pol 
mRNA were quantified using real-time PCR 24hrs post treatment.  The data were normalized against 
Gapdh. [B] Relative promoter activity of sequential deletions of      -924 to +38 upstream region of β-pol 
promoter transfected into hepa 1-6 cell line was determined.  The transfected hepa 1-6 cells were treated 
with H2O2 [100µM] for 2hrs.  Luciferase activity was determined 24hrs post treatment and normalized by 
-galactosidase activity. [C] Effect of folate deficiency and H2O2 treatment on the relative promoter 
activity of -924 to +38 upstream region of β-pol promoter transfected into hepa 1-6 cell line were 
determined. The transfected cells were treated with H2O2 
Luciferase activity was determined 24hrs post treatment and normalized by -galactosidase activity. 
Values represent an average [ S.E.M.]. FA: Folate adequate; FD: Folate deficient. 
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Fig.4.5. β-pol promoter DNase I footprinting analysis.  DNase I footprinting assay was performed using 
the –360 to +97 fragment of -pol promoter and nuclear extracts obtained from liver tissues of mice fed a 
folate deficient and/or folate adequate diet.  DNA fragments were analyzed using ABI Prism 310 Genetic 
Analyzer [Life Technologies, Carlsbad, CA]. Numbers at the top of the panel represent fragment length in 
nucleotides. The specific protected fragment encompassing the CRE/CREB binding site is shown in an 
expanded view.  The DNA sequence of the region is displayed above with the CRE/CREB consensus site 
highlighted. FA: Folate adequate; FD: Folate deficient. 
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Fig.4.6.  Effect of folate deficiency and 2-NP on DNA binding activity in nuclear extracts obtained from 
liver tissues of C57BL/6 mice. [A] Binding of liver nuclear extracts to the -36 to -7 region [FARR, 5’–
AGCCTGGCGCGTGACGTCACCGCGCTGCGC-3’] of the -pol promoter.  Nuclear extracts were 
obtained from liver tissues of mice fed a folate deficient and a folate adequate diet and were analyzed [10 
sing biotin-end-labeled FARR 
oligonucleotide as described in Methodology.  [B] The shifted bands observed in the Panel A [Complex 
1] were quantified using a Bio-Rad ChemiImager
 
System. Values represent an average [ S.E.M.] for 
data obtained from 5 mice in each group and are representative of separate independent experiments. [C] 
The specificity of protein-DNA binding activity was determined by competition assays. Mobility shift 
assays were performed in the presence of 100x molar excess of cold FARR [Lane b, 5’–
AGCCTGGCGCGTGACGTCACCGCGCTGCGC-3’], mutated FARR [Lane c, 5’-
AGCCTGGCGCGTGTGGTCACCGCGCTGCGC-3’], and CRE/CREB Consensus [lanes d-f, 5’- 
AGAGATTGCCTGACGTCAGAGAGCTAG-3’] oligonucleotides. Lane a is a positive control and does 
not contain any competitor. I.D.V., integrated density value.  Values with different letter superscripts 
indicate significant differences at P < 0.05. FA: Folate adequate; FD: Folate deficiency. 
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Chapter 5 
The impact of folate and methionine dietary interventions on base excision repair pathway   
and colon cancer in response to a carcinogen 
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Introduction 
Base excision repair (BER) is one of the major excision repair pathways capable of processing upto 
1,000,000 nucleotides/cell/day.  Base excision repair is a dynamic repair pathway responsible for 
repairing endogenous damages. This DNA repair pathway is a stress inducible pathway capable of 
repairing non helix distorting damages such as oxidative and alkylation damages (196-201). Base excision 
repair is a linear pathway consisting of a series of enzymes which functions in a co-ordinated manner. The 
traditional BER pathway involves the removal of a single damaged base such as an alkylated base or 
misincorporated uracil from the DNA. Briefly, the repair begins with a monofunctional glycosylase which 
removes the damaged base and leaves behind an abasic site. This abasic site acts as the substrate for the 
next enzyme in the pathway, apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1), an 
endonuclease which also functions as a 3’-phosphodiesterase, 3’-phosphatase and 3’-5’-exonuclease 
activities (202). APE1/Ref-1, has also been characterized as a redox factor involved in many redox 
signaling pathways (203,204). The single strand break with 3’-OH end left behind by the endonucleolytic 
action of APE1/Ref-1 becomes the substrate for the next enzyme DNA polymerase  (-pol). -pol, 
functions as a dRPlyase initially removing the dRP flap. This dRPlyase activity has been found to the rate 
determining step in this monofunctional glycosylase initiated pathway (205). After the removal of the 
dRP flap, -pol inserts a new nucleotide to the 3’-OH end. Subsequently, DNA ligase seals the nick 
completing base excision repair. On the other hand, certain other damages such as 8-hydroxyguanosine 
and thymine glycol require a bifunctional glycosylase for its removal. These bifunctional glycosylase’s 
have Ap lyase activity which blocks the 3’end. This blocked end requires trimming by the 3’-
phosphoesterase activity of APE1/Ref-1, thus generating 3’-OH end and subsequently -pol inserts a new 
nucleotide and ligase seals the nick.  The base excision repair pathway and specifically the enzymes 
involved in this pathway are critical during embryonic development. Deletion of both alleles of 
APE1/Ref-1 has been shown to be embryonically lethal, but the heterozygous knockout mice survive and 
are fertile (206-208). In our previous study we have reported the loss of bifunctional DNA glycosylase-
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initiated BER and increased induction of aldehydic lesions during APE1/Ref-1 haploinsufficiency in 
response to oxidative stress (208). Likewise, homozygous deletion of -pol in mice has been shown to be 
embryonically lethal, but again the heterozygous knockout mice survive (209).  Cabelof et al, have shown 
the impairment of the BER pathway and the consequent increase in single strand break accumulation 
during -pol haploinsufficiency (210). Furthermore, dietary manipulations like folate deficiency have 
been reported to deregulate the base excision repair pathway and this impairment was shown to be 
accelerated by -pol haploinsufficiency (211).    
              Folic acid, a water soluble vitamin is essential for one-carbon transfer reactions and plays a vital 
role in all metabolic reactions. The folate cycle consists of three major segments. The first segment 
involves the conversion of dietary folate into tetrahydrofolate and dihydrofolate and the regeneration of 
tetrahydrofolate. During this cycling of folate intermediates one carbon transfers take place for purine and 
pyrimidine especially thymidine biosynthesis. The second segment of the folate cycle is the trans-
methylation pathway, whereby the universal methyl donor s-adenosyl methionine is formed. Methionine, 
an essential amino acid enters the folate cycle at this point from the diet and helps in the formation of s-
adenosyl methionine and homocysteine. Finally, methionine is regenerated with the help of a folate 
intermediate. The third segment of the folate cycle consists of the trans-sulfuration pathway, which results 
in the conversion of homocysteine into cystathionine.  Cystathionine further forms cysteine which in turn 
gets converted to glutathione, a major cellular antioxidant. Therefore, a low folate status because of  its 
multivariate role could impair DNA synthesis, DNA methylation and redox status of the cell.  
               Intrauterine folate deficiency has been very definitively shown to result in neural tube defects in 
newborns and this has lead to the scheme of the current folate fortifications. Folate deficiency has also 
been associated with many other diseases such as anemia, cardiovascular diseases, neurological 
degeneration and cancer, in particular colorectal cancer. Although the exact mechanism behind folate 
deficiency induced tumorigenesis is largely unknown, many studies on folate deficiency have shown 
abnormal epigenetic alterations and accumulation of DNA damages such as single strand breaks and 
93 
 
 
mutations, leading to genomic instability, micronuclei formation, chromosomal aberrations and 
eventually cancer. Further, folate deficiency has been suggested to impair DNA repair pathways which 
provide a plausible explanation for the accumulation of the aforementioned damage. In support of this, 
folate deficiency has been shown to increase the potency of DNA- damaging agents and increase 
mutation frequency and DNA strand breaks (211-213). On the other hand, the second essential component 
of the folate cycle, methionine, when restricted has been shown to extend mean and maximum life-span in 
laboratory rodents (214-216). Methionine restriction has also been shown to reduce free radical leak and 
oxidative stress in laboratory rodents (214-216). Depletion in methionine has also been shown to reduce 
proliferation of cancer cells and promote apoptosis making methionine restriction a potent anti-cancer 
strategy. It is intriguing that these two integral factors of the same cyclic pathway display very different 
effects when they are depleted. Therefore, the objective of this study is to evaluate the differential effect 
of folate deficiency and methionine restriction on the BER pathway and cancer incidence.  
Experimental Procedures  
Animals- All the experiments were performed in male C57BL/6 specific pathogen–free young wildtype 
mice in accordance with NIH guidelines for the use and care of laboratory animals. The Animal protocol 
was approved by the Wayne State University Animal Investigation Committee. The animals were fed the 
standard mouse chow and water ad libitum and were maintained on a 12-hr light/dark cycle.  
Diets and Carcinogen treatment- At 3-4 months of age, the mice were randomly assigned to four dietary 
groups and were fed AIN93G-purified isoenergetic diets (Dyets, Inc.,Lehigh Valley,PA) as described 
previously (211). Diets were stored at -20°C. The control group received a folate adequate/ methionine 
adequate diet (2mg/kg folic acid and8.2 mg/kg methionine: FA/MA).  The experimental groups received 
folate deficient diet (0 mg/kg folic acid: FD), methionine restricted diet (1.64mg/kg methionine: MR) and 
folate deficient/methionine restricted diet (0mg/kg folic acid/1.64mg/kg methionine: FD/MR). All diets 
were supplemented with 1% succinyl sulfathiazole. The animals were monitored for signs of toxicity. One 
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week into the respective diets, mice were treated with 1,2-dimethylhydrazine HCl  (DMH, 30 mg/kg body 
weight) in 10 mmol/litre of NaHCO3 (Fisher Scientific)intraperitoneously once a week for 6 weeks (Fig. 
1A) as previously described (lisa’s,JBC). The animals were monitored for signs of toxicity and the 
experimental diets were continued for 12 weeks. Mice were anesthetized in a CO2 chamber and the 
abdominal cavity was opened up for excising the colon and harvesting the liver tissue. The harvested liver 
was flash frozen and stored in liquid nitrogen. 
Aberrant crypt foci (ACF) analysis- The excised colons were rinsed with cold phosphate-buffered saline, 
cut longitudinally, and fixed flat overnight in 10% neutral buffered formalin as described previously 
(217). The fixed colons were stained with 2g/litre of methylene blue in phosphate-buffered saline for 5 
mins. The number of ACF and aberrant crypts per foci were determined by light microscopy at 10X 
magnification in a blinded manner as described previously (217).  
Tumor Analysis- Randomly selected animals from the folate adequate control and folate deficient groups 
were continued on the experimental diets for 40 weeks after the last dosage of DMH. After 40 weeks 
these animals were anesthetized under CO2 and sacrificed for tumor analysis as described previously 
(217). Briefly, all organs and tissues were examined for grossly visible lesions. Liver and colon tissues, 
including gross abnormalities, were fixed in 10% neutral buffered formalin, trimmed, embedded in 
paraffin, sectioned to a thickness of 5-6uM, stained with H&E, and examined microscopically. 
Preparation of slides for histopathology evaluation was performed by pathologists at the Department of 
pathology, Wayne State University.  
Uracil-Aldehyde-Reactive Slot blot Assay- Liver DNA for the Uracil and aldehyde reactive probe slot blot 
(ASB) assay was extracted using DNeasy Kit (Qiagen, Maryland, USA) as described in the 
manufacturer’s protocol.  
             ASB assay-Aldehydic lesions in the DNA was quantified using the ASB assay as described 
previously (211,218). Briefly, about 8ug of extracted DNA in 1X Tris-EDTA buffer (TE) was treated 
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with aldehyde reactive probe (ARP; Dojindo Laboratories, Kumamoto, Japan) at 37°C for 15 mins. 
Further the DNA was precipitated using NaCl/Glycogen/Isopropanol precipitation and resuspended in 1X 
TE buffer. The probed DNA was heat denatured at 100°C for 10 min, quickly chilled on ice, and mixed 
with an equal volume of 2M ammonium acetate. The nitrocellulose membrane (Schleicher and Schuell) 
was prewet in deionized water and washed for 10 min in 1mM ammonium acetate. DNA was 
immobilized on the pretreated nitrocellulose membrane using an Invitrogen filtration manifold system. 
The membrane was washed in 5X SSC for 15 min at 37°C and then baked under vacuum at 80°C for 
30mins. The dried membrane was incubated in a hybridization buffer (20mM Tris, pH7.5, 0.1 M NaCl, 
1mM EDTA, 0.5% (w/v) casein, 0.25% (w/v) bovine serum albumin, 0.1% (v/v) Tween 20) for 30 min at 
room temperature. The membrane was then incubated in fresh hybridization buffer containing 100ul of 
strptavidin-conjuagated horseradish peroxidase (BioGenex, San Ramon, CA) at room temperature for 45 
min. Following incubation in horseradish peroxidase, the membrane was washed three times for 5min 
each at 37° C in TBS, pH 7.5, (0.26 M NaCl, 1mM EDTA, 20mM Tris, pH 7.5, 0.1% Tween 20). 
Membrane was incubated in Super signal West Pico Chemiluminescent Substrate (ThermoScientific,  
Rockford, IL) for 5 min at room temperature and visualized using Molecular Imager 
R 
system (Bio-Rad, 
Hercules, CA).  
                  Uracil-ASB assay-About 4ug of the DNA in TE buffer was treated with Tris-Methoxyamine 
(Sigma-Aldrich) and incubated at 37°C for 2 hrs. DNA was precipitated using 
NaCl/Glycogen/Isopropanol precipitation and resuspended in 1X TE (pH 8.0). The resuspended DNA 
was treated with Uracil DNA glycosylase (UDG; 1:10 dilution, New England Biolab) for 15 mins at 
37°C. The UDG treated DNA was further precipitated using NaCl/Glycogen/Isopropanol precipitation 
and again resuspended in 1X TE buffer (pH 8.0). Further, the DNA was probed with 2mM ARP ( Dojindo 
Laboratories, Kumamoto, Japan) for 15 mins at 37°C. The probed DNA was further precipitated as 
previously using NaCl/Glycogen/Isopropanol precipitation and resuspended in 1X TE. From here, the 
procedure is similar to the ASB assay.  
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Isolation of Crude Nuclear extract- Nuclear extracts were isolated using a transfactor extraction kit 
(Clontech, Mountain View, CA) as previously described (208). Briefly, a hypotonic buffer is used to lyse 
the cell allowing for the removal of cytosolic fractions, followed by a hypertonic buffer which helps in the 
extraction of nuclear proteins.  All solutions were made fresh and all samples and tubes were maintained 
on ice. Low molecular weight contaminants were removed from extracts by dialysis using Slide-A-Lyzer
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mini-dialysis units (Pierce Biotechnology, Rockford, IL) with a molecular weight cut off of 3.5 KD for 3 
hours at 4°C. The dialysis buffer has 20mM Tris-HCl, pH 8.0, 100mM NaS2O5, 0.1mM PMSF, and 
1mg/ml PepstatinA. Dialyzed extracts were aliquoted and stored at -80°C for subsequent analysis. Protein 
concentrations were determined using to Bradford protein assay kit I (Bio-Rad, Hercules, CA). 
Isolation of Whole cell extract- Whole cell extracts were isolated using hypotonic and hypertonic salt 
solutions from transfactor extraction kit (Clontech, Mountain View, CA). Briefly, 100mg of liver tissue 
was homogenized with the hypotonic salt solution to lyse the cell and further treated with the hypertonic 
salt solution to release the nuclear contents without any fractionations. The whole cell extract thus 
obtained was used for various assays. 
Uracil Excision assay- Uracil excising activity was determined as described previously (211 ) with minor 
modifications. Briefly, the assay reaction mixture contained 70mM Hepes (pH7.5), 1mM EDTA, 1mM 
NaCl, 0.5% bovine serum albumin, 90 fmol of 5’ fluorescein-end-labeled single stranded uracil-
containing 30-mer oligonucleotide (5’ – ATATACCGCGGUCGGCCGATCAAGCTTATT-3’, Sigma-
Aldrich, St.Louis) and 5ug of whole cell extract from liver tissue. The reaction mixture was incubated at 
37°C for 1hr. After 1hr the reaction was terminated using 5g of proteinase K andl of 10% SDS and 
incubated at 55°C for 30min. The reaction mixture was further suspended in a loading buffer containing 
80% formamide, 10mM EDTA, 1g/ml of bromophenol blue and 1g/ml of xylene cyanol. The substrate 
and reaction products were separated on a 20% denaturing sequencing gel (SequaGel Sequencing System, 
National Diagnostics, Atlanta, GA). Glycosylase activity (presence of an 11-mer band) was visualized 
and quantified using a Molecular Imager System (Bio-Rad, Hercules, CA) by calculating the ratio of the 
97 
 
 
11-mer product with the unreacted 30-mer substrate (product/product +substrate). The data are expressed 
as machine counts per g of protein.  
DNA base excision repair activity assay- The G:U mismatch repair assay is developed to measure 
monofunctional glycosylase-initiated base excision repair activity and the assay was performed as 
describe previously (208). Briefly, purified fluorescein-end-labeled 30bp oligonucleotides (upper strand: 
5’– ATATACCGCGGUCGGCCGATCAAGCTTATTdd-3’; Lower strand: 3’-
ddTATATGGCGCCGGCCGGCTAGTTCGAATAA-5’) containing a G:U mismatch and a Hpa II 
restriction site (CCGG) were incubated in a BER reaction mixture containing 50 g nuclear protein. This 
assay uses a 30bp long oligonucleotide with G:U mismatch as no significant difference was seen in the 
catalytic efficiency of the in vitro assay when a plasmid or oligonucleotide was used as a substrate (219). 
Repair of the G:U mismatch to a correct G:C base pair was determined via treatment of the duplex 
oligonucleotide with 20U of Hpa II (Promega, Madison, WI) for 1hr at 37°C and analysis by 
electrophoresis on a 20% denaturing sequencing gel, 19:1 acrylamide/bis-acrylamide (SequaGel 
Sequencing System, National Diagnostics, Atlanta, GA). Repair activity i.e., the presence of a 16-mer 
band, was visualized and quantified using a Molecular Imager System (Bio-Rad, Hercules, CA)  by 
calculating the ratio of the 16-mer product with the unreacted 30-mer substrate 
(product/product+substrate). The data are expressed as machine counts per g of protein.   
Western Blot Analysis- Protein expression analysis was performed using western blot technique as 
previously described (208).  100 g nuclear protein was used to run the SDS-PAGE. Upon completion of 
SDS-PAGE, the region containing the proteins of interest was excised and prepared for western blot 
analysis while the remaining portion of the gel was stained with Gel Code Blue Stain Reagent (Pierce 
Biotechnology, Rockford, IL) to ensure equal protein loading. Manufacturer recommended dilutions of 
anti-sera developed against UDG (Santa Cruz Biotechnology, Santa Cruz, CA), APE1/Ref-1 ( Novus 
Biologicals, Littleton, CO), -pol (Abcam, Cambridge, MA),  and Thioredoxin 1 (Millipore, Billerica, 
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MA) were used to detect proteins of interest followed by incubation with HRP-conjugated secondary 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA). The bands were visualized and quantified using a 
Molecular Imager System (Bio-Rad, Hercules, CA) after incubation in SuperSignal West Pico 
Chemiluminescent Substrate (Pierce Biotechnology, Rockford, IL). Data are expressed as the integrated 
density value (I.D.V.) of the band normalized to -actin. 
Gene expression profiling- The mRNA expression level of Gadd45g was quantified using a real-time 
PCR-based pathway focused on gene expression profiling of mouse DNA damage. Total RNA was 
extracted from liver tissue using RNeasy extraction kit (Qiagen, Valencia, CA). First strand cDNA was 
synthesized from 1g RNA using random primers and purified using QIAquick PCR purification Kit 
(Qiagen, Valencia, CA). Expression of Gadd45g was quantified using real time PCR with specific 
primers for the gene (FP: 5’-AGTTCCGGAAAGCACAGCCAGGATG3’ and RP: 5’-
GCCAGCACGCAAAAGGTCACATTGT-3’).  The gene transcript was normalized to RPLO. External 
standards for all the genes were prepared by subcloning the amplicons, synthesized using the specific 
primers into PGEM-T easy vector.  
Caspase Assay- Caspase-3 activity was measured using Enzchek Caspase-3 Assay Kit No.1 (Molecular 
probes, Eugene, OR) as described previously (208). Briefly, Liver tissues were homogenized, and 
cytosolic extracts were isolated using Transfactor Extraction Kit (Clonetech, Mountain View, CA). The 
extracts (250 g protein) were incubated for 2hr at room temperature in the working solution (25mM 
PIPES, pH 7.4, 5mM EDTA and 2.25% CHAPS) containing synthetic caspase-3 substrate, Z-DEVD-
AMC. Caspase mediated proteolytic cleavage of the substrate yields a bright blue-fluorescent product. An 
additional control assay was performed using reversible aldehyde inhibitor Ac-DEVD-CHO to confirm 
that the fluorescence observed in the sample assay was due to caspase activity. The fluorescence was 
measured using a fluorescence microplate reader (Genios plus, Tecan) at excitation: 342nm, emission: 
441nm. The caspase activity was determined using an AMC (7-amino-4-methylcoumarin) standard curve 
(0-100M), and reported as fluorescence per g of protein.  
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Glutathione Peroxidase Assay- Glutathione peroxidase assay was performed using the assay kit from 
Cayman Chemical Company, Ann Arbor, MI, according to the manufacturer’s protocol. The principle of 
the assay makes use of a coupled reaction between Glutathione peroxidase and Glutathione reductase. 
The oxidized glutathione released during the reduction of hydroperoxide by glutathione peroxidase acts as 
the substrate for glutathione reductase. The conversion of NADPH to NADP+ during the gluatathione 
reaction creates a decrease in absorbance at 340nm. Briefly, about 200mg of the liver tissue was 
homogenized in 1ml of cold phosphate buffer (50mM phosphate, pH6.7, containing 1mM EDTA) and 
centrifuged at 10,000 X g for 15 minutes at 4°C. The supernatant was used for the enzyme assay. The 
supernatant was mixed with the assay buffer (50 mM Tris-HCl, pH 7.6, containing 5mM EDTA), co-
substrate mixture, containing NADPH, glutathione and glutathione reductase, and subsequently treated 
with cumene hydroperoxide to initiate the reaction. The decrease in absorbance was measured at 340nm 
using a microplate reader (Genios plus, Tecan) to 5 time points. Bovine erythrocyte Gpx was used as the 
positive control. 
Thioredoxin Reductase Assay- Thioredoxin reductase assay was performed using the assay kit from 
Cayman Chemical Company, Ann Arbor, MI, according to the manufacturer’s protocol. The principle of 
the assay is the reduction of Ellman’s reagent-DTNB [5,5’-dithio-bis(2-dinitrobenzoic acid)] with 
NADPH to TNB (5-thio-2-nitrobenzoic acid) producing a yellow product with an absorbance range of 
405-414nm. Briefly, liver tissues were homogenized, and cytosolic extracts were isolated using 
Transfactor Extraction Kit (Clontech, Mountain View, CA). The cytosolic extracts were treated with the 
assay buffer (50 mM potassium phosphate, pH 7.0, containing 50mM KCl, 1mM EDTA, and 0.2 mg/ml 
BSA) and subsequently treated with NADPH and DTNB to initiate the reaction. The absorbance was 
measured at 405-414nm using a microplate reader (Genios plus, Tecan). Reactions were conducted with 
and without sodium aurothiomalate to measure reduction of DTNB specifically by Thioredoxin 
Reductase.  Rat liver Thioredoxin reductase was used as the positive control. 
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Single Strand Break Assay- Assessment of single-strand breaks was done using the Fast Micromethod 
DNA Single Strand Break assay as described by Henderson, DNA repair protocols.  100 mg of liver 
tissue was homogenized and whole cellular content was further untilized for this assay. This method is 
based on the ability of the specific fluorochrome Picogreen (Molecular Probes, Eugene OR) to make a 
stable complex with double-stranded DNA, from whole cell content, in alkaline conditions.  The 
preferential binding of Picogreen to double-strand DNA over single-strand DNA or proteins allows 
detection of single-strand breaks in the DNA by following the fluorometric signal intensity.  The 
decreasing signal intensity during denaturation is measured at Excitation/Emission of 485/538 using a 
fluorescence microplate reader (Genios Plus, Tecan) and is proportional to increasing single-strand break 
content.  Results were calculation after 10 minutes in denaturing solution (1M NaOH, 20mM EDTA, 1% 
DMSO) and normalized to reference control sample and expressed as fluorescence units at 538 nm.  
Statistical Analysis- Statistical significance between means was determined using t-test and analysis of 
variance followed by post tukey test wherever appropriate.  P-values less than 0.05 were considered 
statistically significant. 
 Results 
Analysis of Aberrant crypt foci formation during folate deficiency in the colon of C57Bl/6 mice-  
         Folate deficiency has been associated to the development and progression of different types of 
cancer, more notably colon cancer. In this study, we have investigated the effect of folate deficiency on 
the development of cancer in C57BL/6 mice. In the first series of experiments we determined the impact 
of folate deficiency on the development of Aberrant Crypt foci, an early indicator of colon cancer (220-
222). At the commencement of the study, as illustrated in Fig.5.1A., we randomly assigned c57BL/6 mice 
into the folate adequate and folate deficient groups.  These animals were started on a folate adequate 
(2mg/kg of folic acid) and folate deficient (0mg/kg of folic acid) diet at 6 weeks of age. To attain severe 
folate deficiency, the folate deficient diet was supplemented with 1% succinyl sulfathiazole, an 
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antibacterial drug that inhibits folic acid biosynthesis by the colon bacteria. The dietary regimens were 
continued for twelve weeks. And at the end of the 12
th
 week the animals were sacrificed and tissues were 
harvested for analysis. Periodically, the amount of food consumed and body weight measurements were 
taken during the entire study. In line with our previous findings, the amount of food consumed and body 
weight measurements did not significantly differ between the folate adequate and folate deficient groups 
(data not shown). Serum folate levels measured as a competitive assay using SimulTRAC-SNB 
radioassay kit for vitamin B12 (
57
CO) and folate (
125
I), was found reduced by 90% whereas the colon 
folate levels were reduced by 40% in these animals. These results were very similar to results obtained in 
other studies conducted on folate deficiency (data not shown). For measuring the development of 
preneoplastic lesions, i.e. aberrant crypt foci (ACF), the excised colons were opened and flat fixed in 10 
% neutral buffered formalin for 24 hours, stained with methylene blue and scored under a light 
microscope. As shown in fig. 1B, the colons from both folate adequate and deficient group appeared 
morphologically normal and no aberrant crypts were found in them, emphasizing the need for a 
carcinogen to induce these lesions in the laboratory animals. The liver tissue from the same set of animals 
did not show any gross/ visible abnormalities. This study only show that short term i.e., 12 weeks of 
folate deficiency by itself does not generate preneoplastic lesions; therefore it becomes important to 
determine the development of the aberrant crypts during prolonged feeding.  
Analysis of damages to DNA during folate deficiency in the liver of c57BL/6 mice- 
           Methyl donor deficiency has been shown to accumulate preneoplastic lesions in the liver of rats 
(223). Although our liver tissue from our folate deficient animals did not show any gross/ visible 
abnormalities, many studies have shown liver to be a major site affected by folate deficiency. Folate 
deficiency has been reported to increase accumulation of DNA damages such as misincorporated uracil 
and DNA strand breakage (212,225-229). Deficiency in folate reduces the formation of dTMP from 
dUMP resulting in accumulation and misincorporation of uracil into DNA (218,230). Apart from 
misincorporation, uracil can arise in DNA due to cytosine deaminations.  Uracils in DNA are mutagenic 
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and are usually repaired by the base excision repair pathway. Any imbalance in the BER pathway results 
in the accumulation of toxic repair intermediates such as abasic sites and single strand breaks.  Abasic 
sites and DNA single strand breaks can also appear in DNA directly due to spontaneous hydrolytic 
reactions and oxidative stress (231). In addition, abasic sites and single strand breaks are considered to be 
more toxic and mutagenic than misincorporated uracil. Here we evaluated the accumulation of these 
genomic damages during folate deficiency. As demonstrated previously by our lab (218) folate deficiency 
resulted in modest increase in uracil levels (~28%) in the liver genomic DNA as measured by an UDG-
coupled ASB assay when compared to its folate adequate counterparts (Fig.5.2A). 
          Further, uracils in DNA are repaired by monofunctional glycosylases such as Uracil DNA 
glycosylase (UDG) leaving behind an abasic site.  Using ASB assay we measured the abasic sites in our 
folate deficienct animals and observed ~ 33% reduction in them (Fig.5.2B). The abasic site left behind by 
UDG further processed by APE1/REF-1, an endonuclease. This endonuclease upon removal of the abasic 
site leaves behind single strand breaks, the substrate for DNA polymerase  (-pol). We utilized a fast 
micromethod single strand break assay and measured the levels of single strand breaks as a decrease in 
fluorescence. Our data showed no significant difference in the level of single strand breaks between the 
folate adequate and deficient groups (Fig.5.2C). Our folate deficient condition showed only the 
accumulation of uracil whereas the other toxic damages were not significantly induced. This could be the 
result of reduction in spontaneous damage accumulation or efficient base excision repair pathway. 
Therefore, as the next series of experiment we characterized the effect of folate deficiency on the BER 
pathway. 
Analysis of the BER pathway during folate deficiency in liver of C57BL/6 mice 
               Base excision repair becomes important during folate deficiency as all damages created by low 
folate are almost entirely repaired by the BER pathway. BER is a simple, dynamic, environmentally 
responsive DNA repair pathway (232-234) playing an important role in repairing alkylation and oxidative 
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damages. Cabelof et al, have previously reported the imbalance in the base excision repair pathway 
during folate deficiency despite the increase in single strand breaks observed during their study (211). 
Here again, in this study we observed no increase in the invitro G:U mismatch BER activity in response 
to folate deficiency (Fig. 5.3E).  To further characterize the effect of folate deficiency on the individual 
enzymes in the BER pathway, we looked at the expression of the major enzymes involved in the repair of 
misincorporated uracil. Uracil DNA glycosylase, a monofunctional glycosylase is the primary enzyme 
involved in the removal of misincorporated uracil. Apart from UDG, SMUG, TDG and MBD4 act as 
backup glycosylases for the removal of uracil in DNA. Our folate deficient animals showed about 38% 
upregulation in the UDG protein (Fig.5.3A) as has been reported by other studies. In our previous study 
done on 8 weeks folate deficiency, we had reported a tight correlation between the increase in UDG 
protein and its activity (211).  Here in this study with 12 weeks of folate deficiency we did not see a 
corresponding increase in UDG activity (Fig.5.3B). This lack of induction in the UDG activity potentially 
explains the increase in uracil levels in DNA during folate deficiency.  
            The next enzyme in the BER pathway is APE1/Ref-1, an endonuclease which can also act as a 
redox factor. Ape1/Ref-1, probably due to its redox activity functions as the rate limiting enzyme of the 
pathway when repairing an oxidative damage such as 8-OHdG (208). Ape1/Ref-1 endonuclease removes 
the abasic site leaving behind a single strand break.The protein level of this enzyme was significantly 
reduced by 59% in our folate deficient group (Fig. 5.3C). Inspite of this reduced APE1/Ref-1, the abasic 
sites in this condition were lower.  However, the enzyme activity might be adequate enough to carry out 
its function. -pol, the next enzyme in the pathway utilizes the single strand break with 3’-OH as its 
substrate and adds a new nucleotide. -pol, is the rate determining enzyme during the removal uracil from 
DNA.  -pol, has dRPlyase activity which has been shown to be the rate limiting step in this pathway 
(205). In our previous study on folate deficiency where we had subjected the animals to 8 weeks of folate 
deficiency, a significantly higher level of single strand breaks corresponding to lower -pol levels was 
observed (211). Since our single strand break levels in our 12 weeks folate deficient animals were not 
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different from its wildtype counterpart, we expected the -pol protein levels to be similar or greater than 
the folate adequate group. To our surprise, the -pol levels were significantly lowered (~45%) in the 
folate deficient animals (Fig.3D). Our findings clearly show that folate deficiency impairs the efficiency 
of the animals in processing the misincorporated uracil through the BER pathway. Since the repair 
efficiency of the folate deficient animals was reduced, it became important to look at the apoptotic 
capacity of the folate deficient animals. 
Analysis of apoptosis during folate deficiency in the liver of C57BL/6 mice  
            Apoptosis acts as a protective mechanism during stress helping in eliminating the damaged DNA 
and cell (235). To characterize the effect of folate deficiency on cell cycle arrest and apoptosis, we 
analyzed three markers of apoptosis namely Gadd45g (growth arrest and DNA damage-inducible gene, 
p53 and Caspase-3. Using real-time PCR we analyzed the mRNA expression of Gadd45g, a genotoxic 
stress-inducible gene associated with cell cycle arrest and apoptosis. Gadd45g mRNA level showed a 
lowering trend by ~38% during folate deficiency (Fig.5.4A). Since Gadd45g is a p53 responsive gene and 
because p53 is a well established regulator of cell cycle arrest and apoptosis, we next evaluated the 
stabilization of p53 protein in our folate deficient animals. A tight correlation existed between Gadd45g 
expression and p53 protein stabilization with p53 protein levels distinctly lowered by ~41 % in the folate 
deficient animals (Fig.5.4B). The result on p53 was in consensus with our data from a previous study 
conducted by our lab (211). We further determined the activity of one of the main final effectors of 
apoptosis, namely, Caspase-3. Following the Gadd45g and p53 levels, Caspase-3 activity was 
significantly reduced by ~26% during folate deficiency (Fig.5.4C). The folate deficient animal’s display 
reduced apoptotic capacity despite the decrease in base excision repair efficiency. This phenomenon 
could be due to the reduced damage threshold perceived in the liver of the folate deficient animals 
observed as reduced abasic sites and single strand breaks. Therefore, the folate deficient animals display 
reduced repair and apoptotic efficiency, but at same time do not exhibit accumulation of detrimental DNA 
damages. 
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Analysis of the antioxidant response during folate deficiency in the liver of C57Bl/6 mice 
       Thioredoxin and glutathione are the two major cellular antioxidant systems. Thioredoxin is a 12 kda, 
oxidoreductase with a dithiol-disulfide active site. The reduced form of thioredoxin is regenerated by the 
enzyme thioredoxin reductase (TrxR) in a NADPH-dependent reaction. Thioredoxin reductase is the only 
identified enzyme that can regenerate reduced thioredoxins. There are three isoforms of thioredoxin 
reductase, TrxR1, TrxR2, TrxR3 and each isoform is found in the cytosol, mitochondria and testis 
respectively. The thioredoxin system is an important antioxidant in that loss of both copies of the 
thioredoxin gene is embryonically lethal in humans. 
     The other antioxidant Glutathione, is a tripeptide made of, L-cysteine,L-glutamate and glycine. This 
antioxidant is mainly synthesiszed through the transulfuration pathway of the folate cycle. Mice with 
deletions in the catalytic site of the enzyme, glutamate cysteine ligase which is involved in the synthesis 
of glutathione does not survive the first month of birth (236). The regeneration of the reduced form of 
glutathione is done by glutathione reductase which remains constitutively active in the cell. Glutathione 
peroxidase another enzyme part of the glutathione defense system helps in the conversion of lipid 
hydroperoxides to alcohols and also reduces hydrogen peroxide to water. Glutathione peroxidase uses 
reduced glutathione as the acceptor of electrons. Therefore, both the antioxidant system work efficiently 
to reduce the oxidative stress in normal cells.  
     Since folate deficiency has been implicated in creating oxidative stress and also has been demonstrated 
to generate hydrogen peroxide (237,238), we evaluated the thioredoxin system and glutathione peroxidase 
activity in our folate deficient animals. Thioredoxin-1 protein levels showed a moderate reduction by 
~11% in the folate deficient group (Fig.5.5A). Thioredoxin reductase did not show any significant 
difference in its activity between the groups (Fig.5.5B). In similar terms, Glutathione peroxidase also did 
not show any significant difference in its activity during folate adequacy and deficiency (Fig.5.5C). 
Therefore, the folate deficient animals did not exhibit any robust upregulation in its antioxidants 
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compared to its folate adequate counterpart, suggesting that twelve weeks of folate deficiency did not 
sufficiently create any oxidative stress. Having evaluated the repair and apoptotic efficiency of the folate 
deficient animals, we further extended our study to determine if folate deficiency would make the animal 
more susceptible to an external DNA damaging agent such as a carcinogen.    
Analysis of Aberrant crypt foci formation during folate deficiency and methionine restriction in response 
to DMH treatment in the colon of C57Bl/6 mice    
               Folate deficiency has been associated to many different kinds of cancer especially colon cancer 
which has high mortality. Preneoplastic lesions such as aberrant crypt foci induced by the administration 
of a carcinogen, is a well established early indicator of colon cancer in animal models (220-222). To 
determine if folate deficiency increased the predisposition to cancer in our animal model, we used 1,2-
dimethylhydrazine (DMH),  a potent colon carcinogen to induce formation of aberrant crypt foci.  DMH 
is known to be a SN-1 alkylating agent known to generate methyl adducts such as O6Me-G and N7 MeA 
(239). The activation of DMH to its active metabolite, azoxymethane and methyldiazonium ion occurs in 
the liver and these metabolites are carried to the colon via bile and blood (240,241) . During its 
conversion to the active form, DMH also generates hydroxyl radicals and hydrogen peroxide in the 
presence of metal ions (241). Therefore, DMH is a potent carcinogen capable of generating both 
alkylation and oxidative stress.   At the outset of the present study, we randomly assigned c57BL/6 mice 
into four groups: the folate adequate/ methionine adequate (FA/MA), folate deficient (FD), methionine 
restricted (MR: 80% restriction) and combined folate deficient/methionine restricted (FD/MR) groups. 
One week into their respective diets the animals were injected with 30mg/Kg body weight of DMH, once 
a week for six weeks. Six weeks after the final injection, the mice were sacrificed and the colons were 
scored for aberrant crypt foci.  As shown in Fig.5.6B &C., DMH treated folate deficient animals 
displayed significantly higher (~57% more) aberrant crypts as compared to its folate adequate 
counterparts (13 ± 1.8 for FA versus 30 ± 2.2 for FD respectively, p<0.01) in concurrence with other 
studies (30,31-Lisa,JBC). As observed in Fig.5.1B, folate deficiency by itself without any external factor 
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was not enough to induce aberrant crypts in the colon, but it definitely increases the susceptibility of the 
animals to DMH.  
     Methionine, the other essential component of the folate cycle ,has been shown to increase mean and 
maximum life span of laboratory animals (214-216). Further, methionine restriction in rat models has also 
been shown to reduce the occurrence of aberrant crypts when treated with azoxymethane (242). In order 
to dissect out the mechanism through which folate deficiency works and to test whether folate deficiency 
and methionine restriction show similar characteristics, we treated methionine restricted animals with 
DMH. To our surprise, methionine restricted animals showed increased predisposition to carcinogenesis 
compared to both folate adequate and folate deficient animals (Fig. 5.6B &C). Methionine restricted 
animals treated with DMH showed ~38% more aberrant crypts than folate deficient mice (46±2.9 for MR 
versus 28± 2.8 for FD, respectively, p<0.01). Intersetingly, methionine restricted animals displayed more 
advanced crypt multiplicity than folate deficient animals. The advanced aberrant crypts observed in 
methionine restricted animals presented a well defined elevation above the surrounding mucosa and 
appeared more like a microadenoma. This observation with methionine restriction is in contrast to a 
similar study conducted on rats (242). This observed difference could be due to the species difference and 
the difference in their metabolism and signaling.  
       Our fourth group, the combined folate deficient/methionine restricted animals potentially mimics, 
metabolically and physiologically, complete methyl donor deficient rodent models as two of the major 
methyl donors were restricted in this diet. These animals showed early signs of susceptibility to DMH 
with animals in the group dying by the fifth week of the last DMH injection. The animals that survived 
showed signs of Kyphosis, an indication for premature aging. Once the animals were sacrificed, the 
tissues such as the liver and brain appeared pale drained of blood. The colons appeared shrunk and 
presented difficulties under the microscope. Under the microscope, with methylene blue staining, the 
colons from the FD/MR animals showed overall abnormal morphology. Nevertheless, they displayed a 
dramatic increase in aberrant crypts compared to any other group studied (57±5.3 for FD/MR versus 46 
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±2.9 for MR versus 28±2.8 for FD, respectively, p<0.01). It would be interesting and also important to 
further study all the physiological changes in the FD/MR animals. Having observed greater predisposition 
to aberrant crypt foci and adenoma formation in the methionine restricted animals, we further analyzed 
the liver from all the groups studied.  
Analysis of damages to DNA during folate deficiency and methionine restriction in response to DMH 
treatment in the liver of C57Bl/6 mice 
        Folate deficiency has always been implicated in the generation of DNA damages and has been 
shown to act synergistically with DNA damage inducing agents (226,243,244). DMH as mentioned 
previously becomes activated in the liver and in the process generates free radicals and methyl diazonium 
ions, which can cause damages to DNA (241).  We analyzed our experimental groups sequentially for 
damages repaired via the base excision repair pathway to see if the dietary regimens predisposed the 
animals to greater DNA damage accumulation. The folate and methionine adequate animals treated with 
DMH did not show any significant difference in their uracil and abasic levels and showed significantly 
lower single strand breaks compared to its FA/MA counterpart without DMA treatment (Fig.5.7A, B&C). 
Interestingly, folate deficiency in concurrence with DMH showed a ~23% reduction in their uracil levels 
compared to their folate adequate counterparts (Fig .5.7A).  On the other hand, the folate deficient 
animals showed significant increase in their abasic sites and single strand breaks in response to DMH 
(Fig.5.7B&C). Unlike the animals which were on just dietary folate manipulation, the folate deficient 
animals treated with DMH showed increased accumulation of highly mutagenic DNA damages.  
         Since the methionine restricted animals showed significant aberrant changes in their colon, we 
tested their liver for DNA damage accumulation. The methionine restricted animals, similar to the folate 
deficient animals, showed a decline in their uracil levels in response to DMH (Fig.5.7A).  
Correspondingly, the abasic sites in the MR DMH animals were significantly lower than the folate 
deficient DMH treated animals and remained at the basal level (Fig.5.7B).  On the other hand, the single 
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strand breaks in the MR DMH although showed a lowering trend compared to the folate deficient animals 
remained significantly higher than the folate adequate/methionine adequate animals treated with DMH 
(Fig.5.7C). The combined folate deficient /methionine restricted animals as expected showed significantly 
higher uracil levels compared to folate deficient DMH and methionine restricted DMH groups 
individually (Fig.5.7A). Concurrently, they also showed significantly higher abasic sites similar to the 
folate deficient DMH group (Fig.5.7B). Interestingly, the FD/MR DMH group showed noticeably lower 
single strand breaks than the folate deficient DMH and methionine restricted DMH groups but the levels 
remained higher than the folate adequate DMH group. Herein, in contrast to what we observed in the 
colon, the folate deficient animals showed increased accumulation of damages in the liver compared to 
the methionine restricted group. Therefore to better understand the mechanism behind this accumulation, 
we next looked at the base excision repair pathway in these dietary regimes in response to DMH. 
Analysis of the base excision repair pathway during folate deficiency and methionine restriction in 
response to DMH in the liver of C57Bl/6 mice 
            Base excision repair pathway, is a co-ordinated repair pathway with a series of enzymes 
functioning sequentially and are highly inducible to environmental stress (196,197,245,246). Imbalance in 
the base excision repair pathway leads to the accumulation of toxic repair intermediates. Misincorporated 
uracil, abasic sites and single strand breaks are examples of damages which would occur sequentially 
during impaired BER. Therefore, we looked at the overall efficiency of base excision repair in all our 
experimental groups by testing the invitro G:U mismatch BER activity initially.  As expected, the BER 
activity was induced in all the DMH treated groups (Fig. 5.8D). As illustrated in Fig. 5.8D, FA/MA DMH 
animals showed about ~53% upregulation , FD DMH animals showed only ~40 % upregulation, MR 
DMH showed ~53% upregulation and the FD/MR DMH showed ~ 73% upregulation. Interestingly, the 
folate deficient DMH animals were the only group to show significantly lower induction in its BER 
activity. 
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      In order to distinguish between the overall BER activity and the individual enzymes involved in this 
pathway, we looked at the expression and activity of the major BER enzymes involved in the removal of 
uracil from DNA. The monofunctional glycosylase involved in the removal of uracil from DNA, uracil 
DNA glycosylase (UDG) showed significant upregulation in the folate adequate group treated with DMH. 
The protein levels were upregulated by ~90% and the uracil excision activity was up by ~43% 
(Fig.5.8A,B), thereby reducing the uracil content to its basal level. Following UDG, the next enzyme in 
the pathway APE1/Ref-1, also showed an upward trend (~31%) in the FA/MA DMH group, providing an 
explanation for the reduced abasic sites in this condition (Fig.5.8B). The next enzyme in the pathway, -
pol also showed ~27% upregulation in its protein levels (Fig. 5.8D), thereby the  reduction seen in the 
single strand breaks.  On the other hand, the folate deficient animals treated with DMH did not show 
significant upregulation in its UDG protein (Fig. 5.8A) and uracil excision activity (Fig.5.8B). Based on 
the findings from our uracil measurement, we anticipated the UDG levels and activity to be upregulated. 
Interestingly, the UDG levels and activity were not sufficiently induced. Therefore it is inviting to suggest 
that, the decreased accumulation of uracils in DNA could be due to two reasons: (i) the increased 
activities of the backup glycosylase’s such as MBD4 and TDG capable of removing uracil from DNA 
(247) and/or (ii) reduced misincorporation of uracil into DNA due to the increased hydrolysis of dUTP to 
dUMP by dUTPase (247,248). Direct testing of these notions is further warranted. Further, the folate 
deficient animals treated with DMH show markedly reduced APE1/Ref-1 by ~38% (Fig.5.8C) and 
reduced -pol by ~33% (Fig.5.8D) showing loss of stress inducibility by these enzymes. This lack of 
induction displayed by APE1/Ref-1 and -pol provide insights into the increased abasic sites and single 
strand breaks (substrates of the enzymes respectively) observed in the folate deficient DMH animals.  
         The next group of methionine restricted animals also did not show upregulation in its UDG protein 
(Fig.5.8A) and showed an increasing trend in its uracil excising activity compared to the folate deficient 
DMH animals, but remained lower than the FA/MA DMH group (Fig.5.8B). Here again, the lowered 
uracil levels could be due to the increased activities of the backup glycosylase’s, but this part of 
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methionine restriction remains to be explored. The subsequent enzymes of the pathway, Ape1/Ref-1 
and-pol showed inductions by ~23% and 41% in the methionine restricted group treated with DMH 
compared to the folate deficient DMH animals. The moderate increase in APE1/Ref-1 might have been 
adequate enough to bring down the abasic sites to the levels observed in these animals, but interestingly, 
the single strand breaks remained high compared to FA/MA group despite the noticeable increase in its -
pol levels. Methionine restriction in synergism with DMH might be directly inducing the accumulation of 
single strand breaks in the genomic DNA, but again this phenomenon needs to be tested to be presented 
as a plausible mechanism. Furthermore, the combined folate deficient and methionine restricted animals 
treated with DMH showed very significant upregulation in its uracil excising activity, APE1/Ref-1 
protein, and showed lowered -pol levels ( Fig. 5.8B, C, D). Despite the increase in BER enzymes and 
activity the FD/MR DMH group showed increased accumulation of DNA damages.  Based on these 
findings, the folate deficient animals treated with DMH display significantly reduced BER efficiency 
compared to all other groups. Methionine restricted DMH animals although not optimal, showed better 
BER efficiency than the folate deficient animals. As the next series of experiment we looked at the 
apoptotic capacity of these dietary regimens in response to dimethyl hydrazine.  
Analysis of apoptosis during folate deficiency and methionine restriction in response to DMH in the liver 
of C57Bl/6 mice 
                 Having determined the reduced efficiency of base excision repair by the folate deficient 
animals in response to DMH, we ventured to evaluate their apoptotic response. As done previously, we 
analyzed the levels of three markers of apoptosis, Gadd45g, p53 and caspase-3. The folate adequate DMH 
treated animals show an up- regulating trend in their Gadd45g mRNA, p53 protein and caspase-3 activity 
(Fig.5.9A,B,C). As expected the folate adequate animals show ample apoptotic response when treated 
with DMH. Alternatively, the folate deficient DMH treated animals did not show upregulation in any of 
the factors tested (Fig.5.9A,B,C). Our lab had previously reported reduced apoptotic activity in the colon 
of folate deficient DMH treated animals, measured as TUNEL –positive staining cells (217).In line with 
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this data, the livers of folate deficient DMH treated animals, showed no significant induction in Gadd45g, 
p53 and caspase-3 activity, but  rather showed a lowering trend in each of the factors (Fig.5.9A,B,C). To 
further determine whether methionine restricted animals would show robust apoptotic capacity in 
response to DMH, we repeated the same analysis in their liver samples. The MR DMH group, showed 
significant down-regulation in Gadd45g mRNA and p53 protein compared to the FD DMH mice (Fig.5.9 
A, B) but their caspase-3 activity showed an increasing trend (Fing.5.9C). The final group, the folate 
deficient/methionine restricted animals treated with DMH, showed a very significant down-regulation in 
Gadd45g mRNA, p53 protein and caspase-3 activity (Fig.5.9 A,B,C). The reduction in apoptosis in the 
liver of FD/MR DMH animals may possibly be due to the robust DNA repair seen as increased BER 
activity. In conclusion, folate deficiency in conjunction with DMH seems to reduce the efficiency of base 
excision repair and apoptosis thereby increasing the accumulation of toxic repair intermediates, which 
could potentially result in the development of cancer. Conversely, the methionine restricted animals show 
a moderately better base excision repair and apoptotic capacity compared to the folate deficient 
counterparts, but remain below optimum compared to the folate adequate/methionine adequate mice.  
Analysis of the antioxidant response during folate deficiency and methionine restriction in response to 
DMH in the liver of C57Bl/6 mice 
               To further determine the antioxidant response of the experimental groups to DMH treatment, we 
looked at three factors associated to the antioxidant system. As illustrated in Fig. 5.10 A,B,C, all the 
dietary groups showed significant induction in their antioxidants when treated with DMH. Folate 
adequate animals showed an increasing trend in their thioredoxin protein levels and significant 
upregulation in thioredoxin reductase and glutathione peroxidase activities (Fig. 5.10 A,B,C). The folate 
deficient DMH treated mice also show an increasing trend in their thioredoxin protein, but show 
significant upregulation in thioredoxin reductase and glutathione peroxidase activity when compared to 
their folate adequate counterparts (Fig. 5.10 A,B,C). Further, the methionine restricted animals show an 
increasing trend in response to DMH treatment in their thioredoxin protein levels and thioredoxin 
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reductase activity and significant upregulation in their glutathione peroxidase activity when compared to 
the folate deficient DMH mice (Fig. 5.10 A,B,C). On the other hand, the FD/MR DMH group show very 
high thioredoxin protein levels that are even higher than the methionine restricted animals, but their 
thioredoxin reductase activity showed a reducing trend compared to the MR DMH group and remained 
significantly higher or equivalent to other dietary groups (Fig. 5.10 A,B). Furthermore, FD/MR DMH 
group showed significantly lower glutathione peroxidase activity than the MR group treated with DMH 
(Fig.5.10C). Since the FD/MR animals potentially should have their folate cycle rate nearly shut down 
since they have both folate and methionine limiting in their diet, it would be interesting to evaluate the 
biosynthesis of glutathione through the trans-sulfuration pathway.  
          The antioxidant systems, both thioredoxin and glutathione have anti-apoptotic effects in normal 
conditions. Thioredoxin-1 is the physiological inhibitor of apoptosis signal-regulatory kinase 1 (Ask1) 
(249). Ask I via the JNK and p38 MAP kinase pathway act as inducers of apoptosis and increased 
expression of thioredoxin-1 inhibits Ask1 activity thereby inhibiting apoptosis (249). Moreover, inhibitors 
to thioredoxin have been shown to inhibit apoptosis and are effectively used in cancer treatment (250). 
Similarly glutathione peroxidase also plays role in inhibition of apoptosis and has been used in anti-
cancer treatment for several years. Specifically , glutathione peroxidase 1 prevents apoptosis via two 
mechanisms, (i) scavenges hydroperoxides efficiently thereby inhibiting ROS mediated apoptosis and (ii) 
inhibits hydroperoxide mediated stabilization of p53 (251). Based on these studies, it is inviting to suggest 
that the reduced p53 levels and caspase-3 activity observed in the folate deficient and methionine 
restricted mice subjected to DMH is possibly due to the increase in their antioxidant activities. 
Discussion 
Nutritional intervention studies have gained importance in the field of research paving roads for newer 
design of therapy and prevention of disease. Dietary manipulations such as caloric restriction and 
methionine restriction are proven strategies for lifespan extension and decreased susceptibility to diseases 
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in rodents. In addition research on functional components of foods such as curcumin and garcinol have 
been providing insights into the different pathways that can be targeted for treatments such as anti-cancer 
treatments (252-254). Currently, nutritional studies are concentration on understanding the mechanism 
behind aging and age-related diseases which would help in the prevention and treatment of the same.             
Similarly, folic acid an essential component required for the normal functioning and maintenance of the 
cell has been targeted in many anti-cancer strategies. Anti-folate drugs such as methotrexate and 
pemetrexed are well known and commonly used anti-cancer agents (255,256). Folic acid chemically, is an 
essential water soluble vitamin which takes part in one carbon metabolism. Since folate acts as a carbon 
donor it plays a central role in almost all metabolic reactions. As can be deciphered from the folate cycle, 
folic acid plays an important role in DNA synthesis and its maintainence, DNA methylation and 
epigenetics and redox cycling. Impairment in any segment of the folate cycle could lead to accumulation 
of damages in the DNA, increased mutation frequency, genomic instability and eventually cancer. 
               Folate deficiency has always been associated to the development of many types of cancer 
especially colorectal cancer. Individuals with single nucleotide polymorphism in the methylene 
tetyrahydrofolate reducatse gene and low plasma folates are epidemiologically shown to be more at risk 
for the development of colorectal cancer (257,258).  However, studies conducted on folate deficiency and 
supplementations are inconsistent and suggest that the effect of folate on cancer depends on the time 
period of the dietary regimen and the exposure to external agents such as carcinogens (259-263). Our data 
shows that folate deficiency by itself without any external agent does not induce the development of 
preneoplastic lesions, i.e, aberrant crypt foci, in the colon of mice. This distinctly shows that at least 12 
weeks of folate deficiency is a low penetrance event and does not induce preneoplastic lesions in the 
colon and emphasizes the requirement of a carcinogen.  
            Apart from cancer risk, folate deficiency has also been reported to incapacitate DNA repair 
pathways and result in accumulation of DNA damages (211-213,264). Folate deficiency induces 
accumulation of damages such as uracil misincorporation, which are primarily repaired via the BER 
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pathway. Our lab has previously demonstrated and published that eight weeks of folate deficiency 
imbalances the base excision repair pathway and leads to accumulation of damages such as aldehydic 
lesions and single strand breaks (211). In line with our earlier findings, we here report the loss of co-
ordination in the critical BER enzymes with twelve weeks of folate deficiency. We observed an 
upregulation in the expression of the initial glycosylase UDG, but this increase in the protein level did not 
correlate with an increased activity. As a consequence of this attenuated activity ,we observed an increase 
in uracil levels in the folate deficient animals. Subsequently, the next enzyme in the pathway, Ape1/ref-1 
failed to show upregulation, but was in actual fact significantly lower in the folate deficient animals. 
Despite this reduction in APE1/Ref-1 protein, its substrate, abasic site did not show any appreciable 
increase. Our lab has previously reported that abasic sites do not accumulate even when one allele of 
APE1/Ref-1 is knocked out (265).  Therefore, the reduction in abasic sites could be due to adequate 
APE1/Ref-1 endonuclease activity i.e. adequate processing of abasic sites or be a consequence of reduced 
glycosylase activity in this case the UDG activity.  
      The next enzyme in the pathway, -pol, the rate determining enzyme for the removal of uracil, also 
was observed to be significantly lowered at its protein level during folate deficiency. Inadequate -pol 
response has been shown to increase the level of its substrate, single strand breaks (198,211). On the 
contrary, in this study we did not observe any substantial increase in single strand breaks during folate 
deficiency. This lack of accumulation of single strand break emphasizes the reduced processing of the 
abasic sites or increased-pol activity. Alternatively, unrepaired single strand break during replication 
can become double strand breaks which subsequently would induce homologous recombination (HR) via 
parp-1 which would eventually repair the double strand break (266,267). In other words, an increase in 
single strand breaks increases parp-1 activity and parp-1 in turn helps in completing BER but in the 
absence of adequate BER response initiates cross-talk with homologous recombination (266,267). 
Therefore, it is inviting to suggest that this cross-talk with homologous recombination could have 
removed any accumulating single strand breaks, if any, during folate deficiency. All the more, direct 
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testing of this cross-talk during folate deficiency is necessary to suggest this as a plausible mechanism. 
Further, the overall invitro G:U mismatch BER activity was also attenuated during folate deficiency. Our 
data clearly demonstrates that the base excision repair enzymes were down-regulated during folate 
deficiency and the removal of uracil was absolutely not initiated. This is interesting as folate deficient 
animals did not show any adverse signs except for the increased uracil levels when compared to its folate 
adequate counterparts. 
          After establishing the DNA repair capacity i.e., BER capacity of the folate deficient, it was 
important to look at the other tip of the balance, apoptosis. Microarray analysis performed on colon 
cancer cells show that folate deficiency alters expression of genes involved in apoptosis along with DNA 
repair genes (268). Previous data from our lab show that folate deficiency induces apoptosis in the colon 
of mice treated with carcinogen when base excision repair is compromised genetically (217). Our current 
data from the wildtype animals showed that the apoptotic system was not adequately induced during 
folate deficiency despite the lowered BER enzymes, in other words p53, Gadd45g and caspase3 did not 
show any significant upregulation. This lack of stimulation in apoptosis could be due to the lack of 
accumulation of toxic intermediates such as abasic sites and single strand breaks. Uracil was the only 
measured damage which showed accumulation but uracil is considered less cytotoxic than the other two 
damages measured. Therefore, our data states that folate deficiency independently reduces the DNA 
repair and the apoptotic capacity but does not lead to significant accumulation of cytotoxic DNA 
damages. 
                Folate deficiency has been reported to act synergistically with DNA-damaging agents to 
increase damages such as DNA strand breaks, mutation frequency and chromosomal aberrations 
(226,243,244).  These damage accumulations have been suggested to be the consequence of impaired 
DNA repair. Therefore, in this study we determined the effects of folate deficiency on the repair and 
apoptotic capacity of the liver and ACF development in the colon of mice when exposed to a potent 
carcinogen such as 1,2-dimethylhydrazine. In addition, we also studied the effects of methionine 
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restriction on the colon and liver of mice when treated with dimethylhydrazine since many studies have 
shown the beneficial effects of methionine restriction and also because methionine is an integral part of 
the folate cycle.  After restricting the folate pathway either via folate deficient diet or methionine 
restricted diet, we further analyzed the consequence of a combined deficiency in folate and methionine 
restriction on these pathways.    
             Folate deficiency in conjunction with -pol haploinsufficiency showed reduced occurrence of 
aberrant crypt foci, a preneoplastic lesion when exposed to dimethylhydrazine, but folate deficiency in 
wild type animals increased the potency of the carcinogen and showed significantly larger number of 
aberrant crypts in the colon (217). In our current study we show markedly increased aberrant crypts in our 
DMH treated folate deficient wildtype animals, confirming the earlier data obtained by Lucente et al. This 
exacerbation of the system could be due to the underlying functional BER deficiency created by low 
folate levels. In line with this notion, folate deficiency has been shown to increase the mutagenicity of the 
alkylating agent N-ethyl-N-nitrosurea (269). Human colon epithelial cells inefficiently repaired the 
damages created by methyl methanesulfonate and hydrogen peroxide when folate was limiting in its 
medium (226).  Further, colonocytes grown in low folate conditions exhibited poor excision repair 
capability (264).  In order to confirm this phenomenon, we examined the BER capacity of these animals 
in the liver. Similar to what we saw earlier, dimethylhydrazine failed to mount adequate BER response 
during folate deficiency. The UDG protein levels and activity were attenuated in the folate deficient 
animals and the subsequent enzymes in the pathway, APE1/Ref-1 and-pol also showed lack of 
induction. The G:U mismatch BER was also not adequately induced during folate deficiency compared to 
its folate deficient counterparts. This is interesting as the BER pathway is a stress inducible pathway. This 
lack of induction observed in the base excision repair enzymes could be due to the direct regulation of 
expression of these genes at the transcriptional level by folate deficiency. We have previously provided 
evidence for this, wherein the upregulation of -pol expression in response to 2-nitropropane induced 
oxidative stress was inhibited during folate deficiency (270). We further showed increased binding of 
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negative regulatory factor to the folic acid response region of -pol encompassed in its CREB binding 
site, during oxidative stress (270).   
         Folate deficiency, as was demonstrated previously, markedly impaired the base excision repair 
pathway during carcinogen exposure. As a direct consequence of this lack of BER response, toxic repair 
intermediates such as abasic sites and single strand breaks, which formerly did not show any increase 
with folate deficiency alone, were significantly augmented. Here again, it is inviting to suggest that, the 
cross talk between BER and HR could be impaired during the synergistic actions of folate deficiency and 
DMH, leading to the accumulation of single strand breaks. In support of this, parp-1 mRNA levels did not 
show significant upregulation during folate deficiency in response to DMH treatment suggestive of the 
loss of the cross talk (data not shown).  Abasic sites are highly mutagenic whereby an adenine would be 
added against it during replication leading to substitution or frameshift mutations (271). These 
accumulating abasic sites and single strand breaks could potentially lead to increased mutation frequency 
and chromosomal instability, which are the common characteristics of folate deficiency. These findings 
are in line with many other studies conducted on folate efficiency. Observing the lack of base excision 
repair response and increased accumulation of toxic DNA damages during folate deficiency, we studied 
the expression and activity of factors involved in apoptosis. Lucente et al had previously demonstrated the 
increase in apoptosis in folate deficient, -pol haploinsufficient animals when treated with 
dimethylhydrazine, explaining the reduction in aberrant crypts in the colon of animals studied (217). 
Lucente et al, also reported significantly reduced apoptotic activity in their colon, measured as TUNEL-
positive staining cells in the wildtype animals exposed to folate deficiency and carcinogen (217). In 
concurrence with this information, we saw reduced apoptotic response in the liver of our folate deficient 
animals in response to dimethylhydrazine. The mRNA expression of Gadd45g, a cell cycle arrest gene 
was significantly reduced in the folate deficient animals. Gadd45g has been shown to promote apoptosis 
via the p38K-JunNH2-terminal kinase pathway when stimulated by stress (272,273). Therefore, its 
reduction signifies reduced promotion of apoptosis. In addition, the induction of p53 tumor suppressor 
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protein and marker of apoptosis was prevented during folate deficiency and dimethylhydrazine treatment. 
Finally, the activity of Caspase-3 the effector, molecule of the apoptotic pathway was also not adequately 
induced. In normal conditions, lack of DNA repair response and increased accumulation of DNA 
damages triggers the apoptotic machinery to eliminate the damaged cells, but folate deficiency not only 
reduces the DNA repair capacity but also brings down the apoptotic ability of these animals predisposing 
them to the development of cancer.  
          The restriction of the other segment of the folate cycle, i.e., methionine restriction, has been 
reported to increase mean and maximum life-span in laboratory animals when restricted by about 80 % 
from the controls (214-216). Methionine restriction has also been demonstrated to reduce free radical leak 
and oxidative DNA damage and provide resistance to oxidative stress in laboratory rodents which has 
been suggested as a potential mechanism behind the life-span extension (214,274). Furthermore, 
methionine restriction has been shown to reduce the incidence of aberrant crypt foci in rats exposed to 
azoxymethane (242). Depletion of methionine has been shown to induce apoptosis in cancer cells 
(275,276). Methionine restriction has also been shown to reduce the susceptibility of mice to oxidative 
stress created by acetaminophen (216). Based on these studies, we anticipated seeing significantly lower 
aberrant crypts in our DMH treated methionine restricted animals. To our surprise, the methionine 
restricted animals showed significantly more aberrant crypts and crypt multiplicity. With exactly the same 
strategy of experiment used for folate deficiency, methionine restriction showed the development of 
microadenomas. In addition, although our data from liver showed better repair activity and apoptotic 
efficiency than the folate deficient animals, the repair and apoptotic response was not relatively very 
different from the folate adequate/methionine adequate DMH treated animals. Given the fact that 
methionine restriction reduces ROS generations, increases stress resistance and apoptosis, the repair and 
apoptotic activities in our methionine restricted DMH treated animals should have been far greater than 
the FA/MA animals. All the more, methionine restricted animals showed more accumulation of single 
strand breaks in DNA than the folate adequate/methionine adequate group. 
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             This marked difference that we see in our methionine restricted animals compared to other studies 
which portray its beneficial effects might be due to the difference in the time period of the dietary and 
carcinogen exposure. In this study, we exposed the animals to the experimental diets and 
dimethylhydrazine treatment simultaneously without giving the animals sufficient time for adjustment in 
the specific diets. Maybe with sufficient time for adjustment in the respective diets, the animals might 
exhibit different characteristics similar to the lifespan extending interventions. The study conducted to 
demonstrate increased stress resistance to acetaminophen by methionine restricted animals, exposed the 
animals to ~9 months of methionine restriction before treating them with acetaminophen (216). The 
notion that longer dietary period for adjustment might be beneficial is further supported by the study 
conducted by Leu et al, wherein they expose the animals to 4 weeks of (277,278). They observed a 
significant reduction in the number of aberrant crypt foci in the colon of their folate deficient group 
compared to the folate adequate ones (277). Leu et al further demonstrated that these animals, given time 
for adjustment in the diet also displayed reduced incidence and number of colonic tumors in folate 
deficient animals exposed to AOM (278). In conclusion, the only experimental group in our current study 
which actually depicted true failure of the folate cycle is the combined folate deficient and methionine 
restricted group. In the other two groups, folate deficient DMH and methionine restricted DMH , although 
these animals were exposed to the respective diets for a longer term, the carcinogen treatment was 
conducted without giving sufficeint time for adaptation. Therefore in order to dissect out the exact 
mechanism behind folate deficiency and methionine restriction, additional studies allowing an ample 
period of time for adaptation in the respective dietary condition prior to carcinogen exposure is critical.  
        In conclusion dietary interventions such as folate deficiency alter stress response genes altering the 
balance of DNA repair such as base excision repair. This imbalance in DNA repair causes inefficient 
repair of damages leading to its persistence through replication and transcription, becoming permanent 
mutations and genomic instability. And this instability drives the enhancement of aging phenotypes and 
age related diseases such as cancer. 
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Figure Legends 
Figure5.1. Effect of the folate deficient diet on ACF formation in the colon of C57Bl/6 mice. A, 
experimental design: c57Bl/6 mice were fed folate adequate (2mg/kg, FA) or a folate deficient (0mg/kg, 
FD) diet for 12 weeks. After 12 weeks of ingestion of the respective diets, mice were sacrificed by CO2 
asphyxiation. B, exemplary methylene blue stained colons, showing the normal crypts from both FA and 
FD mice. 
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Figure5.2.Effect of folate deficiency on the formation of DNA damages such as uracil misincorporation, 
abasic site and single strand break in the liver of C57Bl/6 mice. A, DNA was isolated from the liver of 
mice fed FA and FD diets using DNeasy kit from Qiagen and the levels of uracil were measured using  
UDG coupled- ASB assay as described under experimental procedures. The data are expressed as the 
I.D.V. of the band/ug of DNA loaded. B, DNA was isolated from the liver of mice fed FA and FD diets 
using DNeasy kit from Qiagen and the levels of uracil were measured using ASB assay as described 
under experimental procedures. The data are expressed as the I.D.V. of the band/ug of DNA loaded. C, 
Levels of single strand break was measured using fast micromethod fluorescence assay as described under 
experimental procedures. The data are expressed as fluorescence units at 538 nm.  Values represent an 
average ± S.E. for data obtained five mice in each group. Values with * indicate significant differences at 
P<0.05. FA, folate adequate: FD, folate deficient. 
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Figure5.3. Effects of folate deficiency on the expression of the enzymes in the BER pathway and the G:U 
mismatch repair activity in the liver of C57Bl/6 mice. A, C, D, The levels of UDG, APE1/Ref-1 and -pol 
protein respectively, in 100 µg of liver nuclear extract obtained from mice fed FA and FD diet were 
determined by western blot analysis. The levels of each protein were normalized with the levels of -
actin. The data is expressed as the integrated density value corresponding to the level of each protein as 
quantified by a Bio-Rad chemiImager system and normalized to -actin. B, The Uracil excision activity 
was conducted using whole cell extracts obtained from livers of mice fed FA and FD diet as described in 
the experimental procedures. The reaction products were resolved on a sequencing gel. Uracil excision 
activity was visualized by the appearance of a 11-base fragment. The relative level of this activity was 
quantified using a Bio-Rad Molecular Imager system. The data were normalized based on the amount of 
protein used in each reaction and expressed as integrated density. Values represent an average ± S.E. for 
data obtained five mice in each group. E, The invitro G:U mismatch BER activity was conducted using 
nuclear extracts obtained from livers of mice fed FA and FD diet as described in the experimental 
procedures. The reaction products were resolved on a sequencing gel. Repair activity was visualized by 
the appearance of a 16-base fragment. The relative level of BER was quantified using a Bio-Rad 
Molecular Imager system. The data were normalized based on the amount of protein used in each reaction 
and expressed as integrated density value. Values represent an average ± S.E. for data obtained five mice 
in each group. Values with * indicate significant differences at P<0.05. FA, folate adequate: FD, folate 
deficient. PC, Positive control: NC, Negative control. 
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Figure5.4. Impact of folate deficiency on apoptosis in the liver of C57Bl/6 mice. A, Gadd45g mRNA 
expression level was quantified using real-time PCR and normalized with RPLO. B, The level of p53 
protein, in 100 µg of liver nuclear extract obtained from mice fed FA and FD diet were determined by 
western blot analysis. The levels of p53 protein were normalized with the levels of -actin. The data is 
expressed as the integrated density value corresponding to the level of each protein as quantified by a 
Bio-Rad chemiImager system and normalized to -actin. C, The level of caspase-3 activity in liver 
cytosolic extract was determined using Enzchek Caspase-3 assay from molecular probes. Values 
represent an average ± S.E. for data obtained five mice in each group. Values with * indicate significant 
differences at P<0.05. FA, folate adequate: FD, folate deficient. 
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Figure5.5. The effect of folate deficiency on the antioxidant status of the liver of C57Bl/6 mice. A, The 
level of Thioredoxin-1 (Trx-1) protein, in 100 µg of liver cytosolic extract obtained from mice fed FA and 
FD diet were determined by western blot analysis. The levels of p53 protein were normalized with the 
levels of -actin. The data is expressed as the integrated density value corresponding to the level of each 
protein as quantified by a Bio-Rad chemiImager system and normalized to -actin. B, The level of 
thioredoxin reductase activity in liver whole cell extract was determined using the assay kit from Cayman 
chemicals. The data is expressed as absorbance measured at 405-414nm. C, The level of glutathione 
peroxidase activity in liver whole cell extract was determined using the assay kit from Cayman chemicals. 
The data is expressed as absorbance measured at 340nm. Values represent an average ± S.E. for data 
obtained five mice in each group. Values with * indicate significant differences at P<0.05. FA, folate 
adequate: FD, folate deficient. 
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Figure5.6. Effect of the folate deficiency and methionine restriction on ACF formation in response to 
Dimethylhydrazine (DMH).  A, experimental design: c57Bl/6 mice were fed different experimental diets: 
folate adequate/methionine adequate (2mg/kg, foltae/8.2mg/kg of methionine, FA/MA), folate deficient 
(0mg/kg, FD), methionine restricted (1.64mg/kg, MR) and Folate deficient/Methionine restricted (0mg/kg 
folate and 1.64 mg/kg methionine, FD/MR) diet for 12 weeks. After 1 week of ingestion of the respective 
diets, mice were injected with 30mg/kg body weight of DMH for 6 weeks. Six weeks after the final 
injection, animals were sacrificed by CO2 asphyxiation. B,and C, ACF formation in the colon of mice 
from the different dietary FA/MA, FA/MA DMH, FD DMH, MR DMH and FD/MR DMH groups. The 
colons from the mice on sacrifice were processed as described in the experimental procedures. The 
methylene blue stained colons were analyzed under light microscopy to visualize the number of Aberrant 
crypts expressed as aberrant crypt foci/mouse. Values represent an average ± S.E. for data obtained five 
mice in each group. Data expressed as relative fold difference compared to FD DMH. Values with 
different superscripts indicate significant differences at P<0.05. FA, folate adequate: FD, folate deficient: 
MR, methionine restriction: FA/MA, folate adequate/methionine adequate: FD/MR, folate deficient/ 
methionine restricted: DMH, dimethylhydrazine. 
 
 
 
 
 
 
 
135 
 
 
 
136 
 
 
Figure5.7. Effect of folate deficiency and methionine restriction on the formation of DNA damages such 
as uracil misincorporation, abasic site and single strand break in response to DMH. A, DNA from the 
liver of mice from each group was isolated using DNeasy kit from Qiagen and the levels of uracil were 
measured using  UDG coupled- ASB assay as described under experimental procedures. The data are 
expressed as the I.D.V. of the band/ug of DNA loaded. B, DNA from the liver of mice from each group 
was isolated using DNeasy kit from Qiagen and the levels of uracil were measured using ASB assay as 
described under experimental procedures. The data are expressed as the I.D.V. of the band/ug of DNA 
loaded. C, Levels of single strand break was measured using fast micromethod fluorescence assay as 
described under experimental procedures. The data are expressed as fluorescence units at 538 nm.  Values 
represent an average ± S.E. for data obtained five mice in each group. Data expressed as relative fold 
difference compared to FD DMH.  Values with different superscripts indicate significant differences at 
P<0.05. FA, folate adequate: FD, folate deficient: MR, methionine restriction: FA/MA, folate 
adequate/methionine adequate: FD/MR, folate deficient/ methionine restricted: DMH, dimethylhydrazine 
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Figure5.8. . Effect of folate deficiency and methionine restriction on the expression of the enzymes in the 
BER pathway and the G:U mismatch repair activity in response to DMH. A, C, D, The levels of UDG, 
APE1/Ref-1 and -pol protein respectively, in 100 µg of nuclear extract obtained from the liver of mice 
from all the dietary groups were determined by western blot analysis. The levels of each protein were 
normalized with the levels of -actin. The data is expressed as the integrated density value corresponding 
to the level of each protein as quantified by a Bio-Rad chemiImager system and normalized to -actin. B, 
The Uracil excision activity was conducted using whole cell extracts obtained from livers of mice from all 
the dietary groups as described in the experimental procedures. The reaction products were resolved on a 
sequencing gel. Uracil excision activity was visualized by the appearance of a 11-base fragment. The 
relative level of this activity was quantified using a Bio-Rad Molecular Imager system. The data were 
normalized based on the amount of protein used in each reaction and expressed as integrated density. 
Values represent an average ± S.E. for data obtained five mice in each group. E, The invitro G:U 
mismatch BER activity was conducted using nuclear extracts obtained from livers of mice from all the 
dietary groups as described in the experimental procedures. The reaction products were resolved on a 
sequencing gel. Repair activity was visualized by the appearance of a 16-base fragment. The relative level 
of BER was quantified using a Bio-Rad Molecular Imager system. The data were normalized based on the 
amount of protein used in each reaction and expressed as integrated density value. Values represent an 
average ± S.E. for data obtained five mice in each group. Data expressed as relative fold difference 
compared to FD DMH. Values with different superscripts indicate significant differences at P<0.05. FA, 
folate adequate: FD, folate deficient: MR, methionine restriction: FA/MA, folate adequate/methionine 
adequate: FD/MR, folate deficient/ methionine restricted: DMH, dimethylhydrazine. PC, Positive control: 
NC, Negative control. 
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Figure5.9. Impact of folate deficiency and methionine restriction on apoptosis in response to DMH. A, 
Gadd45g mRNA expression level was quantified using real-time PCR and normalized with RPLO. B, 
The level of p53 protein, in 100 µg of nuclear extract obtained from livers of mice from all the dietary 
groups were determined by western blot analysis. The levels of p53 protein were normalized with the 
levels of -actin. The data is expressed as the integrated density value corresponding to the level of each 
protein as quantified by a Bio-Rad chemiImager system and normalized to -actin. C, The level of 
caspase-3 activity in liver cytosolic extract was determined using Enzchek Caspase-3 assay from 
molecular probes. Values represent an average ± S.E. for data obtained five mice in each group. Data 
expressed as relative fold difference compared to FD DMH. Values with different superscripts indicate 
significant differences at P<0.05. FA, folate adequate: FD, folate deficient: MR, methionine restriction: 
FA/MA, folate adequate/methionine adequate: FD/MR, folate deficient/ methionine restricted: DMH, 
dimethylhydrazine. 
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Figure5.10. The effect of folate deficiency and methionine restriction on the antioxidant status in response 
to DMH. A, The level of Thioredoxin-1 (Trx-1) protein, in 100 µg of cytosolic extract obtained from 
livers of mice from all the dietary groups were determined by western blot analysis. The levels of p53 
protein were normalized with the levels of -actin. The data is expressed as the integrated density value 
corresponding to the level of each protein as quantified by a Bio-Rad chemiImager system and 
normalized to -actin. B, The level of thioredoxin reductase activity in liver whole cell extract was 
determined using the assay kit from Cayman chemicals. The data is expressed as absorbance measured at 
405-414nm. C, The level of glutathione peroxidase activity in liver whole cell extract was determined 
using the assay kit from Cayman chemicals. The data is expressed as absorbance measured at 340nm. 
Values represent an average ± S.E. for data obtained five mice in each group. Data expressed as relative 
fold difference compared to FD DMH. Values with different superscripts indicate significant differences 
at P<0.05. FA, folate adequate: FD, folate deficient: MR, methionine restriction: FA/MA, folate 
adequate/methionine adequate: FD/MR, folate deficient/ methionine restricted: DMH, dimethylhydrazine. 
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Chapter 6 
Summary and Future Directions 
         Study 1:   Base excision repair is integral to the maintenance of genomic stability. Imbalance in this 
repair process results in accumulation of toxic repair intermediates which are mutagenic and would lead 
to the development of cancer. Base excision repair pathway is central in removing oxidative and 
alkylation damages. And our study on APE1/Ref-1 haploinsufficient animals has further provided support 
for the critical role played by APE1/Ref-1 during oxidative stress. We show that heterozygosity in 
APE1/Ref-1 attenuates the optimal balance between stress response factors such as NF-kB and DNA 
repair when exposed to oxidative stress. Reduction in the redox activity of APE1/Ref-1 is responsible for 
the reduced DNA binding activity of NF-kB. This loss in survival signaling leads to cell cycle arrest and 
apoptosis. This notion is supported by our data which shows increased expression of Gadd45g, a cell 
cycle arrest gene, p53 tumor suppressor protein and Caspase-3 activity, the final effecter of apoptosis. 
This study demonstrates that haploinsufficiency in APE1/Ref-1 and thereby base excision repair pathway 
will make the animal model more susceptible to oxidative stress. Furthermore, our data distinctly shows 
that APE/Ref-1 is the rate determining enzyme during bifunctional glycosylase mediated base excision 
repair and -pol is the rate determining factor during monofunctional glycosylase initiated base excision 
repair. This has important translational significance as polymorphisms in the BER genes have been 
observed within the human population. Further these findings have important implications in cancer 
therapy. Many types of tumor cells have been shown to have increased levels of APE1/Ref-1, therefore, 
knocking down APE1/Ref-1 in these cancer cells would potentially increase their apoptotic response 
which might bring about a positive outcome in cancer therapy.  
Future Directions:  Having characterized the effect of folate deficiency on -pol haploinsufficient 
animals (Cabelof, et JBC: 2004 and Lisa et al, JBC:2010)  it would be interesting to study the impact of 
folate deficiency on APE1/Ref-1 haploinsufficiency. Future studies would evaluate the development of 
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preneoplastic lesions in the colon of the haploinsufficient mice in response to a carcinogen treatment. We 
expect to see dramatic results in the APE1/Ref-1 haploinsufficient mice similar to the -pol 
haploinsufficient ones in response to 1,2-dimethylhydrazine treatment. It would be intriguing to see if 
APE1/Ref-1 haploinsufficiency also would reduce the incidence of aberrant crypt foci during folate 
deficiency and carcinogen exposure. And this study will also focus on evaluating the combined effect of 
folate deficiency and APE1/Ref-1 haploinsufficiency on the expression of genes involved in other DNA 
repair pathways and the apoptotic capacity. These studies as mentioned above will have important 
implications in the development of new strategies for cancer treatment.  
 Study 2: Our subsequent studies on folate deficiency demonstrated the impact of this dietary intervention 
on the base excision repair pathway. Our study demonstrates that folate deficiency has differential effect 
on the expression of the genes involved in base excision repair pathway. We show that folate deficiency 
regulates the expression of -pol, the key enzyme involved in the removal of uracil from DNA, at the 
level of transcription. We identified specific hot spot regions in the promoter of -pol using foot printing 
analysis which are specifically affected during folate deficiency (FARR). Further the negative regulation 
on of -pol was associated to this hot spot and through the interplay of cis-and trans-acting regulatory 
factors. Our data provide evidence for the involvement of negative- regulatory factors which keeps the 
-pol at its basal level and inhibits its DNA damage inducibility during oxidative stress. 
Future Directions: The future studies will include experimental designs to determine the negative 
regulatory factor involved in the inhibition of of -pol. We propose to isolate the negative regulatory 
complex that binds to the folate responsive region (FARR) of the of -pol promoter and further analyze it 
using the proteomics approach. And also we would perform in vitro transcription assays to establish the 
vital role played by the FARR element in -pol expression. And our future studies will also include 
experiments to determine the methylation status of the promoter of other genes involved in the base 
148 
 
 
excision repair pathway. These studies will provide more insights into mechanism by which folate 
deficiency incapacitates the DNA repair pathways.  
  Study 3: Our study on folate deficiency and methionine restriction shows that these dietary restrictions 
increase the incidence of preneoplastic lesions in the colon of mice treated with dimethylhydrazine. 
Further, our study shows that folate deficiency and methionine restriction impairs the efficiency of base 
excision repair pathway on exposure to the carcinogen. We also show that the apoptotic efficiency of the 
mouse models used is affected during these dietary restrictions and carcinogen exposure. The intriguing 
fact about these findings are that methionine restriction, an intervention established to extend life-span 
and decrease oxidative stress also showed increase in cancer incidence. Further, methionine restricted 
animals showed reduced DNA repair and apoptotic efficiency. This differential effect of methionine 
restriction could be due to the difference in dietary exposure time used by us and other labs which show 
the beneficial effects of methionine restriction. If this is true for methionine restriction, folate deficiency 
also might show differential responses when the experimental strategy is modified.  
Future Directions:: The future studies, will design an experimental strategy to provide long term 
exposure to the folate deficient diet before exposing the animals to the carcinogen. We will evaluate 
whether the long term exposure to the diet provides the animals enough time to get adjusted to the stress 
created by the dietary intervention. Further, we will determine, if this long term dietary exposure reduces 
the incidence of cancer when exposed to the carcinogen. We will also evaluate the DNA repair and 
apoptotic efficiency of this long term dietary exposure. This study will have very important implications 
as folate deficiency has been considered to be a global health concern and folate fortifications would be 
viewed with a different perspective.  
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       Folate, an essential water soluble vitamin has been implicated in the etiology of many types of cancer 
especially colorectal cancer. Folate deficiency has been reported to incapacitate DNA repair pathways and 
thereby affect the genomic stability. Our lab has reported previously and here again through this research 
that folate deficiency affects the DNA damage inducibility of base excision repair pathway. Our study 
shows the differential effect folate deficiency has on the expression of the genes involved in this pathway. 
Further, our study shows the increase in preneoplastic lesions in the colon of mice exposed to folate 
deficiency in response to dimethylhydrazine, a colon and liver carcinogen. This study further supports our 
findings from previous studies from our lab that folate deficiency increases the susceptibility to cancer by 
deregulating DNA repair pathways, base excision repair in this scenario.  Similarly, methionine restriction 
also, increases accumulation of preneoplastic lesions and incapacitates base excision repair in mice 
exposed to dimethylhydrazine. Since methionine restriction has shown to produce beneficial effects in 
laboratory rodents when the animals are exposed to long term restrictions, it would be interesting to put 
our animal models on methionine restriction and folate deficient diets for longer periods to test whether 
long term adaptations would bring about any beneficial effects.  
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